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Abstract 
 
Keratolytic winter erythema (KWE) or Oudtshoorn skin disease is a rare autosomal dominant 
skin disorder for which the genetic cause remains unknown. The disorder manifests in the 
form of erythema and hyperkeratosis of the palmar-plantar regions and has been linked to a 
1.2Mb region on chromosome 8p22-23.1 between markers D8S1759 and D8S552. A 
prevalence of 1/7200 has been observed in the South African Afrikaans-speaking white 
population with a lower unspecified prevalence occurring in the coloured South African 
population. A number of positional candidate genes within the critical region have been 
assessed for pathogenic mutations, however to date the causative gene has not been 
identified.  
The objective of the current study was to examine the KWE critical region for highly 
conserved coding and non-coding regions and copy number variants (CNV) and to determine 
if these regions may play a role in the molecular etiology of the disease. Highly conserved 
regions were identified based on sequence conservation across a range of evolutionary 
diverse organisms. These regions were further analysed for possible protein-coding gene 
structure, regulatory motifs and RNA secondary structure. In addition, a custom CGH tiling 
array (384K Roche-Nimblegen) was used to identify CNVs across the extended KWE critical 
region in both affected and unaffected individuals. The multi-species sequence alignment 
revealed eight regions that showed a high level of conservation above a 70% threshold. 
Functional analysis of two of the conserved regions led to the identification of a novel 
protein-coding gene deubiquitinating enzyme 3 (DUB3) within the critical region which 
presented as a credible functional candidate for KWE. Two of the conserved regions were 
identified within an open reading frame c8orf13 which has previously been examined and 
found to contain no pathogenic mutations that segregate with the KWE phenotype. The 
remaining four highly conserved regions were found within non-coding sequence and 
computational analysis revealed putative regulatory motifs in the form of transcription factor 
binding sites.  
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The copy number variation analysis did not show evidence for the presence of any large or 
small consistent CNV alleles likely to impact on any of the functional candidate genes in the 
KWE critical region. No common CNV alleles were observed in all of the KWE affected 
individuals examined and showed absence in unaffected family members. A significant 
variation in copy number was however observed in affected individuals within a previously 
defined copy number variable beta-defensin gene cluster which has been associated with 
psoriasis. Although the exact copy number of the cluster could not be determined in the 
present study due to the cross hybridization between genes in the family, the CNV observed 
in affect individuals for the cluster suggests that it may be involved in the modulation of the 
clinical severity of KWE. 
The present study has led to the identification of a previously uncharacterised novel gene 
DUB3 within the KWE critical region which furthermore presented as a plausible functional 
candidate for the KWE phenotype. In addition, it has revealed that the molecular cause of 
KWE is unlikely to be exclusively due to copy number variation within the genes in the critical 
region. The current study has provided valuable insight into the KWE linked critical region 
and revealed a number of potential regions of interest to be examined in further studies 
exploring the molecular cause of the disease.  
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Chapter 1. Introduction 
 
One of the underlying aims of genetic studies is being able to find sufficient evidence to link 
specific phenotypes with genotypes. The study of monogenic disorders has proven to be an 
indispensible avenue for elucidating gene function and understanding the normal 
physiological and pathological pathways in the human body. The human genome comprises 
approximately 25 000 well described protein-coding genes, a number which has been 
constantly changing in recent years due to our increased understanding of what features 
constitute a functional gene (Gerstein et al., 2007).  Prior to the completion of the human 
genome sequence, variation within these protein coding genes were identified as the 
molecular cause of several Mendelian or monogenic disorders. Although the complete 
human genome sequence and methods such as genome-wide association studies and gene 
expression studies were unknown at that stage, linkage mapping and positional cloning 
approaches were used to link specific inherited phenotypes to chromosomal intervals and 
furthermore to mutations within genes in these critical regions. In conjunction with the 
analysis of family pedigrees, changes in the DNA sequence of a gene could be correlated with 
a disease and the effect of the change in DNA on the biological function of the encoded 
protein determined. 
 
The completion of the human genome project and the availability of a human reference 
genome sequence provided much anticipation for the rapid discovery of the molecular basis 
of many more Mendelian disorders, however in the last 20 years variation in only 2912 genes 
have been found to be the underlying cause of simple Mendelian disorders 
(http://www.ncbi.nlm.nih.gov/Omim - Accessed December 2010). This represents a mere 
22% of the repertoire of known protein coding genes, with the molecular basis of almost 
1776 confirmed inherited monogenic disorders still remaining elusive (OMIM). This 
unexpected trend can be attributed to the focus of disease gene discovery in recent years 
moving away from the rare Mendelian disorders to the more common complex conditions 
such as asthma, diabetes, physiological disorders and cancers which are responsible for the 
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majority of human illness and mortality (Antonarakis and Beckmann, 2006). Although the 
identification of the molecular basis of these diseases is clinically significant, the study of 
monogenic phenotypes has provided much insight into the mutation process and 
understanding of many genetic phenomena and physiological processes. These genetic 
phenomena include uniparental disomy, parental imprinting and the discovery of 
multifactorial disorders involving the complex interaction of variation at multiple genetic loci 
and environmental factors. 
  
Classical gene discovery methods for single-gene disorders are based on the assumption that 
the dissemination of a phenotype within a family is indicative of the transmission of a defect 
in a single gene (Badano and Katsanis, 2002). The localization of this specific gene is then 
identified through the process of successive linkage mapping in affected families to identify a 
small critical interval of usually less than 1cM on a specific chromosome followed by 
screening of candidate genes with functional relevance to the disease phenotype within this 
region for pathogenic mutations. Although a simplistic approach, the genes responsible for 
many Mendelian diseases have been identified using this methodology since in most 
instances Mendelian diseases are rare and the causative gene can easily be identified if 
enough affected families are studied. An important factor in this approach however is the 
ability to link the candidate genes within the critical region to the disease phenotype. In 
many instances genes within the critical region have no known functional relevance to the 
disease or contain no pathogenic variants that segregate exclusively with affected 
individuals. In this case the identification of the causative gene becomes more challenging to 
determine. The identification of causative genes underlying simple Mendelian disorders has 
provided great insight into providing more accurate diagnostic, prognostic and potential 
therapeutic tools for many of these disorders.   
 
With the completion of the human genome project and the sequencing of the genomes of 
various other organisms our understanding of the complex structure and definition of a 
functional gene has constantly been under fundamental change. This has mainly been 
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attributed to the plethora of new laboratory techniques and bioinformatic tools being 
developed to analyse the large amount of experimental data being generated on a daily 
basis. Coupled with the discovery of complex patterns of dispersed regulatory elements 
within previously uncharacterized non-coding regions in the human genome, the operational 
definition of a functional gene has evolved significantly from simple “protein-coding regions” 
to a more complex definition. The implications for the identification of disease genes is 
therefore considerably altered since there appears to be additional functionally relevant 
regions within critical regions of the genome apart from the well characterized known 
protein-coding genes. With the availability of an extensive array of genomic sequences 
together with improved computational tools and advancements in technological platforms 
available for laboratory investigations, the opportunity now exists to extend conventional 
gene discovery methods to identify the molecular basis of many of the simple Mendelian 
disorders such as keratolytic winter erythema (KWE) for which the molecular basis remains 
unknown.     
 
Keratolytic winter erythema or Oudtshoorn skin disease is a rare autosomal dominant 
condition for which the molecular etiology remains unknown. Although it has been linked to 
a critical region on the short arm of chromosome 8 by Starfield et al. in 1997 (Starfield et al., 
1997), classical gene discovery methods have revealed no causative mutations within 
excellent positional candidate genes investigated within this region to date. Since no 
pathogenic mutations have been identified in the candidate genes within the KWE critical 
region it is possible that the molecular etiology of the disease may not be due to the 
presence of a deleterious variant within a protein coding gene that leads to a structural 
alteration of the protein’s function, but is rather as a result of a quantitative change in gene 
expression. If this is the case, the causative mutation may not lie within a previously 
characterised protein-coding gene, but instead within an element in the critical region that is 
involved in the regulation of the genes in the region. 
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1.1. Genomic approaches to identify disease genes for a monogenic disorder  
 
A vast majority of monogenic disorders occur as a result of a mutation in a single gene which 
encodes for a protein with altered functionality. Linkage mapping is the first step in the 
investigation of the molecular basis of monogenic disorders. It aims to localise the disease 
gene based on tracking the inheritance pattern of the disease within families using known 
polymorphic genetic markers, such as restriction fragment length polymorphisms (RFLP), 
microsatellites and more recently single nucleotide polymorphisms (SNP) which are known 
to vary between individuals. The positions of the genetic markers are known and allow for 
the observation of the segregation of a set of marker alleles within affected families and the 
determination of linkage to a critical chromosomal region based on a statistical process. In 
most cases, once a large critical region is defined, additional markers in the region are typed 
in order to reduce the size of the critical region by observing the inheritance of groups of 
markers or haplotypes and identifying rare informative recombination events that may lead 
to a further reduction in the size of the region. The critical region can then be defined as 
lying between specific markers for which the genomic location is known. Delineation of the 
critical region in monogenic disorders using linkage mapping alone has in previous studies 
been sufficiently accurate to identify disease genes, as was the case in the identification of 
the cystic fibrosis (Kerem et al., 1989) (Riordan et al., 1989), Fanconi anemia (Strathdee et 
al., 1992) and hemachromatosis (Feder et al., 1996) genes.  
 
In some cases however linkage mapping provides a starting point to investigate further for 
possible candidate genes. Initial linkage mapping is then followed by linkage disequilibrium 
(LD) mapping to further narrow down the region in which the disease gene must lie. LD is a 
statistical method that depends on identity by descent using single markers. In most 
instances these markers are microsatellites and the allelic associations between these 
markers and the disease are compared between affected individuals and population 
matched controls. Greater power is attained in fine mapping of a region when groups of 
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markers or haplotypes are considered simultaneously. This approach has proven successful 
in the identification of regions of the genome associated with complex disorders.  
 
Prior to the mapping of genes to the human genome the prioritisation of candidate genes 
was a laboratory intensive process which involved positional cloning to produce a physical 
map of the critical region followed by the identification of genes within the cloned DNA using 
methods such as exon trapping and CpG island mapping. These methods proved successful 
and led to the identification of disease genes in important disorders such as Duchenne 
muscular dystrophy (Koenig et al., 1988) and Marfan syndrome (Dietz et al., 1991). With the 
availability of the annotated human genome sequence these methods have been replaced by 
a variety of computational approaches for identifying and prioritising candidate genes for 
further investigation. 
1.1.1. Identification of known genes 
 
Following the completion of the human genome project all known protein coding genes have 
been mapped to the human genome and stored in online genomic databases such as RefSeq 
(http://www.ncbi.nlm.nih.gov/RefSeq/) at the National Center for Biotechnological 
Information (NCBI) and EMBL-Bank at the European Molecular Biology Laboratory database 
(http://www.ebi.ac.uk/embl/). In addition, corresponding protein sequences and additional 
structural and functional information are stored in databases such as Swissprot/Uniprot 
(http://www.expasy.org/sprot) and Protein Information Resource (PIR) 
(http://pir.georgetown.edu) with integrated protein information stored in the Interpro 
database (http://www.ebi.ac.uk/interpro). These databases contain a multitude of sequence 
and annotation data, not exclusively for the human genome but in recent years have 
expanded to include a number of genomes from an array of species as they are being 
sequenced. All genes stored in these databases have been manually curated in some 
instances and experimentally validated and therefore provide a rich resource for all known 
genes within the human genome as well as associated annotation data such as genomic and 
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full length mRNA transcript sequences, expressed sequence tags (ESTs), known 
polymorphisms and protein structures. 
 
Querying these large databases when searching for disease genes is not a trivial task, but is 
achieved through the use of online genome browsers such as Ensembl 
(http://www.ensembl.org/index.html) and the UCSC genome browser 
(http://genome.ucsc.edu/) which allow for the targeted retrieval of information from various 
databases using a specific query. Once the critical region for a disease has been determined 
by linkage analysis, a type of in silico positional cloning method can be used to identify all 
genes in the critical region using the genome browsers mentioned above. The critical region 
is usually defined by two flanking genetic markers such as microsatellites or SNPs and 
therefore all genes in the region can be obtained by using the genomic coordinates of the 
markers to view the critical region within the genome browser. 
 
 
Figure 1.1 A partial screenshot of human chromosome 8:11 317 148 - 12 786 692 from the UCSC genome browser 
showing the position of the region with respect to the entire chromosome followed by horizontal tracks representing 
RefSeq genes, mRNA transcripts, ESTs, a sequence conservation track and SNPs and repeats present in the region. Each 
item is clickable and provides a link to detailed information. (Accessed Dec 2010, NCBI36/HG18) 
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1.1.1.1Candidate gene selection 
 
In theory every gene within the critical region could possibly be responsible for causing a 
disease, however prioritisation of the genes is required as laboratory screening of a large 
number of genes can become a costly and labour intensive process. Selection of candidate 
genes is based on linking the phenotypic manifestations of the disease to known biological 
functions of proteins encoded for by genes in the critical region. This is the starting point and 
clues to reduce the list of genes further may include analysis of all genes expressed in the 
main affected tissue in the disease to determine if any are encoded for in the critical region. 
In certain cases, a single strong biological candidate is identified and can be screened for 
mutations in affected individuals. In some instances however, a single strong candidate is 
difficult to determine and genes have to be prioritized for further analysis.  
 
Although this approach has successfully been implemented to identify many disease 
associated genes, in some instances no promising candidate genes linked to the phenotype 
may be present in the critical region or not enough is known about the etiology of the 
disease to identify a functional candidate. In these cases although it may be more costly and 
labour intensive, an option is to screen all genes within the critical region for mutations if the 
number of genes is not too large. In both scenarios, screening of the genes may lead to no 
significant functional mutations being identified. At this point the exploration of novel genes 
or other functional elements in which the disease causing mutations may reside is the next 
option to identify the disease gene.  
 
Current advancements in computational tools aimed at providing a deeper insight into the 
understanding and identification of all functional elements of the human genome have 
presented a vast new set of genomic elements that may be involved in monogenic disease 
pathology apart from mutations within well known protein coding genes. These genomic 
elements have been found to be involved with the direct regulation of known protein coding 
genes via a number of different mechanisms. With the abundance of genomic sequences 
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that have been generated in recent years, emphasis has been placed on developing efficient 
tools to annotate and characterize these unknown functional regions of the genome. 
Comparative sequence analysis of distantly related species has proven to be an extremely 
useful tool in the study and identification of evolutionarily functional regions in the human 
genome (Loots et al., 2000; Woolfe et al., 2005). 
 
 According to the Human Gene Mutation Database (HGMD) at the Institute of Medical 
Genetics in Cardiff (http://www.hgmd.cf.ac.uk/ac/ - Accessed December 2010) the majority 
of disease phenotypes identified to date are due to mutations within protein coding genes 
with a relative frequency of 56%; however regulatory elements account for just under 2 % 
(Table 1.1). Interestingly the relative frequency of mutations contributing to disease within 
regulatory elements is slightly greater than that of small indels (1.47%) and gross 
insertion/deletions (1.34%), while small deletions account for the second highest percentage 
of mutations at 16%. 
Table 1.1 Relative frequency of different types of mutations underlying disease phenotypes 
Mutation Type Number  Percentage of Total 
Missense/Nonsense 58984 56.10 
Splicing 9969 9.48 
Regulatory 1873 1.78 
Small Deletion 16497 15.69 
Small Insertion 6802 6.47 
Small Indels 1545 1.47 
Repeat Variations 328 0.31 
Gross insertions/duplications 1414 1.34 
Complex rearrangements 1014 0.96 
Gross deletions 6709 6.38 
Total 105135  
Data from the Human Gene Mutation Database – Accessed December 2010 
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1.1.2 Identification of novel genes and regulatory elements using comparative genomics 
 
Comparative sequence analysis or the broad field of comparative genomics was born out of 
the development and success of high throughput sequencing technology. The ability to 
rapidly generate the complete DNA sequence of various organisms has spawned a 
movement away from the focus of traditional molecular genetics. We are now able to 
generate large amounts of data, and the emphasis has been placed on developing efficient 
ways to annotate and provide meaning to this data. Currently the complete or first assembly 
version for 56 vertebrate genome sequences is available via the Ensembl web browser 
(http://www.ensembl.org, Accessed December 2010). The systematic comparison of 
genomic sequences from different organisms forms the basis of the field that is comparative 
genomics. Comparative sequence analysis is based on the premise that functional regions of 
a genome are under selective pressure to remain unchanged and therefore should display a 
higher level of conservation across a wide range of species when compared to non-functional 
regions (Pennacchio and Rubin, 2001; Margulies et al., 2003). Comparative genomic 
approaches are now central to many areas of genomic research and exploratory studies.  
Ultimately comparative sequence analysis aims to interpret and identify all functional 
regions within the human genome. The first comparative analysis was conducted with the 
human, mouse and rat genome sequences and it was found that approximately 5%-6% of the 
sequences were under selective constraints and therefore likely to have a functional role 
(Waterston et al., 2002; Gibbs et al., 2004). Of this 5%-6% only 1-2% is accounted for by 
protein-coding genes (Waterston et al., 2002). The remaining 4%-5% of conserved sequence 
corresponds to proposed functional non-coding regions, whose function remains to be 
elucidated. The comparison of orthologous genomic sequences has thus proven to be a 
powerful tool in the identification of both coding(Pennacchio and Rubin, 2001; DeSilva et al., 
2002; Flicek et al., 2003) and non-coding (Dubchak et al., 2000; Wasserman et al., 2000; Kellis 
et al., 2003; Wasserman and Sandelin, 2004) functional elements in the genome. The non-
coding regions of interest are those that are thought to be involved in the regulation of gene 
expression and therefore may be involved in disease (Hardison, 2000).  
- Introduction - 
10 
 
1.1.2.1 Highly Conserved Regions  
The power of comparative sequence analysis is based on the ability to accurately and 
robustly align genomic sequences. Much effort has been placed into the development of 
algorithms to align long stretches of genomic sequences from a number of organisms and 
produce a meaningful visualization of the results. These algorithms aim to indentify 
conserved regions across multiple orthologous sequences in a manner that considers; a) the 
phylogenetic diversity of the originating species and therefore the general variation in 
sequence conservation, b) the varying neutral substitution rate for different genomic regions 
and c) the characteristics of the generated genomic multi-sequence alignment (Margulies 
and Green, 2003). The power of multi-species sequence alignments to identify highly 
conserved regions, as opposed to pairwise alignments, lies in the fact that the more 
evolutionarily distant organisms are, the lower the fraction of alignable sequence.  
Conserved regions identified in a multi-species sequence alignment with organisms as 
distantly related to humans as the fish and frog are therefore likely to be of more functional 
relevance than those regions conserved only in closely related mammals such as the mouse 
or chimp (Margulies et al., 2006). 
 Multi-species sequence alignments have therefore proven to be the most accurate and 
robust method by which to identify highly conserved regions in evolutionarily distant 
organisms that may be under active selective pressure to remain unchanged due to the 
presence of some unknown biological function (Margulies et al., 2006). Studies comparing 
the power of multiple sequence alignments to pairwise alignments on a defined genomic 
region revealed that a significantly lower percentage of highly conserved sequences were 
identified in humans when compared to pairwise alignments (Margulies et al., 2006). Many 
of these regions corresponded to known coding exons and UTRs. This suggests that more 
accurate and functionally relevant regions are indentified by multiple sequence alignments. 
Multi-species sequence alignment is a powerful tool for the identification of functional 
regions in the human genome whose discovery is difficult to elucidate from experimental 
methods (Hardison, 2000; Pennacchio and Rubin, 2001). With the availability of a large 
number of sequences from a diverse array of organisms there have been several recent 
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efforts to produce whole genome alignments across a range of species as well as develop 
efficient alignment algorithms and visualization tools to identify highly conserved regions. 
1.1.2.2 Conservation versus Functionality 
 
The vast majority of comparative studies have identified consistently high levels of 
conservation within coding exons of genes (Thomas et al., 2003). As much as 40% of the 
human genome can be aligned with the mouse genome and this percentage consists of both 
coding and non-coding sequences (Waterston et al., 2002; Schwartz et al., 2003). It is 
therefore unlikely that all of the non-coding homologous regions are conserved solely due to 
chance. It is widely accepted that non-coding regions displaying high levels of sequence 
conservation must be under selective pressure to remain the same due to functional 
constraints.  As previously mentioned about 5% of the human genome is under purifying 
selection and therefore these regions must be involved in important functional processes.  
The idea of conservation correlating to functionality is still under much debate as the 
constraint exerted on non-coding regions is difficult to quantify (Cooper et al., 2005). 
Previous studies have demonstrated that non-coding regions are under constraint and 
therefore purifying selection operates to ensure that they remain unchanged (Dermitzakis et 
al., 2003; Margulies et al., 2003; Cooper et al., 2005; Cooper and Brown, 2008). The 
challenge is determining the measure of constraint exerted on a specific non-coding 
sequence in order to have confidence in its functional relevance and filter out regions that 
should be considered as “comparative noise” (Thomas et al., 2003; Cooper and Brown, 
2008).   
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1.1.2.3 Assessing functionality of highly conserved regions 
 
Gene regulation was first described by Jacob and Monod (1961) in the lac operon of E.coli 
(Jacob and Monod, 1961). The operon consisted of a region of DNA termed the promoter, to 
which the RNA polymerase binds and a region called the operator to which regulatory genes 
bind (Jacob and Monod, 1961). Further studies revealed a range of other sequences which 
could affect every aspect of gene regulation, from transcription to mRNA degradation and 
post-translational modifications. These regions are found within coding sequences, flanking 
coding regions or may be far away from any known functional element (Gerstein et al., 
2007). Regions found far away from known coding regions are known as enhancers, 
repressors or silencers and can directly affect the expression of distant genes due to the 
complex 3 dimensional folding of the chromatin structure. Regulatory elements therefore 
play an integral role in the expression of most genes, although they are not formally included 
in most of the definitions of a gene (Gerstein et al., 2007). Woolfe and colleagues showed 
that sequences within highly conserved regions are involved in vertebrate development in 
humans (Woolfe et al., 2005), while Nobrega et al. identified long range enhancers within 
non-coding gene desert regions of the human genome (Nobrega et al., 2003).   
Non-coding regions that exhibit high levels of sequence conservation in humans across 
multiple sequence alignments are of great interest since this suggests that they are under 
active selective pressure to remain unchanged and are therefore likely to be of functional 
relevance (Pennacchio and Rubin, 2001; Boffelli et al., 2003; Ghanem et al., 2003). These 
regions are therefore potential novel genetics elements that may be involved in important 
biological functions but have not yet been characterised and experimentally validated. There 
are several possible regulatory elements that these highly conserved regions may encode 
for, including those involved in the spatial and temporal expression of known genes. These 
regulatory elements include conserved RNA structures, transcription factor binding sites, 
promoter regions, enhancers and silencers, CpG islands and unidentified ORFs. These 
regions, like known protein coding genes have the potential to harbor disease causing 
mutations.  
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In an effort to facilitate the characterization of highly conserved regions, several prediction 
algorithms have been developed to identify signatures associated with regulatory genomic 
elements. These algorithms aim to identify motifs and sequence signatures known to be 
associated with regulatory elements. 
1.1.2.4 Transcription factor binding sites and promoter regions 
 
The DNA consensus target sequences for many transcription factor binding sites are known 
and available in publically accessible databases such as TRANSFAC (Matys et al., 2003). These 
databases can be searched to identify potential transcription factor binding sites in a DNA 
sequence. Although most of these transcription factor binding sites are unique, many posses 
a small invariant core sequence surrounded by a number of degenerative nucleotides. This 
leads to a very high false positive discovery rate when searching the database with small 
individual sequences, although in recent years methods have been introduced to reduce this 
through the use of position-specific weight matrices (Matys et al., 2003). These database 
searches can reveal if there are motifs within a highly conserved sequence that is recognized 
by a specific transcription factor.  
 
Promoter prediction databases such as the Eukaryotic Promoter Database, contain well 
annotated, RNA polymerase II promoters for which the transcription start sites have been 
determined experimentally (Perier et al., 2000). These sequences have been found 
immediately upstream of transcription start sites in known genes and can be searched to 
identify if a particular sequence shares common regions with known promoter regions. In 
contrast to the identification of transcription factor binding sites, it cannot be used to 
identify distant regulatory elements. 
CpG islands are short stretches of DNA in which the frequency of CG nucleotides is higher 
than expected in the rest of the genome. Most of the Cs of the CG dinucleotide are 
methylated in the human genome. Unmethylated CpG islands are found at the 5’ end of 
several housekeeping genes and other regulated genes (Bird, 1986; Larsen et al., 1992). It 
has been shown that up to 56% of known human genes are associated with one or more CpG 
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island (Antequera and Bird, 1993).  Methylated CpG islands are able to regulate expression 
since they have been linked to inactive genes, while unmethylated CpG islands promote gene 
expression. CpG islands may undergo selective pressure to remain unchanged in regions 
within close proximity of genes and in particular close to promoter regions. Software 
programs have been developed to identify CpG - rich DNA or CpG islands within genomic 
sequences.   
1.1.2.5 Non-coding RNA genes     
 
Non-coding RNA (ncRNA) genes are usually extremely difficult to identify, however their role 
in the regulation of genes via complex pathways has been well documented in recent years 
(Eddy, 2001; Mattick and Makunin, 2006). The first description of small, non-coding RNA 
mediated regulation of gene expression was observed in the Caenorhabditis elegans gene 
lin14 which was found to be regulated by the lin 4 gene product (Lee et al., 1993). Due to 
their lack of codons and no distinct ORF ncRNAs contain no distinct characteristics at the 
DNA sequence level.  Comparative genomic analysis is therefore a powerful tool aimed at the 
identification of ncRNAs since these regions should be under selective pressure to remain 
unchanged (Frazer et al., 2003; Schwartz et al., 2003). Although no known sequence motifs 
are found within ncRNAS, the structural constraints of specific ncRNAs, such as characteristic 
pre-cursor secondary structure formation can be used to predict if a particular sequence is 
likely to be a ncRNA gene (Washietl et al., 2005). A program such as QRNA is able to identify 
possible RNA genes and is also able to detect regions of pre-miRNA, and mRNA predicted to 
have a conserved secondary structure, which may be involved in splicing, translational 
regulation, or mRNA localization or degradation (Rivas and Eddy, 2001).  
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1.2 Copy number variation 
 
 Comparative genomic approaches have revealed that the sequence of the human genome is 
thought to be about 99.9% identical among individuals in the world (Reich et al., 2002). This 
genetic variation occurs in the form of single nucleotide changes, variable repeat regions and 
microscopically visible chromosomal aberrations. In recent years an additional type of 
genetic variation in the form of copy number variants (CNVs) has been added to the list of 
phenomenon that differentiates us from each other at the DNA level (Sebat et al., 2004; 
Freeman et al., 2006; Redon et al., 2006; Sharp et al., 2006). CNVs are submicroscopic 
variations of DNA segments ranging from kilobases to megabases in size and include 
deletions, insertions, duplications and complex multi-site variants (Sebat et al., 2004; Sharp 
et al., 2006). These CNVs are found in all humans and can be as simple as tandem 
duplications or may include complex duplications or deletions of homologous sequences at 
several sites in the genome (Redon et al., 2006).  
Basic human cytogenetics techniques were the original means by which to study and identify 
variation in whole chromosome copy number, rearrangements and other structural 
abnormalities.  Microscopic chromosomal aberration could be efficiently identified and 
several chromosomal disorders were associated with these variants including Down’s 
syndrome and various other congenital abnormalities (Kunze, 1980).  The identification of 
submicroscopic CNVs was born out of the development of whole genome scanning 
techniques such as comparative genomic hybridization (CGH) arrays, which allow for the 
interrogation of the entire genome at a resolution higher than that of traditional cytogenetic 
techniques. 
1.2.1 Identification of copy number variants  
 
CGH is a classical cytogenetics technique used for comparing copy number of differentially 
labeled test and normal DNA using fluorescent in situ hybridization onto metaphase cells of a 
normal individual (Kallioniemi et al., 1996). Measurement of the fluorescence ratios across 
the entire chromosome gives an indication of the relative gain or loss in the test sample. 
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Array CGH (aCGH) is based on the same principle; however the differentially labeled test and 
normal DNA are hybridized together to arrays containing clones or synthesized probes 
covering the entire genome at a defined resolution or a specific region of interest.   
Following the development of DNA array technologies several studies were conducted to 
analyse genome wide copy number variation. A genome-wide study identified 1 500 regions 
that showed variation in copy number, which included several genes and 360Mb of sequence 
(Redon et al., 2006). Another study revealed that several known disease-associated genes 
flank or fall within CNV regions with 58% overlapping with RefSeq genes and more than 99% 
overlapping with conserved non-coding sequences (Drake et al., 2006). A study conducted in 
a cohort of 60  patients with a history of pancreatic cancer identified 50 CNVs associated 
with the cancer (Lucito et al., 2007). A more focused study looked at copy number variation 
within 15 genes linked to schizophrenia; however no significant associations were identified 
(Sutrala et al., 2007).   
CNVs, like other genetic variants, possess the potential to be benign or harmful depending 
on the region in which the variation occurs. CNVs can have a direct effect on the functioning 
of a nearby gene via at least five possible mechanisms and in some cases lead to disease. The 
first is dosage sensitive genes in which a CNV leads to the deletion or duplication of an entire 
gene. In addition, dosage insensitive genes can also be affected by CNVs if the deletion of 
one copy of a gene unmasks a recessive mutation on the homologous chromosome. 
Secondly dosage sensitive genes that overlap CNV regions can be disrupted by transversions, 
translocations or deletions resulting in reduced expression of that gene. Thirdly CNVs that 
are distant from dosage sensitive genes may occur within regulatory regions and alter 
expression the associated gene, or the inversion or translocation of a regulatory region may 
result in the aberrant expression of another gene. Lastly CNVs could function as susceptibility 
alleles, where the accumulation of multiple variants contributes to a disease phenotype 
(Feuk et al., 2006). Therefore CNVs can directly affect or alter gene expression through 
positional effects and lead to disease phenotypes. 
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1.2.2 CNVs and disease 
 
With the advent of more efficient microarray technologies, the examination of the effect of 
CNVs in human disease has increased dramatically. In the field of cancer genetics the 
identification of CNVs within tumour cells has proven to be a powerful tool to predict tumour 
origins and aid in prognosis. This is attributed to the fact that in many tumour cells 
aberrations are known to affect tumour suppressor genes and oncogenes whose expression 
levels are altered by DNA copy number changes (Pollack et al., 2002; Pinkel and Albertson, 
2005). The increased resolution of aCGH allows for the detection of deletions and 
duplications within tumour cells that were missed using classical cytogenetic techniques 
(Costa et al., 2008). A study conducted by Ruiz et al. in non small cell lung cancer (NSCLC) 
tumours using a combination of aCGH and expression arrays revealed a deletion of 
chromosome 14q23 together with reduced expression of HSP90 which was encoded in the 
deleted region (Gallegos Ruiz et al., 2008). Interestingly however, the reduced expression of 
HSP90 correlated with increased survival in affected individuals and HSP90 inhibitors were 
found to have an anti-proliferative effect on tumour cells in vitro and led to the discovery of 
a novel drug target which has entered clinical testing (Gallegos Ruiz et al., 2008; Ruiz et al., 
2008). de Wilde et al. showed that distinctive gains and losses observed from whole genome 
aCGH arrays could be used to accurately distinguish between positive and negative high risk 
human papiloma virus infected tumours in head and neck squamous cell carcinoma samples, 
aiding in the prediction of later stage progression of the tumours (de Wilde et al., 2008).  
In addition to cancer studies, CNVs have begun to emerge as causal elements in simple 
Mendelian disorders. Gene deletions may not only be responsible for autosomal dominant 
conditions due to haploinsufficiency, but also cause autosomal recessive conditions in the 
presence of mutations inactivating the second allele. Balikova et al. identified one of the first 
Mendelian disorders to be caused by a tandem duplication of a 750kb region on 
chromosome 4 in individuals affected with an autosomal dominantly inherited syndrome 
characterized by microtia (deformity of the outer ear), eye coloboma (hole in one of the eye 
structures) and imperforation of the nasolacrimal duct (Balikova et al., 2008). The duplicated 
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amplicon encompasses a low copy region containing a cluster of olfactory receptor and 
defensin genes known to be variable in the studied population, however the exact amplicon 
of five tandem repeats was not identified in any control samples. Duplications can be 
responsible for monogenic disease by dosage effect when the gene and its regulatory 
sequences are duplicated in their entirety, but intragenic duplications can also lead to 
haploinsufficiency and to recessive disorders. This phenomenon was demonstrated by 
Thienpont et al. who identified a large intragenic duplication within the ATRX gene in ATR-X 
syndrome patients which resulted in a disruption of the transcription of the gene and the 
absence of ATRX mRNA and protein (Thienpont et al., 2007). 
CNVs have been observed on chromosome 8p23.1 within the region of the beta-defensin 
gene family cluster containing DEFB4, SPAG11, DEFB103, DEFB104, DEFB105, DEFB106 and 
DEFB107 (Hollox et al., 2003; Linzmeier and Ganz, 2005). This large repeat cluster shows copy 
numbers of between 2 and 12 in individuals in the UK (Hollox et al., 2003). Increased copy 
number of the beta-defensins within this repeat region has been linked to an increased 
susceptibility to the inflammatory skin disorder psoriasis in individuals of Dutch descent 
(Hollox et al., 2008). Another study found increased copies of the 360kb variable defensins 
region as well as expansion of the olfactory receptor repeat and duplication of the GATA4 
gene were linked to developmental delay and heart defects (Barber et al., 2005; Barber et 
al., 2008). The region of chromosome 8p23.1 is a structurally diverse region mostly due to 
the presence of repeat elements which makes the region prone to genomic rearrangements. 
Since the KWE critical region contains the proximal olfactory receptor repeat, it is possible 
that copy number variants may be present within this region and the surrounding genomic 
sequence.    
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1.3 Gene regulation and disease 
 
Differential control of gene expression is one of the most important mechanisms to regulate 
gene function during development and overall homeostasis in the human body. Regulatory 
DNA regions act as switches to control whether genes are switched on or off in particular cell 
types and regulate gene expression levels to adapt to changing environments and 
physiological conditions (Strahle and Rastegar, 2008). Gene expression can be regulated at 
any of the seven possible control steps which include chromatin structure, initiation of 
transcription, processing of a transcript, transport to the cytoplasm, translation of mRNA, 
mRNA stability and protein activity stability (Villard, 2004). One of the main steps at which 
gene expression is regulated is initiation of transcription, which is mediated by trans-acting 
transcriptional activators or repressors (transcription factors) that bind to cis-acting 
regulatory recognition sites within close proximity or at a distance from a gene resulting in 
either an increase or decrease in transcription . Comparative genomic approaches have led 
to the realization that regulatory regions are usually highly conserved and many studies have 
shown that mutations in these regulatory regions can lead to dysregulation of linked gene 
products and in some cases may lead to disease. A genome-wide study by Stranger et al. 
examined the association of the transcriptional profiles of the 270 individuals in the four 
HapMap populations and 2.2 million common SNPs and identified 1 348 genes associated 
with cis regulatory signals (Stranger et al., 2007). The study revealed that SNP variants that 
lie close to genes, within regions usually involved in gene regulation, could possibly 
dramatically affect gene activity and be involved in disease.  
1.3.1 Promoter mutations and transcriptional control of gene expression  
 
Mutations in the human transcription factor GLI3, are known to cause a variety of 
developmental defect syndromes including Greig cephalopolysyndactyly syndrome (GCPS) 
(Kalff-Suske et al., 1999), Pallister-Hall syndrome (PHS) (Kang et al., 1997), postaxial 
polydactyly type A (PAPA) (Radhakrishna et al., 1997). GLI3 is a key transcription factor 
during early development and is a primary transducer of Sonic hedgehog (SHH) signaling 
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which is responsible for multiple patterning steps during early development. A comparative 
analysis of the GLI3 gene from the pufferfish (Takifugu rubripes) to human revealed 11 
conserved non-coding regions within the intronic regions of the gene which are required for 
full scale transcriptional activation of the gene (Abbasi et al., 2007). Although expression of 
the gene was still activated when these conserved regions were deleted, the levels observed 
were not as high as the wildtype gene and indicated that these conserved regions were 
necessary for complete transcriptional activation of GLI3 and may also harbor mutations that 
lead to the above mentioned syndromes. These 11 regulatory regions were observed within 
intronic regions of the gene; however it was shown that they directly regulate spatial and 
temporal expression of GLI3.  
Ward et al. used a comparative genomics approach to indentify putative transcriptional 
regulatory elements in the non-coding region of the Prop1 gene which is known to cause 
familial multiple pituitary hormone deficiencies (MPHD) (Ward et al., 2007). Although a 
majority of MPHD cases are caused by mutations in the protein coding regions of Prop1 or an 
associated gene important for pituitary development, in some case no mutations have been 
detected in these genes. Three highly conserved putative regulatory non coding regions were 
identified by cross species sequence alignments of the extended gene sequence. Two of the 
regions were within the proximal promoter region of the gene within the first intron and 
another downstream of Prop1 (Ward et al., 2007). All three regions were found to directly 
affect the spatial and temporal expression of the gene and therefore identified as an 
additional intronic region that should be screened for mutations in MPHD cases.  
In addition to regulatory regions that lie within close proximity to the genes they regulate, 
regulators of gene expression may lie significantly far away from their gene targets. A 
combinatorial application of aCGH and the identification of evolutionarily conserved 
sequences was used to identify a long range regulator of the sonic hedgehog gene (SHH) 
(Klopocki et al., 2008). SHH plays an important role in defining the anterior-posterior axis of 
developing limbs. Point mutations in a region upstream to the SHH gene (termed ZRS) have 
been linked to triphalangeal thumb-polysyndactyly syndrome (TPT-PS), also called preaxial 
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polydactyly type II (PPD-II) which is  a well defined autosomal dominant disorder that has 
been described in several families (Lettice et al., 2003). Further analysis of the region 
revealed that it was highly conserved in vertebrates with limbs and absent from those 
without  limbs and was therefore characterized as a long range cis-regulatory element of 
SHH approximately 1Mb upstream of the gene within an intron of another gene  LMBR1 
(Limb region 1 homolog) (Gurnett et al., 2007).  A later study of a large family with variable 
TPT-PS which showed linkage to the same region revealed no mutations within ZRS and a 
whole human genome tiling path bacterial artificial chromosome (BAC) array of the region 
revealed a duplication of the region encompassing ZRS in affected individuals (Klopocki et al., 
2008). This microduplication encompassing the regulator element ZRS leads to the same 
phenotype observed with the point mutations in the region and therefore is an additional 
mechanism by which long range regulation of genes may occur. 
Glycosylphosphatidylinositol (GPI) deficiency is an autosomal recessive disorder which is 
caused by mutations within the PIGA gene. A point mutation 270bp upstream of the PIGA 
start codon was identified in two affected individuals and found to disrupt binding of the 
transcription factor SP1 to it promoter motif resulting in reduced transcription and GPI 
deficiency (Almeida et al., 2006). Familial hypercholesterolemia (FH) is an autosomal 
dominant disorder caused by mutations in the low density lipoprotein receptor gene (LDLR) 
which leads to a reduced clearance of plasma cholesterol from the body and increased risk of 
artherosclerosis and coronary heart disease. A vast majority of cases are caused by 
mutations within the coding region of the gene, however mutations have been observed 
27bp and 60bp upstream of the transcription start site of the gene that have shown 
significant reduction of LDLR and only occur in affected individuals (Francova et al., 2004). 
Congenital erythropoietic porphyria (CEP), also known as Günther disease, is an autosomal 
recessive inborn error that results from the markedly deficient, but not absent, activity of the 
fourth enzyme in the hemebiosynthetic pathway, uroporphyrinogen III synthase (URO-
synthase gene). Mutation analysis of the URO-synthase gene in CEP patients indentifies 
pathogenic mutations in 85-90% of cases; however in the remainder of cases only a single 
causative mutation has been identified (Desnick et al., 1998). Further analysis of the 
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sequence upstream of the transcription start site of the gene revealed four novel mutations 
clustered in a 20bp region that resulted in decreased expression of the URO-synthase gene 
and thus were identified as pathogenic mutations causing CEP (Solis et al., 2001). 
 
In addition to disease causing mutations being identified in regulatory regions, mutations 
within regulatory regions have been found to be associated with altered susceptibility and 
progression of diseases. In human immunodeficiency virus-type1 (HIV-1) a variant within the 
promoter region of the CCR5 gene has been associated with increased progression to AIDS in 
HIV affected cohorts (Martin et al., 1998). The CCR5 gene encodes a cell surface chemokine 
receptor molecule that interacts with the CD4 co-receptor of macrophages and allows entry 
of the virus into the cell. The presence of this particular homozygous variant called CCR5P1 
has been shown to be associated with faster progression to AIDS in three independent 
cohorts and therefore must, via some mechanism, result in an over expression of the CCR5 
receptor causing an increased rate of infection of macrophages by the virus. To date a 
number of additional mutations in the CCR5 promoter region of HIV-1 has been identified 
that alter progression of HIV to AIDS (McDermott et al., 1998; An et al., 2000; Knudsen et al., 
2001). 
 
1.3.2 RNA mediated gene regulation  
 
Micro RNAs (miRNAs) are a class of small non-coding duplex RNAs 21-24 nucleotides in size 
which normally function as negative regulators of target mRNA expression at the 
posttranscriptional level. They regulate translation of target mRNAs by binding to the 3’ 
untranslated region (UTR) resulting in target cleavage or translational inhibition (Ambros, 
2004; Meister et al., 2004). miRNAs have also been shown to possess the functional ability to 
be positive regulators of gene expression in some instances (Vasudevan et al., 2007). The 
mechanisms by which miRNAs regulate gene expression are extremely complex, however a 
significant amount of information relating to miRNA processing and targeting and the 
phenomenon of RNA interference (RNAi) has been discovered since Fire and Mello and 
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colleagues identified the first double stranded RNA molecule responsible for post 
transcriptional gene silencing in Caenorhabditis elegans (Fire et al., 1998).  
 
An abundance of functional miRNAs accounting for up to 5% of the human genome have 
been identified to date and act as key regulators in important biological processes such as 
cell growth, tissue differentiation, cell proliferation, embryonic development and apoptosis. 
Since the discovery of miRNA and the uncovering of their cellular mechanisms and functions, 
it has been shown that like conventional protein coding genes, mutations within these RNA 
genes can lead to various diseases via direct alteration of the expression of miRNAs and 
subsequently that of their gene targets. To date almost 230 diseases have been associated 
with miRNAs (http://cmbi.bjmu.edu.cn/hmdd, Accessed December 2010). miRNA gene 
silencing has therefore emerged as a key mechanism required for cellular maintenance and 
homeostasis. Like protein-coding genes and known regulatory regions, sequence variations 
within miRNA are likely to have a phenotypic effect and contribute to disease susceptibility if 
they perturb core components of the gene silencing machinery by altering the structure and 
expression levels of miRNA or target sites.   
 
There exist two main classes of small RNAs that are involved in RNAi, small interfering RNAs 
siRNAs and miRNAs. In mammals, RNAi is mostly mediated by miRNAs which are 21-24 
nucleotide duplexes incompletely base paired and form partial duplexes with the 3’ UTR of 
targeted gene transcripts via an association with a complex structure of proteins termed the 
RNA-induced silencing complex (RISC) (Rana, 2007). miRNAs are the final product of a 
multistep process that begins with the generation of a primary miRNA transcript (pri-miRNA) 
which forms a hairpin structure containing one or more miRNA precursor. Their functional 
role is to inhibit mRNA translation and thereby regulate expression of their gene targets. 
 
 A number of miRNA genes are located in clusters within the human genome, with the 
largest being found on chromosomes 13q31.3 and 14q32.31. A miRNA cluster found on 
13q31.3 has been associated with colorectal and lung cancer and the target is thought to be 
- Introduction - 
24 
 
an oncogene that enhances cell proliferation (Lanza et al., 2007; Matsubara et al., 2007). The 
largest known miRNA cluster is located at the imprinted Dlk1-Gtl2 domain on chromosome 
14q32.31 containing 35 potentially expressed miRNAs within a miRNA containing gene (Mirg) 
(Tierling et al., 2006). This region has been found to be highly conserved between the human 
and the mouse genomes and contains a number of paternally imprinted genes which are 
expressed only from the maternal chromosome. The miRNAs encoded in this region are 
thought to play an important role in the regulation of imprinted genes within this region 
(Davis et al., 2005). 
 
Although miRNAs are known to play an important role in gene regulation, the effect of 
mutations within these transcripts is still poorly understood. It is possible that 
polymorphisms which lie within regions important for formation of the pri-miRNA or target 
sequence may disrupt the function or processing of the miRNA. A study in which 173 known 
miRNAs were sequenced in 96 Japanese individuals indentified 10 SNPs in total. A single SNP 
mapped to a mature miRNA, miR-30c-2, which was likely to affect interaction of the miRNA 
with its target (Iwai and Naraba, 2005). Calin et al. identified a transition in the miR-16-1 
precursor in two individuals with chronic lymphocytic leukemia which resulted in reduced 
expression levels of miR-16-1 in tumours. This SNP was not observed in 160 control subjects 
screened and reduced expression of the miRNA is thought to result in promoting cell 
proliferation (Calin and Croce, 2007). Many miRNAs have been found to be expressed at 
significantly lower levels in tumours, suggesting that they play an integral role in controlling 
cell proliferation and preventing tumorigenesis (Michael et al., 2003). 
 
As previously mentioned, sequence variation within functional target sites of miRNAs may 
also lead to altered interaction with the miRNA.  The first evidence that mutations in target 
sites can lead to an altered phenotype was observed in the study of Tourette’s syndrome. 
The gene SLITRK1 (Slit and Trk-like family member 1) was found to contain a frameshift 
mutation, which resulted in a truncated protein together with a G to A transition within the 
3’ UTR of the gene which was absent in healthy controls. Further analysis of the variant 
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revealed that it changed a G:U wobble match with a A:U match possibly facilitating the 
binding of miR-189 and accentuating the downregulation of SLITRK1.  The mutation within 
the target gene was responsible for stabilizing the interaction between miR-189 and reducing 
expression of SLITRK1, thereby having a direct role in causing Tourette’s syndrome (Abelson 
et al., 2005). Beetz et al. identified two point mutations in the 3’ UTR of the gene encoding 
receptor expression –enhancing protein 1 (REEP1) in individuals suffering with hereditary 
spastic paraplegia. Mutations within REEP1 have been observed in affected individuals. The 
3’ UTR mutations were observed within a highly conserved segment that showed exact 
complementarity to miR-140, known to be expressed in the central nervous system. One of 
the three mutations resulted in a change from a G:U wobble match to a A:U match possibly 
stabilizing the interaction between the miRNA and the target and therefore could result in 
downregulation of REEP1 causing the disease (Beetz et al., 2008). 
 
Several studies are now focused on the examining the role of miRNA genes in disease using 
high throughput arrays to analyse global miRNA expression in clinical samples, however as 
previously mentioned and noted in the examples above many of these functional miRNAs 
are evolutionarily conserved and can be identified using a comparative genomics approach. 
A number of these global miRNA expression studies are however providing insight into tissue 
specific miRNA profiles as well as identifying novel miRNAs.  A recent study identified the 
first known skin-specific miRNA, miR-203, which was found to be expressed at the highest 
level in skin and over expressed in patients with the most common chronic inflammatory skin 
disease, psoriasis (Sonkoly et al., 2007). One of the targets of miR-203, cytokine signaling-3 
(SOCS-3), which is a negative regulator of the STAT3-pathway which is activated by 
inflammatory cytokines and has important functions in the regulation of both innate and 
adaptive immunity  as well as cell growth, survival and differentiation (Kubo et al., 2003). The 
over expression of miR-203 leads to decreased SOCS-3 levels and sustained activation of the 
STAT3 pathway resulting in prolonged skin inflammation in psoriasis patients. Although the 
over expression of miR-203 has been observed in psoriasis patients, the driving force behind 
the increased expression is yet to be identified. In addition to miR-203 a number of other 
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miRNAs exhibit altered expression levels in psoriasis and are implicated in the innate 
immune response (Sonkoly et al., 2007).  
1.4 Keratolytic Winter Erythema 
 
Keratolytic winter erythema (KWE) (OMIM 148370) is a rare autosomal dominant disorder 
which results in the epidermal keratinization and peeling of the skin of the palmar and 
plantar regions of affected individuals. Symptoms of the disease appear to be aggravated in 
the colder winter months as well as during seasonal changes. The disease was first observed 
and described by Findlay et al. (1977) in a group of South Africans residing in the small town 
of Oudtshoorn. The localized occurrence of this disease led to the belief that the disease was 
unique to South Africa and it initially became known as ‘Oudtshoorn skin disease’ or 
‘Oudtshoorn Vel’. Following the discovery and phenotypic characterization of the disease by 
Findlay, several cases were also observed in German families (Krahl et al., 1994; Starfield et 
al., 1997). Initially it was thought that KWE was unique to South Africa, however other cases 
were subsequently described in a large German family and an apparent spontaneous case in 
a 4 year old German child (Krahl et al., 1994).In South Africa, the prevalence of the disease is 
known to be 1/7200 in the white Afrikaans-speaking population, with a lower undetermined 
prevalence in the coloured population (Hull, 1986). 
1.4.1 History of the disease 
 
In the early 18th century a dermatologist in South Africa observed a number of individuals 
who exhibited similar, distinct clinical manifestations. The distinct nature of these symptoms 
eventually led to the idea that these individuals were afflicted with the same disorder. In 
1977 Findlay led an inter-university study involving many dermatologists and medical 
professionals from various South African institutes to collect and assess information about 
the disease. The aims of the study included determining the general characteristics of the 
disease, naming the disease, identification of affected individuals, tracing of family history 
and establishment of genealogies. In addition, they hoped to carry out linkage studies using 
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serological polymorphisms and to establish a collection of information related to the disease 
including clinical data, photographs and histological material. 
 The study proved to be successful and led to the clinical name for the disease being coined 
as ‘keratolytic winter erythema’ as it emphasized the 3 main characteristics of the disease 
and ‘Erythrokeratolysis hiemalis’ being the alternative Latin equivalent.  Although this was 
the clinical name decided upon, the geographical connection of the disease led to the 
additional names of ‘Oudtshoorn skin disease’ and ‘Oudtshoorn vel’ as previously 
mentioned. The linkage studies were not completed during this study however, based on the 
observed inheritance patterns in affected families, an autosomal dominant mode of 
inheritance was apparent. In addition, enough patients were seen in order to describe the 
vast range of clinical symptoms of the disease and the seasonal modulation of symptoms 
noted as a characterizing feature of the disease that allowed differentiation from other 
similar disorders (Hull, 1986). 
1.4.2 KWE Phenotype 
 
Clinical manifestations of KWE are characterized by initial reddening (erythema) of the 
palmar and plantar regions which occur in recurring cycles (Findlay et al., 1977). These 
lesions occur in a scattered arrangement and progressively enlarge with distinct red margins. 
KWE displays a distinct histopathological appearance which distinguishes it from other more 
common keratodermas.  Although some individuals have complained of itching, in most 
instances there is no discomfort during the formation of these lesions. The progressive 
reddening is followed by thickening of the skin (hyperkeratosis) and leads to the formation of 
superficial dry blisters that originate from a central point from which peeling of the 
thickened skin develops (Starfield et al., 1997). The entire palmar and plantar region is 
usually affected with the dorsa being affected in some individuals. Multiple sites or lesions 
occur on the surface of both the hands and feet proceeding centrifugally until the entire 
upper layer of the skin becomes partially detached. Major skin creases have been found to 
form boundaries at which major peeling may be arrested (Hull, 1986), although in most cases 
the lesions do not extend past the edges of the palms and soles. Characteristic peeling is 
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noted in the web spaces of both the hands and feet. The peeling skin forms a thick scale 
which is not easily dislodged, leading to affected individuals removing the peeling layers to 
reveal a smooth new epidermal layer. 
Perhaps the most interesting feature of this disease is the recurring cycles of the symptoms. 
Affected individuals exhibit seasonal variation in severity of symptoms, with the colder 
winter months aggravating the onset of symptoms, as well as seasonal changes. The colder 
drier weather appears to trigger increased thickening and peeling of the skin, whilst in some 
individuals, symptoms either subside or dissipate completely during the warmer summer 
months. 
The clinical manifestations of KWE varies significantly between individuals and affected 
families, with symptoms ranging from mild localized peeling within webspaces, which is a 
distinct feature of KWE, to severe peeling and erythema of the entire palm or sole region 
(Hull, 1986; Starfield et al., 1997). Although colder winter months have been associated with 
an increase in symptoms in most individuals, this is not always the case and a few other 
factors have been associated with an increase or reduction of symptoms. These factors 
include palmoplantar perspiration and menstrual cycles in women which are associated with 
an increase in skin peeling and symptoms, while pregnancy in females and increased 
humidity levels found in coastal areas has been associated with a reduction or complete 
absence of symptoms (Hull, 1986; Starfield et al., 1997). The disease presents within the first 
5 years and an early age of onset has been associated with increased severity. 
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Figure 1.2 KWE patient's hands, showing severe hyperkeratosis and peeling of the epidermal layer and associated 
erythema with distinct margins. 
 
Figure 1.3 KWE patient's feet following severe peeling. The outline of peeling regions can clearly be seen as well as 
erythema. 
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1.4.3 The Skin 
 
The skin forms the first line of defense against external physical and environmental factors 
that may pose a threat if allowed to freely enter the body. In addition to preventing 
organisms from entering, the epidermis also aids in the homeostatic regulation of internal 
conditions such as temperature regulation, retention of essential body fluids and the repair 
of damaged tissues caused by physical injury. The skin consists of three distinct layers, the 
epidermis, dermis and hypodermis which are distinct in appearance and origin. There exists a 
strictly controlled homeostatic balance between these three layers which results in continual 
development and maintenance of the skin throughout the lifetime of an individual (Ruth K. 
Freinkel, 2001). 
The epidermis forms the outer protective covering of the skin and comprises a multilayered 
epithelium, the interfollicular epidermis and associated hair follicles and sebaceous and 
sweat glands. The epidermis is a resilient structure which is maintained throughout adult life 
by a continual production of stem cells found within the adult hair follicle, sebaceous glands 
and within the epidermis itself (Fuchs and Raghavan, 2002). The maintenance of this layer is 
important for the protection against infection and repair from physical or chemical damage 
that the skin is exposed to on a daily basis. The epidermis is composed of multiple cell layers 
resting on the basal membrane.  The three main cell types are keratinocytes, melanocytes, 
Langerhans cells and Merkel cells. The main barrier of the epidermis is formed by the outer 
most layer which is consistently sloughed off and replaced with new cells derived from the 
inner layers. The maintenance of these cells is controlled by the process of terminal 
differentiation. Terminal differentiation is a process that results in the production of a 
specialized cell that can no longer divide (Niemann and Watt, 2002). 
The epidermis is composed predominantly of keratinocytes, which make up about 90-95% of 
the cell population (Ruth K. Freinkel, 2001). These keratinocytes originate from the 
embryonic ectoderm during early development and are required for the production of 
keratins. Keratins form part of the structural component of keratinocytes and other epithelial 
cells and provide structural integrity together with microfilaments and microtubules. 
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Melanocytes are responsible for the production of melanin, a pigment responsible for the 
colour of skin, eyes and hair. Langerhans cells are primary cells responsible for the 
recognition, uptake processing and presentation of soluble antigens to the T-cells. They 
therefore function in a protective capacity by preventing unwanted substances from 
entering the epidermis (Hosoi et al., 1993).  Merkel cells are believed to be derived from 
epidermal keratinocytes and are associated with nerve endings and therefore function as 
sensory mechanoreceptors in the skin (Gottschaldt and Vahle-Hinz, 1981). 
The dermis is composed of the highest concentration of cells and contains the blood vessels, 
lymph vessels, sebaceous glands and hair follicles. The major cell type found in this layer is 
the fibroblast, which is involved in the synthesis and degradation of fibrous and non-fibrous 
connective tissue such as collagen and elastin (Ruth K. Freinkel, 2001). The hypodermis is the 
most important layer of the skin as it contains subcutaneous adipose fat which insulates the 
skin and is reinforced by collagen and elastic fibre. This layer binds the dermis to underlying 
muscles, stores lipids, insulates and cushions the body. 
1.4.3.1 Maintenance of the epidermis 
 
The epidermis is composed of five structurally defined layers; the basal layer, spinous layer, 
granular layer, stratum lucidum and the stratum corneum (Figure 1.4)(Segre, 2006). The 
stratum lucidum is only visible as a clearly distinct layer in palmoplantar skin. The 
maintenance of the epidermal layers is required in order to continuously provide a 
protective barrier against external harmful factors. This maintenance is achieved through the 
process of terminal differentiation of keratinocytes and the process of keratinisation 
(Niemann and Watt, 2002). Keratinisation is the process whereby rapidly dividing 
keratinocytes within the basal membrane withdraw from the cell cycle and break away from 
the basement membrane and travel towards the outer most layer of the epidermis. These 
cells undergoing a systematic process of differentiation from mitotically active basal cells to 
transcriptionally active spinous cells to enucleated granular cells as they travel towards the 
surface of the skin where they eventually differentiate into enucleated flattened squames in 
the stratum corneum (Barrandon and Green, 1987; Fuchs and Raghavan, 2002). 
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Figure 1.4 Diagrammatic representation of the compositon of the epidermis of normal skin showing position of the 
stratum lucidum only visible in palmoplantar skin (Segre, 2006). 
The basal layer consists of basal cells which are attached to a basal membrane that is rich in 
extracellular matrix (ECM) proteins and growth factors (Fuchs, 2007). Basal cells attach to the 
basement membrane via cell-junction adhesion complexes composed mostly of intergrins .  
The continual division of the stem cells within the basal layer results in the constant 
production of cells which, once they commit to leaving the cell cycle, travel outwards 
towards the skin’s surface.  
 Cells leaving the basal layer enter the spinous layer.  As they enter this layer, the expressions 
of specific keratins are switched on (Fuchs, 2007). The spinous layer cells produce a 
reinforced durable cytoskeleton of keratin filaments which provide mechanical strength to 
the epidermis via large bundles of keratin filaments which mediate cell-cell connections 
known as desmosomes (Collin et al., 1992; Takahashi et al., 1995). The granular layer is 
composed of distinct keratinocytes which produce lipids within lamellar bodies and contain 
keratins bundled into macrofibrils together with filaggrin (Segre, 2006). The granular layer is 
Stratum  
Lucidum 
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directly involved in the formation of the cornified envelope through the production of 
glutamine and lysine residues which are deposited under the plasma membrane of the cells. 
The cell membrane begins to degrade and becomes permeable to calcium which activates 
transglutaminase and results in the cross linking of the glutamine and lysine residues forming 
a reinforced sac around the keratin macrofibrils. This forms the scaffold of the cornified 
envelope after which the entire cell is destroyed and lipids are extruded and packaged in 
lamellar granules onto the cornified envelope.  This is the final stage in terminal 
differentiation and leads to the formation of the stratum corneum which is made up of  dead 
flattened cells (squames) composed of keratin macrofibrils and cross-linked cornified 
envelopes surrounded by lipids (Elias, 1983; Kalinin et al., 2002; Segre, 2006). The stratum 
corneum provides a permeability and antimicrobial seal that is replenished in a homeostatic 
manner as cells from the inner layers move outwards and are eventually sloughed off the 
skin’s surface. 
1.4.3.2 The Stratum Corneum 
 
The stratum corneum varies in thickness in different regions of the body, as well as with age, 
sex and disease. The region of the palms and soles are composed of hundreds of layers, 
while regions such as the upper arm usually possess only 15 layers (Ruth K. Freinkel, 2001). 
The process of epidermal proliferation and differentiation or keratinisation is therefore a 
carefully balanced process, where too little proliferation results in thinning of the epidermis 
and loss of protection and too much leads to hyperproliferation. The homeostatic regulation 
of the stratum corneum in particular relies on the ability of the epidermis to determine when 
an increase in cell proliferation and migration is required, such as is the case when wounding 
of the skin occurs and under normal conditions to replenish cells that are continuously 
sloughed off the surface of the skin.  Many keratodermas occur as a result of defects in the 
regulation of this important process and cause either hyperkeratosis as in the case of 
psoriasis and KWE or hypokeratosis observed in sun damaged or aged skin. 
A majority of the protective function of the skin is provided by the stratum corneum (Elias, 
2005). In addition to providing a physical barrier to pathogenic organisms, the epidermis also 
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produces an array of antimicrobial lipids, peptide toll-like receptors and chemokines that 
form part of the innate immune system (Gallo and Nizet, 2003; Ganz, 2003). The ability of 
the epidermis to control water loss and the entry of harmful microbes is due to the specific 
organization of the stratum corneum into two distinct regions. These two distinct regions are 
the lipid depleted corneocytes and the lipid enriched extracellular matrix.  The molecular and 
chemical characteristics of the lipids in the extracellular matrix together with the structural 
integrity of the corneocyte account for the overall protective function of the stratum 
corneum (Elias and Feingold, 2001). Disruption or perturbation of the stratum corneum such 
as wounding results in a controlled cascade of events which leads to the proliferation of 
keratinocytes and T-lymphocytes which travel to the damaged skin in order to repair the 
wound and prevent infection. In addition the process of terminal differentiation is initiated 
to restore the epidermal barrier (Segre, 2006). 
Defects in the process of terminal differentiation and maintenance of the stratum corneum 
lead to a number of skin disorders which manifest either in the inability to initiate terminal 
differentiation or defects which results in the uncontrollable proliferation of cells. The basis 
of the protective nature of the epidermis is due to the presence of keratinocytes which 
produce a system of dense keratin and keratin-associated proteins which provides the 
structural integrity of the epidermis. Disorders of keratinisation therefore occur as a result of 
mutations in any of the genes whose protein products are involved in this complex process.   
1.4.3.3 Palmoplantar Skin 
 
Although the process of terminal differentiation maintains the skin barrier throughout the 
surface of the body, regional variation in skin thickness and appearance does occur. There 
are two distinct types of human skin; hair bearing skin which covers most of the body surface 
and non-hair bearing or glaborous skin which is found on the palmoplantar regions. The 
composition and thickness of the epidermal layer of these two skin types varies significantly 
as well as the types of keratins that are expressed. The palmar and plantar epidermal layer 
has a significantly thick and compact stratum corneum, well defined stratum lucidium, has 
many sweat glands and a reduced number of melanocytes in comparison to the hair-bearing 
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skin (Swensson et al., 1998; Yamaguchi et al., 1999). Palmoplantar skin also has deep ridges 
which are believed to be an evolutionary specialization due to the amount of physical stress 
that has to be endured. Stem cells are located at the tips of these ridges and this is thought 
to occur since these elevated ridges are in contact with the most amount of stress and 
physical abrasion leading to a need for increased cell proliferation (Swensson et al., 1998).  It 
was also observed that palmoplantar skin shows a more complex pattern of keratin 
expression with the expression of several keratins in addition to those expressed in hairy skin 
(Knapp et al., 1986; Moll et al., 1987; Langbein et al., 1994).  Since keratins function as 
reinforcement molecules within keratinocytes, the increased number of keratins in 
palmoplantar skin may have evolved as a result of the extreme physical stress that it is 
exposed to. Keratins are therefore directly involved in controlling the thickening or 
keratinization of the skin and many genetic palmoplantar disorders have been linked to 
mutations in the various keratin genes. 
1.4.4 Keratodermas 
 
The first elucidation of the molecular basis of a human keratinizing disorder, epidermolysis 
bullosa simplex (EBS), was linked to keratin genes K5 and K14 following linkage of the disease 
to two keratin gene clusters (Bonifas et al., 1991; Coulombe et al., 1991). Analysis of the 
effect of the mutations on the keratin proteins together with the clinical phenotype of EBS 
revealed that these two keratins were involved in providing epidermal cells with mechanical 
strength (McLean and Irvine, 2007). In recent years several mutations in a number of keratin 
genes and other genes have linked to various genetic keratodermas. In most instances the 
disorders occur as a result of uncontrolled cell lysis in a specific region in which the mutated 
keratin gene is expressed. A recent review by McLean and Irving (McLean and Irvine, 2007) 
stated that 21 out of the 54 known keratin genes had been linked to monogenic disorders.  
In a large proportion of these disorders, the mutation leads to overproliferation of a specific 
layer of the skin, in most case the epidermis, together with a certain degree of overall 
fragility of the skin. 
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1.4.4.1 Palmoplantar keratodermas 
 
 Palmoplantar keratodermas (PPKs) are a diverse group of disorders which are associated 
with thickening of the skin on the palms and soles and have been linked to mutations that 
result in the excessive production of keratins. The overgrowth of the epidermis known as 
hyperkeratosis and associated erythema (reddening) are the most common symptoms 
observed in PPKs. In particular mutations in keratin 9, which is exclusively expressed in the 
palmoplantar epidermis leads to thickening and scaling of the palms and soles referred to as 
epidermolytic palmoplantar keratoderma (EPPK) (Reis et al., 1994). There are three clinical 
patterns of PPKs based on the type of epidermal involvement; diffuse, focal and punctuate. 
Both hereditary and acquired forms of PPK have been observed and there are various factors 
that contribute to the development of acquired PPKs, while many genes have been 
implicated as causative in inherited cases. 
Palmoplantar keratodermas exhibit very similar clinical manifestations with a large overlap in 
symptoms and most clinical diagnoses require confirmation by histological examination of 
affected tissues (Itin and Fistarol, 2005). In recent years the molecular basis of several 
keratodermas has been identified and facilitates the accurate diagnosis of a particular 
disorder. Pathogenic mutations have been identified in genes that encode keratins, proteins 
involved in the development of the stratum corneum, cohesion molecules and 
transmembrane signal transduction enzymes (Kimyai-Asadi et al., 2002). The genetic basis of 
several PPKs has been identified to date (Table 1.2) and both autosomal dominant and 
recessive hereditary patterns have been observed. PPKs have also been observed as a 
symptom in the case of other complex disorders, such as Greither disease, which includes 
involvement of the Achilles tendon and hyperkeratosis on the knees and elbows (Fluckiger 
and Itin, 1993). The heterogeneity of PKKs has provided great motivation to identify the 
causative gene mutations in those PPKs for which they are not yet clear, to aid in the 
accuracy of clinical diagnoses.  
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Table 1.2 List of all known palmoplantar keratodermas, their mode of inheritance and associated genes 
Type of Keratoderma Mode of 
Inheritance 
Gene 
Vorner syndrome AD KRT9 
Non-epidermolytic keratoderma  AD KRT1 
PPK with polycyclic psoriasiform plaques AD KRT1 
PPK diffuse nonepidermolytic AD KRT1 
Mal de Meleda AR  SLURP1 
Vohwinkel syndrome (classic) AD/AR GJB2 
Locricrin keratoderma (Camisa) AD LORICRIN 
Pachyonychia congentia I AD KRT6a, KRT16 
Pachyonychia congentia II AD KRT6b, KRT17 
Striate palmoplantar keratoderma AD KRT1, 
DSG1,DSP 
Striate PPK/wooly hair/cardiopathy AR  DSP 
Naxos disease AR  JUP 
Papillon-Lefevre syndrome  AR  CSTC 
Haim-Munk sydrome  AR  CSTC 
Richner-Hanhart syndrome AR  TAT 
PPK with deakness Mitochondrial MTTS1 
Tylosis with esophageal cancer AD EVPL 
Epidermolysis bullbosa simplex AD KRT5 
Epidermolysis bullbosa simplex AD KRT14 
Ichthyosis hystrix Curth-Macklin AD KRT1 
Ectodermal dysplasia/skin fragility syndrome AR  PKP1 
Hidrotic ectodermal dysplasia AR  GJB6 
Erythrokeratodermia variabilis AD/AR GJB4 
Erythrokeratodermia variabilis AD/AR GJB3 
KID sydrome  AD GJB2 
Vohwinkel syndrome  AD GJB2 
Bart-Pumphrey-Syndrome AD GJB2 
PPK associated with sensorineural hearing loss AD GJB2 
Darier disease AD ATP2A2 
Dyskeratosis congenital XL DKC1 
Dyskeratosis congenital AD TERC 
   
AD= Autosomal Dominant AR = Autosomal Recessive XL = X-linked   
         (Itin and Fistarol, 2005) 
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1.4.5 Linkage analysis for KWE 
 
KWE displays an autosomal dominant pattern of inheritance in affected families and the 
genetic cause of the disorder is unknown. Linkage studies using microsatellite markers 
distributed throughout the genome linked the disease phenotype to a 6cM region on 
chromosome 8p22-p23.1 between markers D8S550 and D8S552 (Starfield et al., 1997). 
Further studies using haplotype analysis reduced this region to a 1cM area between markers 
D8S550 and D8S265 based on an ancestral recombination event (Appel et al., 2002). Based 
on a genealogical study all KWE families could be linked back to a single founder from the 
late 18th century. This founder individual was a French sea captain named Francois Renier 
Duminy who worked for the Dutch East India Company and traveled to the Cape in 1775 
(Hull, 1986). Haplotype analysis of KWE in South African families also presented further 
strong evidence for a founder effect in this population.  The founder effect explains the 
relatively high frequency of the disease in the Afrikaans-speaking white and coloured 
populations of South Africa. 
Appel et al., produced a transcript map of the linked region and identified 5 genes in the 
KWE critical region, BLK, MTMR8, TDH, AMAC1 and C8orf13, however sequencing revealed 
no mutations that segregated with KWE affected individuals (Appel et al., 2002). After the 
identification of an error in affection status in a critical cross-over family, the KWE locus was 
reassigned to a larger region on chromosome 8p22-23.1 between D8S1759 and D8S552. This 
critical region contains six candidate genes that have been identified and characterised. The 
genes include FDFT1, CTSB, GATA4, NEIL2, BLK and LONRF1.  
1.4.5.1 KWE candidate genes 
 
Screening for candidates within this newly defined critical region revealed two likely 
candidate genes, farnesyldiphosphate farnesyltransferase (FDFT1) and cathepsin B (CTSB) 
which are both involved in the maintenance of the skin epidermal layer. FDFT1 encodes a 
membrane associated enzyme which plays a critical role in the mevalonate pathway 
responsible for the production of cholesterol, dolichol, ubiquinone, steroid hormones and 
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prenylated proteins in humans (Goldstein and Brown, 1990; Pandit et al., 2000). Cholesterol 
is an important intercellular lipid component found in the stratum corneum of the epidermal 
skin layer and is integral in the formation and maintenance of the permeability barrier 
together with an equimolar amount of free fatty acids and ceramides (Proksch et al., 1993). 
Additional studies have shown strong evidence that inhibition or increased levels of 
cholesterol results in alteration of the normal functioning of the epidermal barrier (Di Nardo 
et al., 1998; Kim et al., 2007).  
CTSB belongs to the family of lysosomal cysteine proteases responsible for intracellular 
protein degradation (Schwartz et al., 2002). The cathepsin family of proteins has been found 
to be involved in a number of skin disorders involving defects in the homoeostatic 
maintenance of the epidermal layer. In addition, CTSB is thought to be involved in the 
regulation of keratinocyte migration via dissociation of cell-cell contacts of keratinocytes 
within the spinous layer (Buth et al., 2004). The migration of keratinocytes through the 
epidermis is essential for epidermal differentiation, keratinisation, wound healing and 
maintenance of the epidermal barrier.  
These two genes were identified as excellent candidate genes for KWE and a fellow student, 
Angela Hobbs, has carried out an extensive mutation detection study of FDFT1 and CTSB in 
KWE affected individuals, however no pathogenic mutations were identified within the exons 
and immediately flanking regions, or the mRNA transcripts. The variability in symptom 
severity and seasonal variation suggests that the molecular mechanism underlying the 
disease may be more complex than a conventional monogenic disorder characterised by a 
mutation in a protein coding gene. It is possible that the causal factor may be due to a 
quantitative change in gene expression due to a mutation in a regulatory region, the 
presence of a CNV within the region, or due to non-coding RNA or an RNA interference 
mechanism.    
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1.4.5.2 Complexities of the KWE critical region 
 
The KWE critical region, lies within an area on the short arm of chromosome 8 that contains 
two low copy olfactory repeat clusters, a proximal repeat cluster (REPP) and distal repeat 
cluster (REPD) (Giglio et al., 2001). The REPD and REPP are 1.3Mb and 0.4Mb, however 
within these two repeats lie two sequence gaps of ~100 000bp for which there is no available 
sequence in the current build of the human genome (HG18) (Fig 1.5). The REPD is flanked by 
a cluster of beta-defensin genes that has been shown to display copy number variation 
(Barber et al., 2005; Hollox, 2008). These two repeat clusters are implicated in mediating a 
large inversion of approximately 3.5Mb that occurs within the region and which has also 
been observed in KWE affected individuals.  The inversion has been observed at polymorphic 
frequencies (Giglio et al., 2001; Shimokawa et al., 2004). 
 Although the presence of the inversion is not directly harmful, it has been found to interfere 
with the correct pairing of chromosomes and increases the chance of non-allelic crossovers 
between the olfactory receptor gene repeats (Giglio et al., 2001). This event leads to 
additional chromosome rearrangements such as inverted duplicated deletion 8, 
supernumerary chromosomes with functional neocentromeres outside the normal 
centromere domain (analphoid chromosomes) and translocations in the offspring of 
heterozygous carriers of the inversion (Giglio et al., 2001; Shimokawa et al., 2004). These 
rearrangements result in genetic disorders associated with mental retardation, heart defects 
and facial abnormalities in affected individuals (Giorda et al., 2007).  
The inverted form of the chromosome has been observed in KWE affected individuals but 
the polymorphic frequency of its occurrence suggests that it is a harmless genomic 
rearrangement. The breakpoints of the inversion lie within the REPP and REPD, however 
their exact locations are still unknown. The approximate breakpoints of the inversion have 
however recently been documented (Giorda et al., 2007). The KWE critical region lies within 
the inverted region of the short arm of chromosome 8 between markers D8S1759 and 
D8S552.  KWE was initially linked to this region, which contains 6 known genes, however in 
the presence of the inversion, the position of D8S1759 could be altered and the region could 
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possibly encompass a much larger area. This is a significantly larger region and a fellow 
student typed further markers to identify haplotypes in families with the critical cross-over 
events in order to redefine the KWE critical region. 
 
 
 
 
 
 
 
 
 
 
 
 
The presence of repeats and the inversion in the KWE critical region has made it a very 
challenging task to identify the genetic cause of the disease. The linkage of KWE to this 
region and distinct autosomal dominant inheritance confirm that there is a monogenic cause 
for the disease, however no mutations have to date been identified in the known positional 
candidate genes identified in the critical region. The unusual seasonal variation of symptoms 
and varied penetrance of the disease suggests that the molecular etiology of the disease may 
involve a quantitative aspect of gene expression, rather than a structural variant of a protein. 
If this is the case, the genetic cause of KWE may lie in an unknown functional region of 
sequence involved in regulatory gene expression that is yet to be identified and 
characterized.  
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Figure 1.5 Schematic diagram of the KWE critical region on 8p22-23.1 showing the location of the markers, REPD and REPP clusters and 
gaps. 
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1.5 Study rationale and aims 
 
As highlighted in the above literature review, classical methods used to identify genes 
involved in simple genetics disorders have undergone significant changes in recent years 
with the discovery of previously undefined functional elements within the human genome. 
Many of these previously undefined regions lie within non-coding regions of the genome and 
play an integral role as gene regulatory elements. Furthermore it has been found that 
regulatory elements found in non-coding regions are highly conserved across different 
species. These elements have been overlooked in past investigations to identify genes 
involved in Mendelian disorders and may be the underlying cause of single gene disorders 
for which the molecular cause remains unknown.  
Secondly, it has been observed that in addition to the presence of genetic variation in the 
form of microscopically visible chromosomal rearrangements and single nucleotide changes, 
there is an abundance of copy number variation of DNA segments throughout the genome. 
Previous studies have shown that like single base changes within protein-coding genes in the 
genome, these CNVs possess the ability to affect phenotype and cause disease.   
As previously mentioned, the molecular basis of KWE is yet to be identified. Much work has 
gone into linking the disease to a candidate region and there is sufficient evidence to suggest 
that the disease is inherited in an autosomal dominant pattern and has a strong genetic 
component. Studies of candidate genes in the region have yielded no significant results with 
respect to the presence of pathogenic mutations.   
Thus, the objective of this study was to examine the KWE critical region on 8p22-23.1 for 
highly conserved coding and non-coding sequences and regions of copy number variation 
and to further characterize these regions to determine if they may play a role in the 
molecular etiology of the disease.   
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This objective was achieved via two main aims: 
Aims:  
1. To search and identify highly conserved regions within the KWE critical region and 
further annotate and characterize these regions to determine if the may play a role in 
KWE. 
 
2. To examine the KWE critical region for copy number variation and assess the impact 
of the variation on the region and the KWE phenotype.
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Chapter 2. Subjects and Methods 
 
Two approaches where employed in this study to annotate and examine the KWE linked 
critical region and are summarized in Figure 2.1. 
 
 
 
Reassessment of KWE critical 
region
Extraction of homologous 
sequences from different 
species
Identification of highly 
conserved sequences
Analysis of highly conserved 
sequences  to identify potential 
novel functional elements
Comparative genomics 
hybridisation array (aCGH) 
of KWE affected and 
unaffected individuals
Identification of CNVs 
present in KWE affected 
individuals
Analaysis of CNVs to 
determine if they may play 
a role in KWE
Figure 2.1 Schematic flow diagram of the methodology employed in the present study. The two main aspects of the 
project included the identification of highly conserved regions within the KWE critical region using a computational 
approach and the identification of copy number variants within the KWE critical region using an aCGH approach in 
affected and unaffected individuals. 
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2.1 Subjects 
 
DNA samples were obtained from a cohort of South African KWE families of which four 
families were selected for the CGH fine tiling array experiment representing a total of 10 
samples. Three of these families were composed of an affected and unaffected individual, 
while the remaining family consisted of four related individuals as indicated in the pedigrees 
(Figure2.2). A total of 5 KWE affected and 5 unaffected samples were used and following 
informed consent, 10ml of blood was collected in EDTA tubes from each individual. The 
samples for this project were collected as part of a concurrent KWE study conducted by a 
colleague, Miss Angela Hobbs, and ethics clearance for the use of the samples was obtained 
from the Human Research Ethics Committee, ethics approval number M070423.  
Nimblegen No. KWE No. Affection Status 
7732502 KWE46_1.1 Affected 
7739102 KWE46_1.2    Unaffected 
7732402 KWE46_2.1    Unaffected 
7739302 KWE46_2.2    Affected 
7737602 KWE23_1.2 Unaffected 
7755202 KWE23_2.1   Affected 
7737902 KWE45_1.2 Unaffected 
7738002 KWE45_2.2 Affected 
7739402 KWE48_1.2 Affected 
7738902 KWE48_2.1 Unaffected 
7732502 
7732402 
7739102 
7739302 
7737602 
7755202 
7738002 
7737902 
7738902 
7739402 
Figure 2.2 Pedigrees showing the ten individuals from the four families used in the CNV study together with the 
corresponding Nimblegen codes. 
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2.2 Methods 
 
2.2.1 Assessment of KWE critical region and polymorphic inversion  
 
A detailed analysis of all previous data on the polymorphic inversion on 8p22-23.1 was 
reviewed to assess the impact of the inversion on the KWE critical region. Although the 
presence of the inversion was known prior to the identification of the KWE critical region, 
the exact breakpoints were not well defined and were not considered in previous KWE 
studies. The positions of the approximate proximal and distal breakpoints of the inversion 
were reassessed in order to determine if they directly affect the KWE critical region. In 
addition, a previous KWE haplotype study (Starfield et al., 1997) was reviewed in order to 
confirm the correct order of markers within the inverted region.  Using the data pertaining to 
the inversion together with the current marker order for the region obtained from the UCSC 
genome browser (http://www.genome.ucsc.edu/) a physical map of the KWE region was 
generated.  Two genetic maps of the extended KWE critical region were constructed; one 
representing the order of markers on the inverted chromosome and the other representing 
the non-inverted chromosome. Based on these genetic maps a colleague, Miss Angela 
Hobbs, retyped markers within the KWE region and those flanking the breakpoints in KWE 
families in order to confirm the KWE critical region and identify markers that segregated with 
affected individuals. This information was used to define the KWE critical region to be 
assessed further in this study. 
2.2.2 Identification of highly conserved regions 
 
The human genomic sequence for the KWE critical region was obtained from the UCSC 
genome browser from approximately 200 000bp upstream of marker D8S1759 to 100 000bp 
downstream of marker D8S552. The human genomic sequence for the KWE critical region 
therefore corresponds to the March 2006 assembly (HG18), i.e. chromosome 8:11 317 148 – 
12 899 353. For all further analyses, the coordinates of the regions mentioned correspond to 
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those in the human reference genome sequence. The identification of evolutionarily 
conserved genomic sequences is a potentially powerful means by which to identify 
functional regions of the genome. Conserved non-coding regions (CNCs) among mammalian 
and more distantly related organisms provide further regions of the genome that may harbor 
genetic variants that contribute to disease in addition to known protein-coding regions. In 
this study, the KWE critical region was examined to identify evolutionary conserved regions 
using a computational approach which facilitates the comparison and visualization of 
genomes of various species. 
2.2.2.1 Comparative genomic analysis of KWE region 
 
The choice of species was based on the ability to extract enough biological information from 
the multispecies alignment as possible. The ideal pairwise comparison to identify novel 
regions of functional relevance is based on the comparison of genomes from two 
physiologically or biologically similar organisms.  However, there must be a balance between 
biological relevance, evolutionary distance and sequence analysis in order to identify 
sequences that appear to be under evolutionary constraint to remain unchanged in the 
background of sequence that has diverged due to random genetic drift.  Multispecies 
sequences alignments of divergent species allows for a balance in the amount of sequence 
conservation observed as the comparison of closely related species results in an abundance 
of conservation obscuring functional regions, while the comparison of divergent species 
shows too little conservation and are  less informative. To achieve this 8 species with a range 
of evolutionary distance from humans were chosen to conduct the multispecies sequence 
alignment and are listed in table 2.1 together with the corresponding genome builds. 
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Table 2.1 Species used in comparative genome analysis 
Species Common Name Genome Build 
Pan troglodytes Chimpanzee March 2006 
Macaca mulatta Rhesus Macaque Jan 2006 
Canis lupus familiaris Dog May 2005 
Mus musculus Mouse July 2007 
Gallus gallus Chicken May 2006 
Takifugu rubripes Puffer Fish (Fugu) v.4.0. 
Danio rerio Zebrafish March 2006 
Xenopus tropicalis Frog v.4.1. 
 
2.2.2.2Alignment  
 
The first step in comparing genomic sequences is to map the letters of each DNA sequence 
to each other. This is achieved through the computation of an alignment which takes into 
consideration the selection of a reference or base genome against which sequences are 
compared on a pairwise basis. The human KWE critical region was selected as the reference 
sequence and all other sequences where then aligned to it on pairwise basis. In this study a 
combination of a global and local (“glocal”) alignment technique was used to produce a 
multiple sequence alignment of the KWE critical region across 8 species. 
 The selection of a glocal alignment method was based on previously noted shortcomings of 
both local and global alignments to identify highly scoring local alignments within a larger 
syntenic region that has undergone a rearrangement event. GenomeVISTA , one of the tools 
available from the VISTA suite (http://genome.lbl.gov/vista) utilizes a modified version of a 
local alignment algorithm, Shuffle-LAGAN (S-LAGAN) to produce pairwise alignments of the 
human genomic sequence and another species using a local aligner such as BLAT to indentify 
- Methodology - 
49 
 
orthologous sequences and then progressively extends the pairwise alignments using a 
species phylogenetic tree to produce an accurate multispecies sequence alignment. The 
species tree is used to decide at what stage syntenic blocks of sequence should be aligned 
and is important since species with greater sequence similarity should be aligned first to 
obtain an accurate multi-species alignment.  Glocal alignments therefore ensure that smaller 
high scoring local alignments are properly captured within the context of the global 
alignment.   
 
 
Figure 2.3 Approach to constructing multispecies sequence alignments with a human reference genome. The human 
sequence (center) is being aligned with two other sequences (above and below). The final alignment shows that 
nucleotides from the two other sequences do not need to retain their original order or orientation and they may be 
subjected to inversions (blue) or duplications (green) (Margulies et al., 2007). 
 
The human genomic sequence for the KWE critical region of approximately 1.6Mb was 
submitted to the VISTA server in partitions of 300kb. The region was divided into 300kb 
intervals in order to efficiently view and explore the resulting alignments within the VISTA 
browser and extract sequence data for further investigations. GenomeVISTA allows for the 
selection of various parameters to be used when viewing the multi-species sequence 
alignment and includes the window size, which defines the smallest conserved region to be 
considered and the percentage conservation level. These parameters do not have any effect 
on the pairwise alignments but define the regions of interest observed when viewing the 
final multispecies sequence alignment. The multispecies alignment was visualized using a 
sliding window of 100bp and a minimal conservation score of 70% identity across all 8 
species in order to identify regions of 100bp or larger that showed high levels of sequence 
conservation within the KWE critical region. These criteria were chosen on the basis that 
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many studies have shown that regulatory elements showing experimentally validated 
functional properties were found to meet these criteria (Loots et al., 2000; Donfack et al., 
2005; van Deursen et al., 2007).      
2.2.2.3 Visualization and identification of highly conserved sequences 
 
The resulting alignments were visualized using the genomeVISTA browser, a web –based 
JAVA applet allowing for the interactive viewing of multispecies sequence alignment for each 
of the regions submitted. The applet displays a separate track for each species, one below 
the other which contains a conservation curve based on the selected parameter values. Each 
of the curves represents the level of conservation observed between the pairwise alignments 
of each species with the human genome (base genome). In addition, annotation tracks 
containing known genes, SNPs and repeat regions are provided. Regions under the curve are 
highlighted using different colours allowing for the identification of conservation of exons, 
UTRs and non-coding regions. 
The alignment of with all 8 species was analysed and regions that exhibited levels of 
sequence conservation greater than 70% across all species including the zebrafish, fugu and 
frog were identified.  These regions overlapped many annotated genes as was expected, 
however only non-protein coding regions that displayed high levels of conservation were 
identified as regions of interest for further analysis.  The corresponding human and 
orthologous sequences, genomic coordinates and alignments for each region were extracted.  
2.2.3 In silico analysis of highly conserved regions 
 
The regions that exhibited high levels of conservation across all 8 species were subjected to 
an in silico analysis to determine if they contained any motifs associated with known 
functional elements. Each region was subjected to a BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) search to confirm the identification of the 
orthologous sequences and to identify any matches to known human cDNAs. Further 
characterization of the conserved regions was conducted by submitting the sequences to 
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various genomic functional annotation tools which aim at predicting whether a sequence 
contains any functionally relevant signatures associated with known gene and regulatory 
elements. 
2.2.3.1 Prediction of gene structures 
 
Each conserved sequence was submitted to two gene prediction programs, GeneID 
(http://genome.imim.es/geneid) and GeneScan (http://genes.mit.edu/GENSCAN). Both 
programs predict genes in genomic sequences using different methodologies. GeneID is 
designed based on the hierarchical prediction of splice sites and start and stop codons using 
a Hidden Markov Model. Each site is scored and exons built from these sites, followed by 
prediction of the final gene structure based on maximizing the sum of scores of the 
assembled exons. GenScan predicts genes using a similar approach, based on generalized 
Hidden Markov Model for coding DNA. 
2.2.3.2Identification of transcription factor binding sites 
 
Conserved sequences were assessed for transcription factor binding sites by searching 
against the JASPAR database of known transcription factor binding sites. The JASPAR 
database contains a collection of all experimentally validated transcription factor binding 
sites and the factors that bind to them. The database was established as a repository for all 
transcription factor binding site consensus sequences and position-weighted matrices which 
are used to estimate the likelihood that a given sequence binds to a specific transcription 
factor. These matrices have been derived from experimental data on transcription factors 
and their binding sites. The database was accessed through the ConSite suite of tools. The 
sequences were first subjected to a single sequence analysis which searches for transcription 
factor binding sites within a sequence based solely on position weight matrices derived for 
all previously characterised transcription factors.  Each of the sequences were subsequently 
subjected to a second analysis which searches for major transcription factor binding sites 
based on the submission of the aligned mouse and human sequences. This approach which is 
known as phylogenetic footprinting serves to reduce the number of false positive predictions 
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by only identifying putative sites conserved between the mouse and human sequences. All 
conserved sequences were assessed for the presence of transcription factor binding sites 
and the results further analysed to determine the likelihood that the sites found were 
biologically functionally relevant. This assessment was based on the position of the sites in 
relation to transcription initiation sequences of genes within the region and the presence of 
clusters of transcription binding sites know to occur together to bind dimer transcription 
factors. 
2.2.3.3Identification of conserved RNA structures 
 
The prediction of non-coding RNA genes is a difficult process; however there are several 
algorithms designed to detect regions of pre-mRNA and mRNA predicted to have a 
conserved secondary structure which may be involved in translational regulation or mRNA 
localisation or degradation. The prediction of potential micro RNA (miRNA) structure 
formation of the conserved sequences was carried out using the automated Vienna RNAfold 
server (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi). Sequences were submitted to the 
prediction pipeline which predicts potential miRNAs based on the following factors: 
formation of a stem-loop secondary structure, calculation of free energy, the identification of 
homologues in relative species and conservation with other known miRNAs.  All predicted 
RNA secondary structures were further assessed to determine their possible biological 
significance through the analysis of possible gene targets were potential secondary structure 
formation was identified. Potential RNA genes were subjected to a BLAST search against all 
known expressed sequence tags and coding sequences to identify possible gene targets and 
these genes were assessed to determine if they could play a potential role in the etiology of 
KWE. 
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2.2.4 Laboratory validation of identified functional regions 
 
In the case where potential functional elements were identified within highly conserved 
sequences of the KWE critical region, these regions were sequenced by a colleague, Miss 
Angela Hobbs in affected and unaffected KWE samples to determine if there were any 
variations that were found exclusively in affected individuals.  
2.2.5 Comparative Genomic Hybridisation Array (aCGH) 
 
Comparative genomic hybridization arrays provide a means by which to compare the copy 
number of differentially labeled test and reference DNA by hybridizing the DNA together to 
an array containing thousands of probes covering a particular region of the genome. The test 
and reference samples are labeled with either Cy3 or Cy5, which are fluorescent cyanine 
dyes with different emission and excitation wavelengths.  The measurement of the resulting 
fluorescence ratios is then plotted probe by probe, in relation to the probe position and 
provides an efficient means to accurately determine copy number of defined regions. The 
high resolution capabilities of aCGH allows for the identification of extremely small regions 
that may show CNV. An aCGH was employed in this study to identify the presence of copy 
number variants within an extended KWE critical region in KWE affected individuals. 
2.2.5.1 DNA Extraction  
 
DNA was extracted from whole blood by diagnostic laboratory personnel using the salting 
out method. The quality of the extracted DNA was confirmed by running it on a 0.8% agarose 
gel and the quantification and purity (OD260/280) of the samples were ascertained using the 
Nanodrop ND-1000 Spectrophotometer. The DNA was then aliquoted into final volumes 
containing 10µg of DNA.  The DNA samples were sent to Roche NimbleGen® core facility in 
Iceland where the aCGH experiments were conducted. 
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2.2.5.2 Custom CGH tiling array design 
 
A custom tiling array (Roche-NimbleGen) containing roughly 385 000 probes at a resolution 
of 11bp was designed based on an extended region encompassing the inverted region on 
chromosome 8p and the KWE-linked critical region between markers D8S1759 and D8S552 
(chr8:11 415 050-12 886 829). The array was designed to provide a high resolution tiling path 
of the entire region and therefore regions known to contain copy number variants and 
repeat elements were included in the design. The array production and hybridization 
experiments were conducted by Roche- Nimblegen following their standard protocol. Each of 
the ten samples were fragmented, labeled and hybridized to a single array together with an 
equivalent amount of DNA from a differentially labeled reference sample which consisted of 
a pool of DNA from six Caucasian individuals supplied by Roche-Nimblegen. The use of a 
pooled reference sample allowed for compensation for the effect of normal copy number 
variation present in the genome of a single individual affecting the results of the experiment. 
The same reference sample was used for each of the hybridizations. Following the 
hybridization experiments, the microarrays were scanned and the fluorescence intensity 
data extracted. 
2.2.5.3 Data Analysis of 385k tiling array 
 
Both normalized and raw datasets were obtained for each experiment from Roche 
NimbleGen. The fluorescence intensity raw data was normalized for each spot using the 
qspline algorithm. Normalisation of the data is required in order to compensate for the 
differences in intensity between the Cy3-labeled test sample and the Cy5-labeled control 
sample. Qspline normalisation is a quantile-based simple and robust non-linear method for 
normalisation of two-colour array experiments that has been shown to perform comparably 
to loess normalisation (Workman et al., 2002). It is the preferred method of normalisation 
compared to lowess-based methods as it is computationally more efficient, deterministic and 
can normalise for signal dependant bias across arrays with different features. In addition, a 
window averaging dataset was obtained using a transformation algorithm to reduce the data 
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points based on averaging across 10 data points. This dataset therefore contained the 
average intensities across 100bp (10 data points on average). This dataset provided a means 
by which to analyse larger regions for CNV. These two datasets were used for further 
analyses. 
 
Two datasets used: 
1. Normalised dataset – 384 702 datapoints 
2. 100bp Averaged dataset – 54 632 datapoints 
 
2.2.5.4 Visual Analysis using SignalMap  software 
 
Both datasets were visually interrogated using the SignalMap software provided by Roche 
NimbleGen to identify variation within known genes.  The SignalMap software allows for the 
visualization of the intensity log2ratio for each probe in relation to its position in the genome 
in the form of signal intensity plots. SignalMap provides a gene annotation track that allows 
for the examination of CNV is relation to known genes. The criteria for the analysis involved 
visually inspecting probes covering the length of known genes for variation in copy number 
based on deviations from the expected intensity for normal copy number. The log2ratio 
conversion of signal intensities in the case of normal copy number allows for the relative 
probe intensities to lie close to zero while intensity values representing deleted regions are 
indicated by negative values and amplified regions are represented by positive values.  
Regions that exhibited copy number variation overlapping known genes in both affected and 
unaffected samples were noted.  
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2.2.5.5. Analysis using TM4 Microarray Software Tool- MultiExperiment Viewer (MeV) 
 
MeV is a versatile multi-experiment tool which is part of a suite of software developed for 
the analysis of expression microarray data using sophisticated algorithms for clustering, 
statistical analysis and visualization (http://www.tm4.org/). MeV was further developed to 
include powerful tools for the visualization and analysis of aCGH data. The tool allows for 
comparison of samples to identify common regions duplicated or deleted between samples. 
 
2.2.5.6 Analysis of known genes 
 
MeV was utilized to confirm if any CNVs overlapped known RefSeq genes within the tiled 
region.  The algorithm uses an approach which identifies probes which have an intensity log2 
value of ≤ -0.8 or ≥ 0.8 for the identification of single copy deletions and duplications 
respectively and intensity log2 values of ≤ -1 and ≥ 1 for 2 copy deletions and duplications 
respectively. When searching for significant CNVs within genes, this algorithm is applied 
across all probes covering the length of a gene.  
2.2.5.7 Identification of CNVs present only in affected samples 
 
Since the aim of the experiment was to identify CNVs that may be involved in KWE, regions 
that are either deleted or duplicated across all affected samples were identified. This was 
achieved by doing a pairwise assessment of samples based on the comparison of each 
affected sample with their unaffected relative. The comparison algorithm used a threshold 
value for CNVs as previously mentioned. In addition, the algorithm searches for regions that 
exhibit copy number variation (where more than one adjacent probe is assessed for CNV) as 
opposed to single clones. The algorithm identifies duplicated or deleted regions present in 
either the affected or unaffected sample or both. CNVs identified in both the affected and 
unaffected samples were excluded since they are unlikely to be involved in KWE. CNVs 
identified in only the affected samples were noted and 10 datasets (5 for duplicated regions 
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and 5 for deleted regions in each affected sample) for the pairwise comparisons were 
obtained for regions showing either duplications or deletions in each affected sample. These 
10 datasets were then compared using the web based tool Galaxy 
(http://main.g2.bx.psu.edu/) and to identify regions that were commonly deleted or 
duplicated across the pairwise datasets. This approach provided a means by which to identify 
CNVs present exclusively in KWE affected individuals and therefore likely candidates to be 
further assessed for involvement in the etiology of KWE. 
 
 2.2.5.8 Assessment of potential functional impact of CNVs 
 
All regions that exhibited copy number variation in both protein coding and non-coding 
regions were further assessed to determine if they were likely to be involved in the 
molecular cause of KWE. In the case of CNVs within known or predicted genes, this 
assessment was based on a literature search to identify whether the established molecular 
functioning of the genes were associated with the phenotypic manifestations of KWE. Where 
CNVs were identified within non-coding sequences of the KWE critical region, these were 
assessed for possible functional impact on the previously identified candidate genes based 
on their location with respect to these genes. CNVs found upstream or downstream of 
candidate genes have the potential to be involved in the regulation genes that they lie close 
to and were therefore further analysed.
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Chapter 3. Results 
 
The aim of this study was to examine the KWE critical region on chromosome 8p22-23.1 to 
identify: (a) highly conserved regions and (b) regions of copy number variation that may be 
associated with the molecular etiology of the disease. This study first explored the possibility 
that the pathogenic mutation may lie within a previously uncharacterised highly conserved 
genomic element in the KWE critical region. Secondly an extended region encompassing the 
KWE critical region was analysed to identify copy number variation that may be present in 
KWE affected individuals. Copy number variation has been found to be associated with 
several genetic disorders and thus may play a role in the molecular cause of KWE. Although 
both approaches are aimed at analyzing the KWE critical region for possible functional 
elements related to the molecular etiology of the disease, the two approaches are diverse in 
their methodology and application and are therefore dealt with separately with interesting 
regions of overlap being addressed in the discussion.   
3.1 Validation of KWE critical region 
 
Although the KWE critical region had previously been identified as lying on the short arm of 
chromosome 8 the details of the polymorphic inversion that occurs in this region was not 
clearly defined and therefore the impact of the inversion on the KWE critical region was 
unknown. Previous KWE studies (Starfield et al., 1997; Appel et al., 2002) together with 
current studies examining the polymorphic inversion (Giglio et al., 2002; Giorda et al., 2007) 
revealed that the breakpoints of the inversion had been localized to 2 distinct regions on the 
short arm of chromosome 8.  
 
Data from the molecular genotyping of microsatellite markers and construction of 
haplotypes surrounding the KWE critical region generated by a colleague Angela Hobbs, 
revealed a common haplotype in 4 KWE families. The haplotype analysis was conducted 
based on the evidence that the KWE critical region lies on an inverted chromosome. 
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Additional markers not used in previous KWE studies were also incorporated in order to 
increase the informativity of the haplotypes. By tracking the inheritance of alleles based on 
Mendelian segregation, the KWE critical region was found to lie in the region between and 
including markers D8S1759 extending distally towards the REPD and D8Sdi on the inverted 
chromosome.  Lack of additional informative recombination events therefore defined the 
KWE critical region as lying between markers D8S1819 and D8Sdi on the inverted 
chromosome. Although a common founder haplotype was present in the affected families 
studied, the exact boundaries of this haplotype could not be accurately determined. The 
KWE critical region was previously defined as lying between markers D8S1759 and D8S552 
on the uninverted chromosome and was found to encompass the REPP (Figure 3.1) where 
one of the breakpoints of the inversion is known to occur. In the presence of the inversion 
the critical region will still appear to lie between the two previously mentioned markers, 
however the region is significantly increased to approximately 6Mb encompassing many 
more genes (Figure 3.1).  
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Figure 3.1 Schematic representation of the position of the KWE critical region. (A) Shows part of chromosome 8p 
in the normal orientation, whilst (B) shows the altered position of the KWE critical region on the inverted 
chromosome based on the haplotype analysis. 
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Although the additional haplotype analysis revealed a possible new KWE critical region on 
the inverted chromosome, the markers that were typed could not provide accurate 
information regarding the boundaries of this new region.  Further markers would need to be 
typed in future studies between markers D8Sdi and D8Stet and D8S1819 and D8S1759 in 
order to define the boundaries. Due to the lack of more informative information from the 
haplotype analysis, the results from previous studies were used to assess the region to be 
analysed for conservation.  In the absence of additional information to define this new 
critical region as observed on the inverted chromosome, the original KWE critical region 
between markers D8S1759 and D8S552 was used as the starting point to identify highly 
conserved regions. The region analysed for conservation was therefore defined as lying on 
the uninverted chromosome 8 approximately 200kb upstream of marker D8S1759 and 100kb 
downstream of D8S552 at position 11,317,148-12,899,353 (Mar.2006, HG18). The flanking 
regions were included so as to ensure that the sequence surrounding the markers was also 
included in the analysis. 
 
Figure 3.2 shows the annotated genes within the region between markers D8S1759 and 
D8S552. The region is known to contain 8 protein coding genes, a beta-defensin gene cluster 
and a number of additional hypothetical genes and open reading frames. In addition, the 
region also contains a clone gap in the assembly of the human genome sequence which is 
approximately 100kb in size.   
 
 
Figure 3.2 A representation of the KWE critical region between markers D8S1759 and D8S552 showing RefSeq annotated genes 
in the region (UCSC Genome Browser – Accessed January 2010). 
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3.2 Comparative genomic analysis of KWE critical region 
 
A number of analytical approaches have been developed to address the challenge of 
identifying conserved regions across multiple orthologous sequences. Each of these 
approaches has attempted to take into account a number of confounding factors which can 
dramatically affect the outcome of the alignment of sequences from multiple species. The 
KWE critical region was aligned with 8 evolutionarily diverse organisms in order to identify 
regions that were highly conserved.  The 8 organisms were selected on the basis of 
representing both closely and distantly related organisms; hence the regions of interest were 
those that exhibited a high level of sequence conservation across a majority of the most 
evolutionarily diverse species. The comparison of DNA sequences from multiple species that 
range in evolutionary distances allows for the identification of not only slowly evolving 
coding sequences but also the conserved non-coding elements that may harbor important 
functional or regulatory elements.  For this reason, the species used in the comparative 
genomic analysis ranged from the human and pufferfish which diverged approximately 450 
million years ago to the human and mouse which diverged from a common ancestor 
approximately 40 – 80 million years ago. A significant number of conserved regions were 
observed, with majority of the conservation occurring within the exons of annotated protein 
coding genes in the region.  Although these regions were highly conserved, this was expected 
and served to prove the premise that functional regions in the form of protein coding genes 
are under selection to remain unchanged, even between distantly related organisms.   
3.2.1 Identification of highly conserved regions 
 
To optimize the chance of identifying all possible non-coding conserved regions the 
GenomeVISTA server  uses a computational strategy whereby the query sequence contigs 
are anchored to a base genome using a local approach followed by a global alignment of 
larger anchor regions.  In order to identify regions within the KWE critical region that were of 
potential functional relevance, genomic regions which were at least 100bp in length and 
conserved at a level of greater than 70% across species were identified. Based on these 
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criteria a large proportion of the KWE critical region was found to be conserved between the 
closely related organisms such as the primates and mammals. This was expected as the 
majority of evolutionarily conserved regions are under constraint to remain unchanged and 
thereby preserve their functionality. The conservation of the previously studied KWE 
candidate genes in the region were of significant interest, since both FDFT1 and CTSB 
showed high levels of conservation across all 8 of the species (Figure3.3). Although the main 
focus of this study was to identify non coding regions, additional regions of interest in 
potential coding regions were also investigated due to their high levels of conservation 
between species. 
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Eight distinct regions of significance were identified in the multiple sequence alignment. The 
identification of these regions was based on the analysis of the GenomeVISTA multiple 
sequence alignments. The level of conservation between the human genomic sequence and 
all other sequences were assessed across the entire KWE critical region in 300kb segments. 
Regions exhibiting levels of conservation above the 70% threshold were indicated by peaks in 
the GenomeVISTA display (Figure 3.3). Of these eight regions, six were identified within non-
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Figure 3.3  GenomeVISTA conservation plot showing the two KWE candidate genes FDFT1 and CTSB. The blue peaks 
represent exons that show conservation of greater than 70%, while the pink regions represent non-coding conserved 
regions. Each track is the alignment of the human genome sequence with (a) Chimp, (b) Rhesus, (c) Dog, (d) Mouse, (e) 
Chicken, (f) Fugu, (g) Zebrafish and (h) Frog. 
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coding regions of the genome while the remaining two were identified within a previously 
annotated open reading frame.  Each of these regions ranged in size from 100bp to 406bp 
(Table 3.1). These regions were selected as regions of interest based solely on the fact that 
they shared orthologous regions in at least 6 of the most evolutionarily diverse species which 
were included in the multispecies alignment.   
3.2.2 Assessment of highly conserved regions 
 
Regions 1 and 2 were found to be conserved across all 8 species within a region that had 
been characterised as a predicted open reading frame c8orf13 (Figure 3.4). As previously 
mentioned, although this region was identified within a possible coding region of the 
genome, the high level of conservation presented it as a region of interest for further 
analysis. Region 3 was a large intergenic non-coding region of 406bp which was conserved in 
6 of the 8 species inclusive of the Zebrafish and Fugu. This region was situated between two 
known RefSeq genes BLK and GATA4 and therefore could possibly be involved in the 
regulation of these genes. Regions 4 and 5 were two smaller conserved regions within 
approximately 4500bp of each other. These intergenic non-coding regions were 154bp and 
124bp in size respectively and were found to be conserved in 6 species inclusive of the 
evolutionarily distant Fugu and Zebrafish (Figure3.5).  Similarly regions 6 and 7 were two 
small regions found within 537bp of each other which were conserved in 6 of the species in 
the alignment (Figure 3.5). At the time that the alignment was first conducted, these two 
regions were identified as non-coding intergenic regions although in figure 3.5 the region is 
shaded in blue indicating a protein coding exon. The reason for this will be addressed later in 
section 3.2.3.1.  The close proximity of regions 4 and 5 and regions 6 and 7 to each other 
respectively presented them as interesting potential functional candidates. Region 8 was 
found to be conserved in 6 of the 8 species including the Fugu and Zebrafish and spanned 
262bp. Interestingly, this region showed high levels of conservation across the two primates 
and dog, but was not conserved in the mouse and the chicken.  
The length of the conserved sequence for each of the regions varied between organisms. The 
lengths indicated in table 3.1 are the longest regions of conservation that was observed for 
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each of the regions. The corresponding coordinates and genome builds for each of the 
conserved regions in the different species analysed in the multiple alignment is shown in 
appendix C. 
Table 3.1 Human chromosomal coordinates of regions showing high levels of conservation across at least 6 species with a 
cutoff of 70% over 100bp 
 Region  Length  %Conservation  
1 Chr8: 11 319 292 – 11 319 555  264bp  70 – 98  
2 Chr8: 11 338 950 – 11 339 330  381bp  70 – 99  
3 Chr8: 11 512 454 – 11 512 859  406bp  76 – 98  
4 Chr8: 12 023 858 – 12 024 011  154bp  71 – 90  
5 Chr8: 12 028 566 – 12 028 689  124bp  71 – 92  
6 Chr8: 12 032 672 – 12 032 771  100bp  70 – 98  
7 Chr8: 12 033 308 – 12 033 490  183bp  72 - 95  
8 Chr8: 12 412 983 – 12 413 244  262bp  70 – 94  
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Figure 3.4 Genome VISTA conservation plot for the open reading frame c8orf13. The red boxes clearly show the conservation 
of the exons in the hypothetical open reading frame c8orf13. Each track is the alignment of the human genome sequence 
with (a) Chimp, (b) Rhesus, (c) Dog, (d) Mouse, (e) Chicken, (f) Fugu,  (g) Zebrafish and (h) Frog 
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Figure 3.5 GenomeVISTA plot showing conservation of  non-coding regions 4 &5 (red box) upstream of regions 6&7 (blue 
box) that showed two distinct regions of sequence conservation within a hypothetical gene which was previously 
uncharacterised. Each track is the alignment of the human genome sequence with (a) Chimp, (b) Rhesus, (c) Dog, (d) 
Mouse, (e) Chicken, (f) Fugu, (g) Zebrafish and (h) Frog   
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3.2.3 Functional analysis of highly conserved regions 
 
The evolutionary conservation of the regions identified above presented them as potential 
functional elements in the KWE critical region. Therefore each of the eight highly conserved 
regions was assessed for potential functional roles via three in silico approaches; gene 
structure prediction, RNA secondary structure formation and the prediction of transcription 
factor binding sites.  There are several computational approaches which have been 
developed to address the challenges associated with predicting in silico functional elements 
in the genome. These methods use the information gathered from experimentally validated 
functional elements to create models and algorithms that allow for the prediction of 
functional elements. Although these approaches have matured significantly in recent years 
resulting in the identification of several experimentally validated functional elements in the 
genome, the prediction of vast amounts of false positives remains a significant challenge. In 
order to address this problem the prediction approaches and tools used in this study were 
those found to be most robust to minimise the occurrence of false positive results. 
3.2.3.1 Prediction of gene structures 
 
The identification of possible gene structures in the conserved sequences was conducted 
using two of the most accurate gene prediction programs, GENSCAN and geneID. Since the 
identified conserved regions may have formed part of exons within possible gene structures, 
1000bp of flanking sequence upstream and downstream was included for the analysis of 
each region. As previously mentioned, the close proximity of conserved regions 4 & 5 and 6 
& 7 presented them as possible exons within a larger gene structure. Similarly, regions 1 and 
2 had previously been identified as c8orf13 and therefore these regions were analysed 
independently as well as together as one large sequence. Both GENESCAN and geneID aim to 
create prediction models that capture the general and specific compositional properties of 
the functional units of a eukaryotic gene which include exons, splice sites and promoters. 
Table 3.2 shows the results obtained from the analysis of the regions using both programs. 
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Table 3.2 Gene structure prediction results showing the highest scoring gene predictions for each of the conserved regions using the two different prediction tools, 
GENESCAN and GeneID 
  GENSCAN Prediction GeneID Prediction 
Region Genomic 
Coordinates 
No. of 
exons 
Length of coding 
sequence (bp) 
Length of AA 
sequence (aa) 
Exon Type No.of 
exons 
Length of coding 
sequence(bp) 
Length of AA 
sequence(aa) 
Exon Type 
1 chr8:11318292 - 
11320555 
1 264 87 Terminal 1 264 88 Terminal 
2 chr8:11337950 -
11340330 
3 684 228 Internal 1 381 127 Initial 
1 & 2 chr8:11318292 -
11340330 
3 645 214 Initial 
Terminal, 
PlyA 
2 282 94 Initial 
Terminal 
3 chr8:11511454-
11513859 
1 198 66 Internal 1 159 53 Internal 
4 chr8:12022858-
12025011 
2 492 164 Initial  
Internal 
2 525 175 Initial 
Internal 
5 chr8:12027566-
12029689 
1 1248 416 Initial 1 1248 416 Initial 
6 chr8:12031672-
12033771 
1 1593 530 Single 1 1593 531 Single 
7 chr8:12032308-
12034490 
1 1371 457 Initial 2 1305 435 Initial 
Internal 
4,5,6,7 chr8:12022858-
12034490 
2 1593 530 Single, 
 PlyA 
1 1593 531 Single 
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8 chr8:12411983- 
12414244 
1 120 40 Internal None    
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Despite advances in the field of computational gene prediction, the methods employed in 
gene-finding are far from being able to accurately predict the exonic structure of genomic 
sequences due to the prediction of a large number of false positive exons and genes. The 
combination of two of the most widely used methods was therefore adopted in order to 
compare the results obtained to address this issue. 
3.2.3.1.1 Gene structure in regions 1-3 
 
Regions 1 and 2 were previously shown to be conserved sequence within a characterised 
open reading frame c8orf13. The function of this open reading frame is yet unknown; 
however it has been shown to be expressed and was previously characterised as a 
hypothetical protein. Based on the gene structure prediction, region 1 showed evidence for a 
possible single terminal exon (3’ splice site to stop codon), while region 2 showed a possible 
gene structure consisting of 3 internal (3’ splice site to 5’ splice site) exons. The prediction for 
regions 1 and 2 together with the intervening sequence produced varying results for each of 
the programs. GENESCAN predicted 3 possible exons consisting of an intial (ATG to 5’ splice 
site) exon, terminal exon and polyA tail, while GeneID predicted an initial and terminal exon. 
In this case, the position number and lengths of the exons varied significantly between the 
two programs. The likely reason for this is based on the fact that c8orf13 has previously been 
characterised as containing 3 exons with the region analysed only encompassing the last 2 
exons and partial fragment of the first exon. In addition, the region is also known to overlap 
with another characterised open reading frame c8orf12, although the conserved regions fall 
within the intronic sequence of this open reading frame. Gene-finding programs such as 
GeneID have been shown not to be able to deal with uncommon phenomena such as nested 
genes, alternate splicing and genes within introns.  
Interestingly at the time that the study was conducted, the region had been annotated as 
open reading frame c8orf13. Subsequently the region has been validated as a hypothetical 
protein coding gene and renamed Homo sapiens family with sequence similarity 167, 
member A (FAM167A). Although this region initially presented as an interesting positional 
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candidate since little is known about its function, it was located significantly upstream of the 
boundary marker D8S1759 for the KWE critical region and had been examined for variations 
in a previous KWE study (Appel et al., 2002). None was detected to co-segregate with KWE. 
The gene structure prediction for region 3 revealed a single internal exon within the region 
using both programs. The score for the prediction was extremely low in both instances and 
since the predicted exon was that of an internal exon with no initial or termination signals, 
the prediction was unlikely to be real, although it could possibly be part of a larger gene 
structure. This was however unlikely based on the fact that the surrounding regions did not 
show any evidence for sequence conservation.  
3.2.3.1.2 Gene structure in regions 4 – 8 
 
As previously mentioned, the close proximity of these conserved regions to each other 
presented them as likely candidates for possible exons within an extended gene structure. 
Individually regions 4 and 5 were both predicted to contain a gene structure consisting of 2 
and 1 exons respectively. In the case of region 4, both an initial and internal exon was 
predicted of similar size encompassing the same region using both programs. The gene 
structure did however lack any signal for a terminator exon and therefore scored poorly for 
possible overall gene structure in both approaches. In this instance however it could be likely 
that the region formed a partial segment of a gene and the terminator signal may be found 
further downstream. Similarly region 5 revealed an identical prediction of a large initial exon 
of 1248bp using both prediction approaches.  
Region 6 presented the most interesting result, with both programs predicting a possibly 
single-exon gene structure. This prediction is based on the identification of an ATG start 
codon followed by a significantly long exon terminating in a stop codon. The predicted exon 
was found to be 1593bp in length, encoding a peptide product of 531 amino acids. Region 7 
was predicted to contain 1 and 2 exons respectively based on each programs prediction, 
although both predictions produced similar coding sequence lengths and predicted peptide 
sequences. Again here it must be noted that due to the close proximity of regions 6 and 7 to 
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each other, the addition of the flanking 1000bp resulted in an overlap of sequence between 
the two regions. Due to this factor, the entire region encompassing regions 4 – 7 was also 
analysed for gene structure using both programs. Interestingly the highest scoring significant 
result obtained for the larger region using both approaches was for the single-exon gene 
structure predicted previously for region 6. In addition, GENESCAN predicted a polyA tail in 
addition to the single-exon structure. This presented region 6 as a strong candidate for a 
possibly novel gene within the KWE critical region. 
Analysis of region 8 using GENESCAN revealed a low scoring internal exon of only 120bp 
encoding a predicted peptide of only 40 amino acids, whilst GeneID failed to predict any 
gene structure for the region. The GENESCAN prediction was therefore likely to be a false 
positive result and the region is therefore unlikely to contain any elements associated with a 
functional gene. 
3.2.3.1.3 Further analysis of region 6-7 
 
Region 6 -7 therefore presented as a possible functional candidate based on the presence of 
a predicted single-exon gene structure. Although single-exon genes are more abundant in 
prokaryotes, a significant percentage has been identified in multi-cellular organisms 
including humans. In order to determine if there was experimental evidence for the 
transcription of region 6, the sequence was subjected to a BLAST search against the NCBI 
Transcript Reference Sequence database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). An exact 
hit was identified against an mRNA sequence described as Homo sapiens deubiquitinating 
enzyme 3 (DUB3).  The alignment of the region to the mRNA was an exact match represented 
by 100% identity over the length of the query sequence. There was an additional slightly 
lower scoring hit with a maximum identity of 96% to an mRNA sequence described as Homo 
sapiens ubiquitin specific peptidase 17 (USP17). Interestingly USP17 shared a high sequence 
similarity to region 6-7 with exactly the same mRNA sequence length with only 4% differing 
between the two sequences. USP17 had been mapped to a region on the short arm of 
chromosome 4 and characterised as a functional deubiquitinating enzyme gene. The high 
similarity of DUB3 suggested that the presence of the significantly similar sequence on 
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chromosome 8 might have been due to a rearrangement or transposition of USP17 within 
the human genome. However since region 6 exhibited an exact match to DUB3 mRNA 
coupled with a slight variation in sequence similarity to USP17 this provided sufficient 
evidence to suggest that the region on chromosome 8 was actively transcribed to produce an 
mRNA.  
DUB3 was first cloned by Burrows et al.(Burrows et al., 2004) and identified as a cytokine 
inducible deubiquitinating enzyme. The gene had however not been mapped to the human 
genome prior to this study due to the presence of a number of highly homologous sequences 
throughout the human genome. The prediction of the single-exon gene based on the 
conserved genomic sequence of region 6-7 coupled with the match to the experimentally 
validated mRNA sequence provided significant evidence to suggest that the mRNA sequence 
for DUB3  mapped to this region. Region 6-7 therefore presented as possible novel protein 
coding region within the KWE critical region. 
Deubiquitinating enzymes or DUBs function by removing the covalently attached ubiquitin 
from proteins, thereby controlling substrate activity and/or abundance. The mechanisms and 
targets of most DUBs as well as their regulation is still poorly understood, however it was 
shown that DUB3 is expressed as mRNA in many different tissues including the heart, spleen, 
kidney, colon, skeletal muscle and liver. DUB3 is a cytokine inducible protein expressed 
transiently and is thought to play a role in blocking cell proliferation and inducing apoptosis 
through the ubiquitin pathway. The molecular function of DUB3 therefore could be involved 
in the observed KWE phenotype and this presented it as a likely novel candidate gene for 
KWE.  
Subsequently during the duration of the study DUB3 was annotated to region 6-7 within the 
KWE critical region on the human genome and was found to consist of a single exon lacking a 
5’ or 3’ UTR and encoding a protein of 530 amino acids. This result correlated perfectly with 
the gene prediction obtained previously for region 6. The newly defined DUB3 was situated 
within the defined KWE critical region however it was previously not examined in other KWE 
studies. Further validation of this region revealed that due to the fact that it shared a 
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significant amount of sequence similarity with USP17 and had likely occurred due to a 
rearrangement or transposition of USP17, it was subsequently renamed Homo sapiens 
ubiquitin specific peptidase 17-like 2 (USP17L2).   
3.2.3.2 Prediction of transcription factor binding sites 
 
Since regions 1 & 2 and 6 & 7 were found to represent c8orf13 and DUB3 respectively they 
were excluded from the analysis for the prediction of transcription factor binding sites 
(TFBS). Each of the remaining conserved regions was subjected to a computational analysis 
to identify possible regulatory regions represented by transcription factor binding sites. As 
previously mentioned, although there are a number of tools available for the prediction of 
possible transcription factor binding sites within a DNA sequence, these tools are hindered 
by the prediction of a vast amount of false positives. To address this problem, a combination 
of two prediction methods was used to identify possible transcription factor binding sites 
within the remaining 4 conserved regions. Predictions were first conducted for each region 
using ConSite which predicts possible TFBS based on the JASPAR CORE database which 
contains curated, non-redundant matrix models for experimentally validated TFBS in 
humans. This prediction is based purely on the use of matrix models describing the binding 
preferences of transcription factors based on known sites for a particular DNA binding 
protein. The model matrices for all known human transcription factors were used to scan 
each region to predict TFBS. The top 5 highest scoring TFBS were noted from these results 
for each region (Table 3.3). The second approach identified TFBS using the JASPAR CORE 
database for humans TFBS, however this prediction was based on a phylogenetic 
footprinting approach whereby the human and mouse sequence were used to identify TFBS 
within conserved regions.    
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Table 3.3 Transcription factor binding site predictions for conserved regions 
 ConSite Single Sequence Prediction ConSite Phylogenetic Footprinting Prediction 
Region Transcript
ion Factor 
Sequence Motif Score Stra
nd 
Transcription 
Factor  
Sequence 
Motif 
Score Strand 
Region 3 c-REL GGAAATACCA 10.391 - SOX9 CCATTGTCC 10.380 - 
 P65 GGAAATACCA 10.192 - SRY ATTGTCCAC 7.585 - 
 SOX-9 CCATTGTCC 10.380 - GATA-3 TTATCA 6.894 - 
 Thing1-
E47 
CTGCCAGATC 10.551 - GATA-2 TATCA 5.778 - 
 SP1 ACCAAGCCTC 9.172 -     
         
Region 4 SP1 GGGGCGGTGT 10.535 + SP1 GGGGCGGTGT  10.535 + 
 Hen-1 CCGCAGCAGGTC 9.170 +     
 c-REL GGTATTTCCC 8.954 -     
 p-65 GGTATTTCCC 8.783 -     
 SPI-1 GGGAAG 8.579 +     
         
Region 5 GATA-3 CTATCT 8.388 - SP1 GCGGCAGTGT 8.274 + 
 SP1 GCGGCAGTGT 8.274 +     
 p65 AGGTATTTCC 8.255 +     
 c-REL AGGTATTTCC 8.104 +     
 NRF-2 AGCGGCAGTG 8.058 +     
         
Region 8 Myf CAGCAGCAGCTG 15.399 + NRF-2 AGCGGAAGCC 10.103 + 
 Myf CAGCAGCAGCTG 14.747 + SPI-B AGCGGAA 9.933 + 
 Tal1beta-
E47S 
GCCAGATGGTCC 12.862 - SAP-1 AGCGGAAGC 9.282 + 
 Myf CAGCAGCAGTTG 11.939 +     
 Myf CAGCAGCAGTTG 11.963 -     
 
The prediction of possible TFBS using the JASPAR CORE database produced numerous 
putative TFBS for each of the regions. This was expected since this type of analysis has a high 
sensitivity but a complete lack of selectivity since the prediction is based purely on the 
identification of sites in a single genomic sequence based on the matrix models for each 
transcription factor. Although the sites are defined binding motifs for known transcription 
factors they may not have any biological function in vivo.  The phylogenetic footprinting 
approach adds a secondary layer of prediction based on the identification of TFBS occurring 
only in highly conserved orthologous regions.  
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In the case of all the regions analysed it was found that the footprinting method significantly 
reduced the number of putative sites predicted.  Region 3 was predicted to contain a 
number of different sites with the highest scoring prediction for the single sequence analysis 
revealing a predicted c-REL and SOX9 TFBS. The footprinting approach predicted the highest 
scoring site to be a SOX9 binding site together with possible SRY, GATA-3 and GATA-2 sites. 
The footprinting approach failed to predict a number of the higher scoring sites predicted by 
the single sequence analysis. Region 3 occurs in a region approximately 90kb upstream of 
GATA-4 and approximately 54kb downstream from BLK. Although the region is quite a 
distance from these two genes these TFBS could possibly play a role in their regulation.  
In the case of regions 4 and 5 only a single TFBS, SP1 was predicted to occur in the region 
using the footprinting approach. For region 4 this had been the highest scoring site using the 
single sequence approach; however for region 5 the highest scoring site, GATA-3, failed to be 
predicted using the footprinting approach.  Regions 4 & 5 occur approximately 3.5kb 
upstream from the DUB3 and approximately 19kb downstream from ZNF705D. SP1 is a 
common TFBS found within several documented promoter regions and the presence of this 
binding site could possibly play a role in the regulation of either of these two genes. 
Region 8 showed conflicting predictions using the 2 approaches. The single sequence analysis 
revealed an overrepresentation of a number of Myf TFBS throughout the region together 
with a Tal1beta-E47S site. In contrast the footprinting approach failed to identify any Myf 
TFBS but instead predicted NRF-2, SPI-B and SAP-1 binding sites. Region 8 is located in a gene 
poor region of the genome with the closest functional element being a predicted gene 
FAM86B2 approximately 75kb upstream of the region. Together with the conflicting binding 
site predictions it appears unlikely that the region contains any biologically relevant TFBS. 
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3.2.3.3 RNA secondary structure prediction 
 
One of the main criteria for the identification of novel miRNA structures is evidence for the 
expression of a particular genomic sequence. Of the 8 highly conserved regions identified, 
the only two regions which showed experimental evidence for the expression of a validated 
mRNA sequence were regions 1 & 2 and regions 6 & 7. Region 1 & 2 were found to 
encompass part of a characterised ORF, c8orf13, which has subsequently been classified as a 
hypothetical protein-coding gene FAM167A, while region 6 & 7 has been identified as a 
known protein coding gene DUB3. Therefore it was unlikely that any of these four regions 
were likely to be involved in the formation of secondary RNA structures and miRNAs. Of the 
remaining conserved regions, region 3 showed no experimental evidence for expression, 
while a number of cDNAs were found to map to the region encompassed by regions 4 and 5 
and region 8. These cDNAs were however significantly longer in length, with each of the 
conserved regions covering a very small portion of the cDNA. These conserved regions were 
therefore analysed to assess the possibility of secondary RNA structure formation.  
3.2.3.3.1 RNA secondary structure in region 4, 5 and 8 
 
The RNAfold server from the Vienna RNA web suite of tools was used to predict the 
secondary structure for each of the conserved regions.  In each case the partition function, 
base pairing probability matrix and minimum free energy (MFE) structure were predicted 
based solely on the RNA sequence. One of the defining criteria to be met for the 
identification of functionally relevant miRNAs is the identification of a predicted minimum 
free energy fold-back precursor with extensive base-pairing in the miRNA region which 
should not contain any large internal loops or asymmetric bulges. The lower the free energy 
of a structure, the more likely it is that the structure is formed, since energy is released. 
Determining the base-pair configuration with the minimum possible free energy forms the 
basis of secondary structure prediction algorithms. Like most in silico approaches it is prone 
to an overrepresentation of false positives; however there are a number of additional 
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algorithms that have been developed to increase the confidence in secondary structure 
predictions. 
Region 4 was predicted to have a MFE of -50.80 kcal/mol producing a secondary structure 
represented in figure 3.6. The corresponding “positional entropy” for the structure is 
indicated by the varying colours in the thermodynamically stable MFE structure ranging from 
red (low entropy, well-defined) via green to blue and violet (high entropy, poorly defined). It 
is clear that there exists a strongly predicted possible stem-loop region on the right of the 
secondary structure, however the rest of the secondary structure appears to be poorly 
predicted based on the positional entropy. Although the stem-loop structure is confidently 
predicted it lacks the required amount of nucleotides within the stem to possibly be 
processed into a functional miRNA. 
 
Figure 3.6 Minimum free energy predicted secondary structure for region 4 
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Figure 3.7 Minimum free energy predicted secondary structure for region 5 
Region 5 was predicted to produce a secondary structure with a MFE of -37.43 kcal/mol. A 
number of stem and loop structures were predicted within the secondary structure; however 
the positional entropy of these regions failed to support the MFE structure with most of the 
structure exhibiting high entropy. The prediction of the secondary structure was therefore 
most likely to not be biologically relevant. 
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Figure 3.8 Minimum free energy predicted secondary structure for region 8 
Region 8 displayed a prediction of a number of stem-loop structures in an overall MFE 
secondary structure of -119.23 kcal/mol. The overall secondary structure exhibited a very 
low MFE however the stem-loop regions varied significantly in the level of positional 
entropies providing little confidence in the prediction.    
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3.3 Comparative genomic hybridization array of KWE critical region 
 
The second part of this study aimed to identify regions of copy number variation within an 
extended KWE critical region. It is now known that copy number variation of specific regions 
of the genome contributes to the neutral variation observed in all individuals. It therefore 
remains a challenging task to identify CNVs that may contribute to a disease phenotype.  
3.3.1 Copy number variation within genes 
 
Visual analysis of copy number variation across the tiled region revealed several regions that 
exhibited deletions or duplications (Table 3.4) in individual samples. Closer analysis of these 
regions showed that most variation was observed within the olfactory repeat region which 
also harbours the gene family of the beta-defensins in a repeat cluster. As previously 
mentioned two olfactory repeat clusters are found within the tiled region and flank the two 
sequence gaps, a proximal (REPP) and distal (REPD) repeat region (Figure 3.9). These two 
repeat clusters are implicated in a large inversion (3.5Mb) that occurs within the region 
which has been observed in KWE affected individuals. This inversion is polymorphic (Giglio et 
al., 2001; Shimokawa et al., 2004). In addition to the beta-defensin genes, there are a 
number of other hypothetical genes that also exhibited copy number variation including 
FAM90A, SPAG11A and FAM90A25P. FAM90A is a primate-specific gene family having 
thought to have arisen due to multiple duplications and rearrangement events, while 
SPAG11A is a sperm associated antigen. The beta-defensin gene cluster has previously been 
shown to exhibit variations in copy number (Figure 3.9). 
Although the regions mentioned in Table 3.4 did show evidence for varying copy number, no 
duplications or deletions were identified that were consistent in all five KWE affected 
individuals. In addition, these regions all fell significantly outside of the KWE critical region.  
All well characterized RefSeq genes, including those genes within the KWE critical region, did 
not show any CNVs based on the visual analysis as well as the analysis using the MeV 
software based on the previously defined thresholds. 
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Table 3.4 Regions identified as displaying copy number variation by visual analysis of normalized and 100bp averaged 
probe intensity plots in all 10 samples using SignalMap. These regions exhibited variation from the normal copy number 
and were either duplicated or deleted 
 
 
Figure 3.9 Part of tiling array showing the olfactory repeat regions REPD and REPP, gap positions and segmental 
duplications highlighted. The beta-defensin gene cluster within the olfactory repeat region is expanded below. 
Genes Location 
Defensin A1\Defensin A3 6 822 602 – 6 863 213 
FAM90A-Pseudogene cluster 7 101 853 – 7 140 853 
DefensinB 106A 7 327 453 – 7 331 319 
DefensinB 107A 7 340 777 – 7 354 343 
FAM90A-Pseudogene cluster 7 393 430 – 7 427 585 
DefensinB 106A 7 720 103 – 7 723 935 
SPAG11A 7 742 811 – 7 758 729 
FAM90A25P 12 316 403- 12 322 770 
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Figure 3.10 aCGH plot for the normalised data in two unaffected individuals for the region encompassing the FAM90A 
pseudogene cluster and beta-defensin gene cluster. Regions of reduced copy number can clearly be noted in the case of 
the green and red bars, with a distinct difference in copy number between the two samples being observed for the blue 
bar. 
 
3.3.2 MeV Analysis of samples for CNVs 
 
Analysis of the 100bp dataset revealed no regions that were either duplicated or deleted in 
all 5 KWE affected individuals (Table 3.5). Two deleted regions were identified in three of the 
five affected individuals, however these regions are found within the distal olfactory repeat 
region. The analysis of the complete normalized dataset revealed many regions that showed 
copy number variation only in the affected individuals, however no common regions were 
identified consistently in all 5 affected individuals. There were however several regions that 
showed deletions in three of the five affected individuals and one region that was deleted in 
four of the affected individuals. 
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The regions found to show copy number variation in three of the affected individuals were 
further investigated and many were found to occur within the beta-defensin gene cluster 
with two deletions occurring within DEFB104A and DEFB107A. The regions surrounding the 
various beta-defensin genes were subjected to BLAST searches against the human genomic 
reference sequence (HG18) and where found to occur at a number of locations on 
chromosome 8 within the repeat regions. These regions therefore share sequence homology 
with a number of loci on chromosome 8 and therefore the intensities observed at a set of 
probes could be due to the hybridization of sequences from a number of highly homologous 
loci. This made it impossible to distinguish the copy number of each of these loci individually.  
Increased copy number of the beta-defensin genes including DEF104A and DEF107A has 
however previously been shown to be associated with the skin disorder psoriasis(Hollox et 
al., 2008). In this case, however, there did not appear to be any consistent increase or 
decrease in copy number of specific beta-defensin genes in the affected individuals.   
Copy number variation was also observed within the intronic regions of annotated genes, 
however not within any genes in the KWE critical region chr8:11,415,050-12,886,829. The 
critical region contains at least six well characterized genes including BLK, GATA4, NEIL2, 
FDFT1, CTSB and LONRF1. None of these genes showed any variation in copy number. Genes 
that were shown to possess some level of CNV within their coding sequence included MSRA, 
RP1L1, PINX1 and XKR6. Although these genes were found outside of the KWE critical region, 
investigation of their molecular function did not suggest any link with the pathogenesis of 
KWE. 
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Table 3.5 Copy number variation observed in affected samples in both the normalized and 100bp averaged datasets using MeV. 
Normalised Dataset 
Common Deleted Regions Samples Closest Known Region 
              
7119740 2502 8002 9402     Downstream DEFB103A chr8:7273826-7275092 
7131188 2502 8002 9402     Downstream DEFB103A chr8:7273826-7275092 
7134548 2502 8002 9402     Downstream DEFB103A chr8:7273826-7275092 
7141881 2502 8002 9402     Downstream DEFB103A chr8:7273826-7275092 
7235589   8002 9402 5202   Downstream DEFB103A chr8:7273826-7275092 
7267619   8002 9402   9302 Downstream DEFB103A chr8:7273826-7275092 
7315664   8002   5202 9302 DEFB104A/B chr8:7315241-7320014-Intronic region a 
7385662   8002 9402 5202   Downstream DEFB107B chr8:7340778-7354243 
7396040 2502 8002 9402     Downstream DEFB107B chr8:7340778-7354243 
7399547 2502 8002 9402     Downstream DEFB107B chr8:7340778-7354243 
7666127 2502 8002 9402     Upstream DEFB107A chr8:7706652-7710648 
7671765   8002 9402 5202   Downstream DEFB107A chr8:7706652-7710648 
7707275   8002 9402 5202   DEFB107A chr8:7706652-7710648-Intronic region a 
7813392   8002 9402   9302 Downstream DEFB4 chr8:7789609-7791646 
7816127   8002 9402 5202 9302 Downstream DEFB4 chr8:7789609-7791646 
7832001     9402 5202 9302 Downstream DEFB4 chr8:7789609-7791646 
8336792 2502 9302 9402     Upstream PRAGMIN chr8:8212668-8276667 
10230336 2502 8002 9402     MSRA chr8:9949240-10323809 -Intronic region a 
10365044 2502 8002 9402     Downstream MSRA chr8:9949240-10323809 
10376988 2502 8002 9402     Downstream MSRA chr8:9949240-10323809 
10562516 2502 8002 9402     RP1L1 (AK127545)  chr8:10,516,016-10,607,107-Intronic region a 
10685589 2502 8002 9402     PINX1 (NM_017884) chr8:10660294-10734709- Intronic region a 
10839888 2502 8002 9402     XKR6 chr8:10791067-11096285-Intronic region a 
10897727 2502 8002 9402     XKR6 chr8:10791067-11096285-Intronic region a 
11168769 2502 9302 9402     Upstream MTMR chr8:11,179,410-11,223,062 
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a  Regions within genes are shown in italics with white backgrounds.  
b Copy number variants within the vicinity of KWE candidate genes
12071685 2502 8002 9402     Upstream DUB3 chr8:12032086-12033678b 
12315046 2502 8002 9402     Upstream DEFB130 chr8:12212843-12220196 
12969776 2502 8002   5202   Downstream DLC1 chr8:12985243-13416766 
              
              
Common Amplified Regions Samples     Region 
6891692 2502 8002 9302     Downstream DEFA5 chr8:6,900,239-6,901,669 
9886092 2502 8002 9402     Downstream TNKS chr8:9450855-9677265 
11082753 2502 8002 9402     XKR6 chr8:10791067-11096285-Intronic region a 
11771928 2502   9402   9302 Upstream CTSB chr8:11737445-11763055b 
12219524 2502 8002 9402     DEFB130 chr8:12212843-12220196 
12219718 2502 8002       DEFB130 chr8:12212843-12220196 
              
100bp Averaged Dataset 
Common Deleted Regions   Samples       Region 
7131200-7131300 2502 8002 9402     Downstream DEFB103A chr8:7273826-7275092 
7405600-7406000 2502 8002 9402     Downstream DEFB107B chr8:7340778-7354243 
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3.3.3 Two regions of copy number variation for further investigation 
 
Two regions of interest that exhibited copy number variation were identified. The first lies 
upstream of deubiquitinating enzyme 3 (DUB3) (Figure 3.11). This region was found to be 
deleted in three of the five affected individuals and lies 38007bp upstream of DUB3 and is 
24bp in length. Although this region lies significantly upstream of DUB3 and out of range of a 
promoter region, DUB3 is a newly characterized gene which codes for a single exon and has 
no know 5’ UTR and therefore may have regulating factors that lie significantly upstream of 
the gene. BLAST results revealed that the sequence does share similarity with a number of 
other regions on chromosome 8 and therefore the result may be a false positive due to cross 
hybridization.  This region is still a possible candidate region for KWE due to its close 
proximity to the newly identified KWE candidate gene DUB3. 
The second region lies 8873bp upstream of CTSB and was found to be duplicated in three of 
the affected individuals (Figure 3.11). CTSB is a strong candidate gene for KWE, however no 
mutations have been identified in the gene to date. This 70bp duplicated sequence appears 
to be unique and therefore it is likely to be a real copy number variant and could possibly be 
involved in the transcriptional regulation of CTSB.  
 
                                   11,737,445-11,763,055         11,771,928-11,771,996                       12,032,086-12,033,678                    12,071,685-12,071,708     
8pTel       
                                                   
                                               8873bp                             38007bp  
 
DUB3 CTSB CNV CNV 
Figure 3.11 Two identified copy number variants and their locations in relation to KWE genes of interest 
8pCen 
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Chapter 4. Discussion 
4.1 Discussion outline 
 
The findings of this study aimed to provide further insight into the KWE linked critical region 
through the identification and annotation of novel functional elements in the region.  This 
was achieved via two main approaches; a comparative genomic analysis of the KWE linked 
critical region and an analysis of the KWE linked critical region for copy number variation. To 
date the molecular cause of KWE remains unknown although the disease was first identified 
over 3 decades ago(Findlay et al., 1977) with the first linkage studies starting in 1985 and the 
gene been localized to 8p in 1997 (Starfield et al., 1997).  A number of positional candidate 
genes have been examined for mutations in affected individuals, however none has 
presented with significant evidence to be linked definitively to KWE. The elusive nature of 
the associated genetic basis for KWE suggests that the molecular cause may lie in a 
previously uncharacterised element within the critical region. The results of this study aimed 
to address this possibility.   
The comparative genomic analysis of the KWE linked critical region led to the discovery of a 
novel gene structure, DUB3, which upon further investigation presented as a very strong 
functional candidate gene for KWE. The approach, as demonstrated in previous studies, 
proved successful in identifying functional regions in the genome based on the conservation 
of these regions in a range of evolutionarily diverse organisms. In addition, a number of 
possible regulatory regions were identified in the form of putative transcription factor 
binding sites, and possible non-coding RNA genes although these were not able to be 
confirmed with much confidence based on computational predictions.   
The aCGH of the KWE critical region led to the identification of a number of copy number 
variable regions within the KWE critical region. Variation in the copy number of functional 
segments of the genome has been implicated as the cause of a number of inherited 
disorders (Stankiewicz and Lupski). No consistent copy number variation was identified in the 
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KWE affected individuals, suggesting that the molecular etiology of KWE might not be due to 
alterations in copy number of functional segments in the KWE critical region. 
Since the aims of this study were divided into two main components the structure of the 
following discussion will be divided into two sections. The first will look at the identification 
of novel functional elements in the KWE critical region and explore the possible link that 
these regions might have to the KWE phenotype, followed by the identification and analysis 
of copy number variants observed within the KWE critical region.  
4.2 Comparative genomics for the identification of functional elements in 
the human genome 
The comparative genomic analysis of the KWE critical region identified 8 regions that 
displayed high levels of sequence conservation across the 8 evolutionarily diverse organisms. 
The inclusion of a range of evolutionarily distant organisms such as the chicken, zebrafish, 
pufferfish and frog was aimed at being able to identify deep phylogenetically conserved 
regions. The addition of more closely related organisms such as the primates and mammals 
was aimed at the identification of highly constrained functional elements.  The comparison 
of genomic sequences at different divergence levels has proven more reliable in the 
identification of regulatory sequences which unlike protein-coding regions are known to be 
under varying levels of constraint (King et al., 2007). Deciphering the relationship between 
function and conservation of non-coding regions is still a topic of much research in recent 
years which has been spurred on by the rapid generation and availability of whole genome 
sequences from a variety of different organisms.      
Although the area of comparative genomics has matured significantly in the last 5 years, the 
challenges involved in accurately identifying regions of the genome that are under functional 
constraint to remain unchanged, are far from being concluded. The underlying premise that 
forms the basis of comparative genomics has however been well established since the first 
comparison of genomic sequences was conducted following the sequencing of the human, 
mouse and rat genomes. The initial comparison of the mouse and human genomes revealed 
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that almost 40% of the mouse genome aligned to the human genome with an average 
nucleotide identity of 67.2% (Waterston et al., 2002; Hardison, 2003). An estimated 5% of 
the 40% of aligned sequence encompasses protein-coding genes and associated regions 
shared between the two organisms which are under strong selective pressure to remain 
unchanged. The function of the remaining 35%, although highly conserved, remains 
unknown. It has been estimated that the rate of divergence in independently evolving 
vertebrate genome is on average 0.1-0.5% per million years (Tautz, 2000). The estimated last 
common ancestor shared between mice and humans approximately 80 million years ago 
placed them at a strategic position to identify shared functionally conserved sequences. 
Subsequently a number of additional mouse-human comparisons validated this finding 
through the identification of a number of additional functional sequences based solely on 
this pairwise analysis (Loots et al., 2000; Pennacchio and Rubin, 2001; Gottgens et al., 2002). 
These findings led to the development of the application of the genomic comparison of 
sequences to identify previously unannotated novel genes, larger functional regulatory 
regions as well as the identification and characterization of transcription factor binding sites 
in conserved non-coding sequences.      
With the generation of a number of additional genomic sequences from a range of 
evolutionarily diverse organisms, the application of comparative genomics was extended 
rapidly to include the comparison of phylogenetically diverse organisms. These studies which 
explored the conservation of sequences across both mammalian and non-mammalian 
organisms demonstrated that in addition to functional protein coding-regions, a substantial 
fraction of non-coding sequence is also strongly conserved between evolutionarily diverse 
organisms (Waterston et al., 2002; Dermitzakis et al., 2003; Thomas et al., 2003; Dermitzakis 
et al., 2005). This led to the realization that the inclusion of a range of evolutionarily diverse 
organisms in comparative strategies was appropriate to identify both conserved slowly 
evolving functional protein-coding regions between closely related organisms as well as 
conserved non-coding regions of the genome which may harbour possible novel functional 
regions.   
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For the reasons mentioned above the comparison of the KWE critical region included a range 
of evolutionarily diverse organisms ranging from the closely related primates to the 
evolutionarily divergent chicken, zebrafish, pufferfish and frog. It must however be noted 
that the choice of species in a comparative sequence analysis is a challenge and in most 
instances is derived based on available data and the selection of organisms that share a 
common physiology or biology. In most studies this approach is useful, however in instances 
where the comparison is between closely related organisms, the conservation is usually too 
high leading to the masking of functionally relevant regions.  This was clearly observed in the 
conservation plots (Appendix B) for the KWE critical region between the closely related 
primate lineages. The comparison of closely related organisms has proven useful in the 
identification of functional elements sharing a common biological role in the organisms 
compared.  However, a balance of biological relevance, evolutionary distance and sequence 
analysis, is the most suited approach for the identification of conserved sequences that 
appear to be under evolutionary constraint against the background of sequence that has 
randomly diverged due to genetic drift (Nobrega and Pennacchio, 2004).    
4.2.1 Identification of evolutionarily conserved elements 
 
In the present study 8 regions were identified that exhibited high levels of sequence 
conservation across the KWE critical region. The 8 regions were found to exhibit some level 
of evolutionary constraint based on the fact that they displayed high levels of sequence 
similarity and were therefore subject to some sort of evolutionary pressure to remain 
unchanged. As previously mentioned for the purpose of this study, regions of interest were 
those that displayed a sequence conservation of at least 70% and a minimum length of 
100bp across at least 6 of the evolutionarily diverse organisms.   
As expected, the annotated protein-coding genes within the region displayed a high level of 
sequence conservation within exonic regions. This was particularly observed for the two 
previous KWE candidate genes in the region FDFT1 and CTSB that showed high levels of 
sequence conservation for exons down to the evolutionarily divergent zebrafish, pufferfish 
and frog (Figure 3.3) , suggestive of a shared biological role for these genes in all the 
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organisms studied.  FDFT1 was previously identified as one of the strong biological candidate 
genes for KWE and encodes a membrane-associated enzyme which is involved in the 
mevalonate pathway, a pathway responsible for the production of critical biological end 
products such as cholesterol, dolichol, ubiquinone, steroid hormones and prenylated 
proteins (Pandit et al., 2000). The enzyme is also essential for the production of essential 
lipids and additional proteins that are required for the regulation of keratinocyte 
differentiation and proliferation in the skin. Similarly CTSB is known to encode a protease 
that is believed to be involved in the control of epidermal keratinocyte proliferation, 
differentiation and migration which are essential processes involved in epidermal 
differentiation and keratinisation as well as involved in the repair mechanism of disrupted 
epidermal barrier (Buth et al., 2004). The strong evolutionary constraint of these regions 
highlights their important functional roles in all the species studied, however a recent study 
examining the genomic DNA and expression of these two candidate genes in KWE affected 
individuals failed to identify any variants that segregated with the disease and thus excluded 
them as likely candidate genes for KWE (Hobbs et al, in press).    
The level of conservation observed between the two non-human primate lineages (chimp 
and rhesus) and human was significantly high across the KWE critical region. This finding was 
to be expected due the relatively recent divergence of the lineages approximately 6-7 million 
years ago. Although interesting events have taken place during this period which has led to 
changes in the human genome responsible for significant alterations in morphology, 
physiology and behavior in humans, the extremely high levels of conservation shared 
between humans and primates make it exceedingly challenging to identify conserved regions 
that are under positive pressure to remain unchanged due to functionality.  The question of 
conservation versus constraint is raised when comparing sequences from two very closely 
related organisms.  
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4.2.1.1 Conservation versus constraint 
 
The premise of the approach used in this part of the study was based on the underlying 
assumption that functional DNA sequences between the species examined have changed 
significantly less than neutral DNA over the relevant phylogenetic distances between them. 
Most evolutionary change between species occurs as a result of mutations with minimal or 
no functional impact that are fixed via random genetic drift. In contrast, mutations in 
functional elements such as coding exons or cis-regulatory elements are likely to impair 
function, be deleterious to the organism, and are subsequently eliminated by purifying 
selection. The detection of sequences affected by purifying selection, which are under 
evolutionary constraint, can be used to annotate novel functional sites in the genome. It is 
however important to distinguish between conservation and constraint. Conservation is 
simply the observation of similarity between sequences whereas constraint is the hypothesis 
about the effects of purifying selection. The conservation of a particular sequence when 
observed to be in excess of levels predicted by a neutral model, can be used to infer 
evolutionary constraint (King et al., 2007; Cooper and Brown, 2008). However, the presence 
of conservation does not necessarily imply constraint nor does its absence imply a lack of 
constraint. It remains a challenge to measure the effects of selection on any given sequence 
of the human genome when comparing only closely related genome sequences, such as non-
human primates, as due to the recent divergence of these organisms a vast majority of 
neutral sequences remains conserved between these organisms. 
 The use of multi-species sequence alignments has been used to address this question and 
several studies have shown that many stringently constrained non-coding sequences are 
indeed functional, even across evolutionarily diverse organisms such as mammals and fish 
(Nobrega and Pennacchio, 2004; Woolfe et al., 2005; Bejerano et al., 2006). The comparison 
of distantly related organisms like the zebrafish and Fugu are so divergent that neutral sites 
have been completely saturated with changes and therefore any sequence that aligns 
between these organisms is almost certainly under constraint. In contrast, the converse also 
however holds true in the fact that some apparently constrained sequences may have little 
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or no obvious function. This has been observed in studies conducted by several groups on 
the globin gene complexes, where a number of cis-regulatory modules (CRMs) have been 
experimentally identified within the globin gene complexes however subsequent multiple 
sequence alignments revealed that some of them are not conserved between human and 
mouse alignments (Dermitzakis et al., 2002; Hughes et al., 2005; King et al., 2005). It should 
therefore be noted that the focus only on deep evolutionarily conserved regions in this study 
served as a means to hone in on regions that were most likely to represent sequences that 
were highly conserved due to constraint. 
4.2.2 Identification of a novel gene deubiquitinating enzyme 3 (DUB3) 
 
The functional analysis of the conserved region 6 identified within the KWE critical region 
revealed a possible single-exon gene structure based on the computational predictions using 
both GENESCAN and GeneID. Coupled with the high levels of sequence conservation of the 
region, this provided a sufficient amount of evidence to suggest that the region was under 
selection and thus subjected to some level of functional constraint. Further evidence for the 
active transcription of the region was observed based on the mapping of a number of 
experimental mRNA sequences to the region. Single exon genes (SEGs) are characteristic of 
prokaryotic genome architecture due to the lack of the intron-exon gene structure observed 
in eukaryotic genomes; however several SEGs have been identified in eukaryotic genomes 
(Brosius, 1999; Gentles and Karlin, 1999; Venter et al., 2001; Sakharkar et al., 2004). The 
presence of SEGs in eukaryotic genomes is quite unexpected and yet to be completely 
understood, however the evolution and origin of some of these SEGs is thought to be due to 
retro-transposition of spliced mRNA derivatives of eukaryotic genes within the genome and 
accounts for approximately 3000 genes in the genome (Sakharkar et al., 2004). The 
prediction of SEGs has therefore in recent years been included in computational prediction 
programs such as GENESCAN and GeneID for the prediction of human gene structures.   
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4.2.2.1 Genome complexities of the DUB3 region 
 
Prior to the start of the current study, the region had been defined as non-coding DNA 
although the gene DUB3 had previously been characterised in a study by Burrows et al. in 
2004 (Burrows et al., 2004). The gene had been identified as belonging to a group of 
deubiquitinating enzymes, which are a group of proteases responsible for the cleavage of 
ubiquitin from ubiquitin-conjugated proteins. To date five families consisting of 
approximately 95 members have been identified including the Ubiquitin C-terminal 
Hydrolases(UCHs), the Ubiquitin Specific Proteases (USPs), the Machado-Joseph Disease 
Protein Domain Proteases (MJDs), the Ovarian tumour Proteases (OTUs) and the JAMM 
Motif Proteases (Wilkinson, 1997; Komander et al., 2009). DUB3 belongs to the DUB/USP17 
subfamily which is the largest family, consisting of approximately 56 members. These 
proteins are characterised by their two well conserved motifs known as the Cys and His 
boxes which are essential for their catalytic activity (Wilkinson, 1997).   The DUB3/USP17 
subfamily of deubiquitinating enzymes was first identified as immediate early genes induced 
in response to cytokine stimulation in both mice (DUB1, DUB1A, DUB2) and humans (DUB3) 
(Zhu et al., 1996b; Zhu et al., 1997; Baek et al., 2004; Burrows et al., 2004). 
Previous studies suggested that the murine genes originally identified were part of a head-
to-tail repeat of DUB/USP17 genes on chromosome 7 of the mouse which had arisen due to 
a tandem duplication event (Zhu et al., 1997). Initial studies also reported that the human 
DUB3/USP17 is encoded as a 1593bp ORF within a megasatellite tandemly repeated region 
on chromosome 4p15 (Kogi et al., 1997) which was shown to be highly polymorphic ranging 
in copy number from 20 to 103 (Okada et al., 2002). In addition, it was also demonstrated 
that a limited number of repeat units are present on chromosome 8(Gondo et al., 1998). 
Although these repeat units were identified on chromosome 8 previously, due to the initial 
mapping of DUB3 to chromosome 4, the region remained annotated as non-coding on 
chromosome 8 at the beginning of this study.   
Furthermore recent evolutionary studies of the DUB3 genes on both chromosomes 4 and 
chromosome 8 have revealed that there is a cluster of 3 DUB/USP17 repeat units on 
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chromosome 8 which appears to have arisen as a result of a duplication of one of the entire 
repeat unit blocks as opposed to a tandem duplication of individual sequences as was found 
on chromosome 4 (Burrows et al., 2010). These clusters occur at varying positions on 
chromosome 8 with only the annotated functional DUB3 occurring within the KWE critical 
region. This hypothesis of a duplication of an entire block of sequence encompassing the 
DUB3 gene was confirmed by analysis of the surrounding sequence.  
It has previously been shown that a beta-defensin gene cluster also occurs on chromosome 8 
(Hollox, 2008). The cluster consists of DEFB107, DEFB105, DEFB106, DEFB104, SPAG11, 
DEFB103, DEFB4, DEFB108 and DEFB109 surrounded by FAM90A/olfactory receptor genes 
which have been shown to be variable in copy number (Groth et al., 2008; Hollox, 2008). Two 
of the DUB/USP17 repeat units are present within the mapped beta-defensin gene cluster 
(Figure 4.1 A &B), with the remaining DUB3 containing cluster not found within the 
recognised copy number variable beta-defensin cluster but associated with a cluster of other 
beta-defensins , FAM90A  and olfactory receptor genes (Figure 4.1 C.) This suggests that 
although the same conserved blocks appear to be derived from a common ancestral block, 
the third region which contains the functionally annotated DUB3 gene is not located within 
the copy number variable beta-defensin cluster. 
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Figure 4.1 Regions on chromosome 8 surrounding DUB/USP17 family members. Diagrams of chromosome 8 (GRCh37 
primary reference assembly) from bases (A) 7 185 000 – 7 205 000 (B) 7 820 000 – 7 840 000 and (C) 11 980 000 – 12 000 
000. The approximate position of the identified DUB/USP17 sequences as well as the adjacent beta-defensin, FAM90A 
and olfactory receptor genes are indicated by the boxes illustrated in the key below (Burrows et al., 2010).    
The above mentioned studies served to explain why DUB3 had not previously been 
annotated to the KWE critical region. The focused analysis of the KWE critical region did 
however lead to the successful identification of the gene as a possible protein-coding region. 
To date there is no experimental evidence to suggest that any of the additional intact 
DUB/USP17 ORFs apart from DUB3 on chromosome 8 and USP17 on chromosome 4  are 
active. 
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4.2.2.2 DUB3 as a possible KWE candidate gene 
 
DUB3 contains two conserved domains, UBP5 and Peptidase_C19E. These domains were 
identified through the alignment of the human DUB3 protein sequence with that of the 
mouse DUB1, DUB2 and DUB2A for which the functional domains have already been 
characterised (Burrows et al., 2004). UBP5 represents the ubiquitin C- terminal hydrolase 
which is believed to be responsible for the post translational modification, protein turnover 
and chaperone activity of the DUB3. Peptidase _C19E is part of the Peptidase C19 family 
which contains ubiquitinyl hydrolases which are intracellular peptidases that remove 
ubiquitin molecules from polyubiquitinated peptides by cleaving isopeptide bonds. The DUB 
enzymes act at several points in the ubiquitin pathway, which plays an important role in 
many molecular mechanisms such as cell division, cell cycle regulation , transcription, 
differentiation and development, apoptosis regulation  and in the degradation of short lived 
regulatory proteins. In particular DUB3 expression is regulated by the cytokines interleukin 4 
(IL-4) and interleukin 6 (IL-6) (Burrows et al., 2004). Cytokines are polypeptide growth factors 
that are involved in transmitting signals between cells. Cytokines regulate immunity and 
inflammation and are produced in response to an immune stimulus and are known to be 
synthesized and secreted by keratinocytes (Feliciani et al., 1996). Keratinocytes represent the 
majority cell type in the skin and the production of cytokines from epidermal cells maintains 
the normal homeostatic mechanisms in the skin and can induce dramatic changes due to 
injury or any external stimulus (Feliciani et al., 1996). Cytokines may have both a pro-
inflammatory and anti-inflammatory function and improper regulation of cytokines have 
been implicated in a number of skin diseases, including psoriasis, atopic dermatitis, lupus 
erythematosus and squamous cell carcinoma (Feliciani et al., 1996).   
Further studies have implicated the DUB genes in cell growth and survival, in particular DUB1 
expression results in cell cycle arrest prior to the S-phase, while DUB2 expression has been 
found to directly inhibit apoptosis induced by cytokine withdrawal (Zhu et al., 1996a; Migone 
et al., 2001). More recent studies have shown that the constitutive expression of DUB3 can 
directly block cell proliferation via the regulation of the ubiquitination and activity of the 
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“CAAX” box protease Ras converting enzyme 1 (RCE1) (Burrows et al., 2004; Burrows et al., 
2009).  In addition, it has also been found that overexpression of the UPS17 family members 
can lead to apoptosis and in particular a recent study has shown that DUB3 regulates the 
ubiquitination and stability of CDC25A which is known to play an integral role in the 
progression of the cell cycle. 
DUB3 therefore presented as a strong candidate gene for KWE, not only because of its high 
level of conservation, but also due to the involvement in blocking cell proliferation and 
inducing apoptosis (Burrows et al., 2004). Apoptosis is a highly conserved basic physiological 
process in which dead unwanted cells are removed without inducing an inflammatory 
response. In self-renewing tissue like the epidermal layers of the skin, cell numbers are 
regulated by a delicate balance between proliferation, differentiation and cell death 
(Reefman et al., 2005). In some human skin diseases such as psoriasis, apoptosis is thought 
to play a role in the development of the disease (Chen et al., 2006). The induction of 
apoptosis results in an increase in the amount of dead skin cells which need to be removed 
from the skin’s stratum corneum. If for some reason, the balance between proliferation, 
differentiation and apoptosis is disrupted, it could lead to the development of abnormalities. 
It has been demonstrated that the transient expression of DUB3 is regulated by the cytokines 
interleukin 4 (IL-4) and interleukin 6 (IL-6). Any form of stress to the palmoplantar surfaces of 
the skin will result in the stimulation and release of cytokines, including IL-4 and IL-6, which 
will stimulate the transient expression of DUB-3. The constitutive expression of DUB3 will 
block growth factor-dependent cell proliferation and possibly induce apoptosis. DUB3 may 
function to regulate immune responses by influencing cell proliferation and survival (Burrows 
et al., 2004). 
The comparative genomics approach therefore proved successful in the identification of not 
only a novel gene in the KWE critical region, but a gene which based on what is known about 
its molecular function presented as a strong functional candidate for the KWE phenotype. 
The gene was subsequently analysed by a colleague, Miss Angela Hobbs, in a sample of KWE 
affected individuals to identify possible mutations within the coding sequence of the gene. 
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Six genetic variants were identified within the DUB3 genomic sequence, however all six 
variants were observed at a frequency of >70% in a corresponding control group analysed 
(Hobbs, Unpublished). Since KWE has displayed a strong autosomal dominant inheritance 
pattern and high penetrance these variants are unlikely to be the cause of KWE. However 
these findings do not completely exclude DUB3 as a possible molecular cause for KWE since 
an investigation into the expression of the gene in KWE affected individuals is yet to be 
explored. Since DUB3 is an excellent candidate gene for KWE it is possible that there may be 
variants present outside the coding region of the gene which may be involved in controlling 
the levels of expression of the gene. As previously mentioned, DUB3 is constitutively 
expressed in response to external stimuli by cytokines, hence it is expected that there should 
be a number of cis-regulatory modules (CRMs) either close to or distant from the gene which 
are responsible for the regulation of the gene’s expression. Variants within these CRMs 
which alter binding sites for necessary regulatory proteins such as transcription factors could 
directly affect the expression of the gene. 
Although a complete analysis of the expression levels of DUB3 in KWE affected individuals is 
required, there are a number of challenges in conducting this study effectively. Firstly, DUB3 
is a single-exon gene with no described 5’ UTR, hence if varying levels of expression are 
observed in KWE affected individuals it will be challenging to determine exactly where the 
regulatory regions are located. Secondly, due to the high similarity between USP17 located 
on chromosome 4p15 and DUB3 it would be challenging to attempt to differentiate between 
the transcripts encoded by these two genes and hence accurately determine the expression 
levels of DUB3.   
4.2.3 Transcription factor binding sites within conserved regions 
 
The computational identification of TFBS within the human genome remains a challenging 
task. In the present study a contributing factor to the complexity of identifying novel TFBS 
was confounded by the fact that the conserved regions analysed were not found within close 
proximity to any known genes.  Although most transcriptional regulation of genes are 
mediated by the sequence specific binding of a combination of TFs to TFBSs close to the 
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transcription start site, the formation of a transcription initiation complex (TIC) which is 
responsible for the recruitment of RNA polymerase involves the interaction of a number of 
additional elements which may not necessarily be found close to the gene that is being 
regulated (Maston et al., 2006). One of these elements may include distal TFBSs which may 
bind TFs a significant distance from the gene that they regulate and contribute to the 
formation of the TIC via protein-protein interactions or chromatin remodeling complexes 
together with non-DNA-binding co-factors and a cluster of TFBS which together form a CRM 
(Figure 4.2). These distal binding sites may be either enhancers or silencers of gene 
expression and ultimately control the spatial and temporal expression of genes. The 
conserved regions identified in this study could therefore contain TFBS which might be 
involved in the spatial and temporal regulation of genes in the KWE critical region.  
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Figure 4.2 Diagrammatic representation of all the possible elements involved in the regulation of gene expression. 
Transcription factors can bind to specific sites that are either proximal or distal to a transcription start site. (Wasserman 
and Sandelin, 2004) 
In the present study a number of transcription factor binding sites were identified within the 
conserved regions 3, 4, 5 and 8 using the conventional approach for the identification of 
motifs based on the position weight matrices (PWMs) for known TFs stored in the JASPAR 
database. As previously mentioned this approach treats each site independently and even 
though the PWMs within the JASPAR database contain only PWMs for experimentally 
validated TFs, the scanning of the conserved sequences with these PWMs led to a number of 
spurious matches which may occur in the genome by chance and not be functional in vivo. 
This was certainly apparent since although only the top scoring hits are shown in Table 3.3, 
the total number of predicted TFBS for regions 3, 4, 5 and 8 were 106, 42, 39 and 80 
respectively. The addition of the phylogenetic footprinting approach was used to in order to 
address this problem of the overrepresentation of possible false positive TFBS. The 
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consistent prediction of a SOX9 binding site for region 3 provided some additional evidence 
that the site may indeed be a likely functional site. Similarly the consensus predictions using 
both methods for region 4 and 5 were that of an SP1 TFBS, while region 8 produced 
completely conflicting results using the two methods. These results served as an example of 
the varying predictive power of the different approaches for identifying de novo TFBS based 
purely on genomic sequences. An assessment of 13 publicly available methods for the 
prediction of transcription factor binding sites showed that no method surpassed others in 
predictive power of a set of data, indicating that the problem of motif discovery is far from 
solved (Tompa et al., 2005). 
4.2.3.1 Computational predictions of regulatory elements 
 
Ultimately the conservation of the regions above together with the prediction of putative 
TFBS presents convincing evidence to suggest that these regions may harbour some 
regulatory elements.  Although the results focused on the highest scoring predictions, it is 
also possible that these conserved regions may harbour multiple TFBS, since as previously 
described; transcriptional regulation usually involves an interaction between a number of 
TFs, chromatin remodeling complexes and other non-DNA-binding co-factors. In essence 
activation or repression of a gene is seldom a binary switch whereby the gene is either 
switched on or off. It is rather a modulation of the rate of transcription through a complex 
process involving a number of TFs and TFBS. These predicted TFBS within the conserved 
regions could be involved in the complex regulation of any of the genes either within close 
proximity or significantly far away. Mutations in regulatory elements are generally assumed 
to not have a pronounced phenotypic effect, since the expression pattern as opposed to the 
structure or function of the protein is altered. In addition, as previously mentioned it has 
been found that a single gene may have multiple regulatory elements with each having a 
small contributory function (Nobrega et al., 2003; Pennacchio et al., 2006). Although this has 
been observed, a number of mutations within non-coding sequences close to or within genes 
have been noted and include diseases such as macular degeneration (Dewan et al., 2006),  
pyruvate kinase deficiency (Manco et al., 2000), Hirschsprung disease (Emison et al., 2005) 
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and X-linked adrenal hypoplasia (Goto and Katsumata, 2009). In addition, diseases such as 
pre-axial polydactyly have been found to be caused by a mutation within a well conserved 
region located approximately 1Mb away from the associated gene SHH (Lettice et al., 2002) , 
while a mutation within an enhancer located 10kb upstream of IRF6 has been associated 
with cleft lip (Rahimov et al., 2008).  
These regions could possibly harbour regulatory elements, which are involved in the 
regulation of genes in the KWE critical region and therefore present as possible candidate 
regions for further investigation. Unfortunately the computational approach to identifying 
regulatory elements possesses its limitations. Recently high-throughput methods such as 
chromatin immunoprecipitation coupled with high throughput sequencing (ChIP-seq) have 
been used to identify genomic sequences bound by a particular protein in vivo. These types 
of experiments allow for the identification of different types of regulatory elements in vivo. 
Such studies are currently being conducted on a genome-wide scale and will provide more 
experimentally based evidence for regulatory regions and insight into the regulation of the 
annotated genes within the KWE critical region.    
 
 
4.2.4 Identification of RNA secondary structure 
 
Regions 4, 5 and 8 did not produce any biologically relevant secondary structures.  Although 
all three predicted secondary structures contained possible hairpin loops, which are 
characteristic of miRNAs, the thermodynamics of the structures did not provide strong 
evidence for the formation of the particular secondary structures. A larger proportion of 
mammalian miRNAs have been mapped to introns of protein coding genes or long mRNA-like 
non-coding transcripts (Rodriguez et al., 2004; Kim and Kim, 2007). In addition, increasing 
evidence suggests that miRNAs are regulated and transcribed similar to protein-coding genes 
(Soifer et al., 2007).  Since regions 4, 5 and 8 all have experimental mRNA sequences mapped 
to them, it is possible that they may form part of larger transcribed region within the KWE 
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critical region which is yet to be annotated. It would however be expected that the 
conserved regions within a non-coding mRNA transcript would be the regions encompassing 
the functional components of the non-coding RNA, i.e. the regions that are conserved in 
order to form hairpin secondary structures required for functional miRNA processing. Since 
these were the regions that were identified and analysed for secondary structure in this 
study it is unlikely that the conserved regions 4, 5 and 8 contain any functional non-coding 
RNA genes. 
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4.3 Copy number variation and KWE 
 
The present study identified a number of regions that exhibited varying levels of copy 
number variation within the KWE critical region. It must be noted that since it is known that 
KWE exhibits a strong autosomal dominant pattern of inheritance and is known to occur due 
to a founder effect, it was expected that if the molecular cause was due to copy number 
variation this too would be present as a common feature across all five of the affected 
individuals.  Hence the premise for the analysis of the aCGH data was based on the fact that, 
if KWE was caused by a duplication or deletion, we expected to find a common pattern of 
CNV in all KWE affected individuals when compared to the healthy controls. However, no 
region was found which displayed a consistent CNV across all 5 affected individuals when 
compared to the controls. None the less, a number of regions of copy number variation were 
observed within regions with potential clinical links to the KWE phenotype which are 
discussed further below. 
4.3.1. CNV of the beta-defensin gene cluster  
 
The regions that exhibited the most variation in copy number in the present study were 
observed within the REPP and REPD clusters. Since these regions are known to be composed 
of low copy repeats (LCRs), which are fragments of DNA greater than 1kb in size and possess 
a sequence identify of greater than 90%, it was expected that they may be responsible for 
mediating nonallelic homologous recombination (NAHR) resulting in the duplication or 
reciprocal translocation of segments of the region. The region was therefore expected to 
show a significant amount of neutral CNV with no significant phenotypic effect. The 
upstream cluster consists of DEFB107, DEFB105, DEFB106, DEFB104, SPAG11, DEFB103, 
DEFB4, DEFB108 and DEFB109 and is flanked by FAM90A/olfactory receptor gene cluster.  
Interestingly the beta-defensin cluster mentioned above is found to vary in copy number 
commonly ranging between 2 and 7 copies in healthy individuals (Groth et al., 2008; Hollox, 
2008). The variation in copy number of this region appears to be a neutral polymorphism; 
however recent studies have shown variation in copy number of distinct defensin genes in 
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the region. Linzmeier and Ganz showed that DEFB4 and DEFB104 varied in copy number 
from between 2 and 8 with a mode of 6 copies per diploid genome (Linzmeier and Ganz, 
2005). Interestingly subsequent studies revealed that epithelial DEFB4 expression and the 
concentration of the corresponding peptide is regulated by the cytokine interleukin- 1 (IL-1) 
and that the mRNA levels of DEFB4 were proportional to DEFB4 gene copy numbers (Hollox 
et al., 2003). This finding therefore made it clear that the copy number of a gene can directly 
affect the expression levels of that gene. Although the region encompassing this cluster of 
beta-defensin genes lies substantially outside of the defined KWE critical region on the 
inverted chromosome, the cluster is incorporated into the region that was investigated.  
Interestingly a later study looking at the possible role of the beta-defensin gene cluster in the 
inflammatory skin disorder psoriasis found a significant association between higher copy 
numbers of the repeat unit encompassing the beta-defensin genes  DEFB4, SPAG11, 
DEFB103, DEFB104, DEFB105, DEFB106 and DEFB107 (Hollox et al., 2008). Psoriasis is a 
common inflammatory skin disease with a strong genetic component as well as an 
environmental contribution. A number of loci and alleles have been identified that confer 
risk of the disease with the beta-defensin cluster on chromosome 8 being identified as one of 
the genetic components. The disease is characterised by red-scaling and elevated plaques, 
commonly found on the elbows, knees and trunk. Beta-defensins are small secreted 
antimicrobial peptides which are encoded by the DEFB genes which are found in three main 
clusters; two on chromosome 20 and one on chromosome 8p23.1 (Ganz, 2003). DEFB1 
encoding the protein hBD-1 and DEFB103 encoding the protein hBD-2 are expressed 
constitutively in the skin and DEFB4 encoding the protein hBD-2 can be induced by cytokines 
in cultured keratinocytes (Harder et al., 1997). Since beta-defensins possess cytokine-like 
properties, high levels of expression may be induced due to skin injury or some other 
environmental trigger. In the case of KWE it is known that severity of disease symptoms is 
increased in the colder winter months during periods of low humidity. Low humidity has 
been found to stimulate keratinocyte proliferation and amplification of the hyper 
proliferative response to barrier disruption resulting in inflammation (Denda et al., 1998). 
The inflammation response is mediated by the beta-defensins and therefore it is possible 
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that increased copy number of the beta-defensin genes described above could lead to an 
inappropriate inflammatory response due to the environmental stimuli of low humidity 
levels resulting in the clinical symptoms typical of KWE.  
Although in this particular study it was not possible to determine the exact copy number of 
the beta-defensin genes, since it is known that the copy number of these genes can vary in 
normal individuals, the variation observed within the cluster suggests that the copy number 
varies significantly between individuals with KWE. Although this is the case, no consistent 
duplications or deletions of specific beta-defensin genes were identified in the 5 KWE 
affected individuals in the present study. At this point the results do suggest that CNVs 
within the beta-defensin cluster described above may be linked to the clinical severity of 
KWE, but not essentially its presence or absence, and presents as an interesting avenue to be 
explored in further studies.   
4.3.2 Copy number variation of known genes in the region 
 
None of the previously characterised genes in the region displayed any consistent levels of 
copy number variation across their entire coding length in the present study. In particular the 
two main candidate genes, FDFT1 and CTSB were both found to be present in the normal 2 
copies for all the individuals analysed. Smaller regions of CNV were however observed within 
intronic regions of MSRA, RP1L1, PINX1 and XKR6. Although these regions of copy number 
variation may be significant to the analysis of the molecular function of the genes they failed 
to identify any link to the phenotypic manifestations of KWE. Previous studies implicating 
CNV as the cause of molecular disorders usually result from the change in copy number of 
dosage sensitive genes (Lupski, 1992; Lupski, 2009). This has been observed in Charcot-
Marie-Tooth disease type 1 A (CMT1A) and hereditary neuropathy with liability to pressure 
palsies (HNPP) where the duplication or deletion of the gene PMP22 results in these two 
diseases, respectively (Chance and Fischbeck, 1994; Reiter et al., 1996). It was therefore 
expected that, should some occurrence of CNV variation be responsible for causing the KWE 
phenotype, it would encompass an entire gene leading to a gene dosage effect.  In addition, 
in this case the altered CNV of the gene should be consistently observed across all KWE 
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affected individuals. Since this was not the case it seemed unlikely that KWE was caused by a 
change in copy number of a dosage sensitive gene within the critical region. 
4.3.3 CNVs within potential regions of interest 
 
 In the current study a number of CNVs were identified within non-coding sequences of the 
region analysed.  Although the most common molecular mechanism for CNVs to cause a 
specific phenotype is through the alteration of copy number of a gene or multiple genes 
sensitive to the dosage effect, CNVs can also result in a position effect (Kleinjan and van 
Heyningen, 2005; Lupski, 2007). A majority of these CNVs were small regions varying in size 
from 20bp to 200bp within the vicinity of known genes in the region. Although these regions 
were significantly small and unlikely to disrupt coding genes, it is possible that they may 
harbour regulatory elements required for the control of spatial and temporal expression of 
genes close to or significantly distant from them. Such effects have been observed in 
diseases such as spastic paraplegia type 2 where a microduplication located downstream 
from the PLP1 gene has been associated with the disease (Lee et al., 2006). Similarly  Dathe 
et al. detected a 5.5kb duplication in a non-coding sequence located approximately 110kb 
downstream of the BMP2  gene in chromosome 20p12.2 as the cause of brachydactyly type 
A2 in two families (Dathe et al., 2009). The duplicated region was found to contain highly 
conserved sequences suggestive of a long-range regulator of the gene.  
Although the regions of CNV observed in the present study are much smaller in size there is 
still a possibility that they might harbour regulatory elements utilized by one of the genes in 
the region. Two of the most plausible CNVs possibly involved in a position effect were those 
identified upstream of the two strong KWE candidate genes CTSB and DUB3. The CNV 
upstream of CTSB is located only 8873bp upstream of the gene and was found to be 
duplicated in 3 of the five affected individuals with no variation been observed in the control 
samples. It is possible that this region may harbour some regulatory elements involved in the 
control of expression of either CTSB or another gene in the region. Similarly, the CNV of 24bp 
found 38007bp upstream of the newly identified gene DUB3 which was deleted in 3 of the 5 
affected individuals could possibly be involved in the regulation of DUB3.  Interestingly these 
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two regions did not fall within any of the highly conserved areas identified in the 
comparative genomics approach of the current study. In addition, as mentioned above most 
disease causing CNVs involving regulatory regions encompass large regions of regulatory 
sequences ranging in size from kb to Mb. It is therefore possible that although the location of 
these two CNVs in relation to candidate genes in the region presents them as likely areas for 
further investigation, it is unlikely that these regions alone would be involved in the 
molecular etiology of KWE. 
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4. 4 Limitations and future studies 
4.4.1 Limitations 
 
The comparative genomics analysis of the KWE critical region served as an exploratory 
method to provide further insight into the region which has been strongly linked to the 
disease. Although the comparison of orthologous sequences has proven to be a successful 
approach for the identification of potentially novel functional elements in the human 
genome, all findings require laboratory validation since computational approaches are far 
from being completely accurate. Although the approach led to the identification of a number 
of regions which appear to be highly conserved it remains a challenge to determine 
conclusively the molecular forces driving this conservation. Due to the extensive 
evolutionary diversity of the organisms included in the comparative sequence analysis it is 
possible that some of these regions may be conserved due to shared functional relevance, 
however the high level of divergence such as between the human and the pufferfish can lead 
to the loss of important mammalian specific functional regions. The present study focused 
exclusively on the identification of regions conserved in the most evolutionarily distant 
organisms. A drawback of this approach is that there may be additional regions that are 
conserved between the more closely related mammals which may be involved in mammalian 
specific functions which have been lost from more divergent species. The current study 
focused exclusively on the identification of conserved sequences across phylogenetically 
distant organisms and hence additional functional non-coding sequences may be identified 
through the examination of conserved regions present only in closely related organisms. 
Although the array CGH data provided significant insight into copy number variation present 
within an extended area of the KWE critical region the method has a number of drawbacks 
which hinder the interpretation of results. Firstly, as previously mentioned in the 
methodology section each sample was hybridized to the array together with a control 
sample consisting of a pool of DNA from six unrelated Caucasian individuals.  The 
downstream consequences of this are that there may be significant population differences in 
the copy number variation in the patients who are of South African Afrikaans origin that may 
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be masked due to allelic CNVs in the group of controls. Although the pooled control aims to 
overcome this factor, if there is a significant population difference in CNVs, as has been 
observed for SNPs, the copy number at known CNVs such as the beta-defensin gene cluster 
would be inaccurately represented. An attempt was made to address this problem through 
the pairwise comparison of affected and unaffected individuals within each family; however 
this did not yield any interesting results which pointed to a specific CNV allele consistently 
present in affected individuals.   
Secondly, KWE has an autosomal dominant inheritance pattern with high penetrance. If KWE 
was caused by a CNV, it would be expected that the CNV would occur on one allele at a 
single locus.  Although array CGH approaches are able to detect copy number variation at a 
single locus the resulting intensity observed is the “sum” of copy number at the two alleles 
for a particular individual. This may result in a masking effect as for a particular locus one 
KWE affected individual may possess three copies of a region on one allele and one on the 
other, while another affected individual may possess two copies on each allele resulting in 
the same intensity on the array. If the three copies were characteristic of a KWE allele it 
would be impossible to detect this based solely on the array CGH results.    
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4.4.2 Future Studies 
 
Although the critical region analysed in this study has shown strong linkage to KWE, a 
thorough examination of the exact defining boundaries of the critical region is required via 
the typing of additional markers in affected and unaffected individuals. As mentioned in the 
limitations above, a more in depth exploration of evolutionarily conserved regions 
specifically in closely related organisms might lead to the identification of further functional 
regions that are yet to be annotated in the region.  
The current advances in high throughput technologies in the field of molecular biology 
present a number of options for future studies in KWE. An examination of the gene 
expression patterns within KWE affected skin versus normal skin using microarray 
technology could provide some interesting insight not only into the molecular cause of the 
disease but also into the pathways involved in the modulation of the symptoms. The gene 
expression array should ideally include all of the characterised genes within the KWE critical 
region including the strong positional candidate genes examined in previous studies in order 
to understand if they are likely to be involved in the molecular etiology of KWE.   
One of the recent advances in the field of disease gene discovery has been the development 
of an exome sequencing approach. Essentially this technology is based on a targeted array 
capture system followed by massively parallel sequencing which provides a genome wide 
approach to sequencing all expressed regions, including protein-coding regions (“exomes”) 
of the genome. Such a study would involve sequencing the “exomes” of a sample of KWE 
affected and unaffected individuals and indentifying variants within the exons present within 
the KWE critical region. Although the sequencing of several candidate genes in the critical 
region has already been done, this approach would allow for all genes within the KWE critical 
region to be assessed for variations regardless of their prior functional links to the KWE 
phenotype.  
Finally, the most comprehensive approach for future KWE studies would be the complete 
sequencing of the KWE critical region, which has become a feasible option in recent years 
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due to a significant reduction in costs. The complete sequencing of the critical region in a 
significant number of affected individuals and healthy controls would allow for all variants in 
the region to be identified and their possible link to the KWE phenotype assessed. In contrast 
to the exome sequencing approach this method will allow for the identification of non-
coding variants in addition to expressed and protein-coding variants.  
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4.5 Conclusions 
 
The findings of the current study have provided a significant amount of further insight into 
the KWE critical region. The comparative genomic analyses of the critical region successfully 
identified a number of highly conserved regions which may be potentially unannotated 
functional regions. Further investigation of these regions led to the identification of a 
previously unannotated gene DUB3 which presented as an excellent functional candidate for 
KWE. Although no possible pathogenic mutations were identified in the gene upon 
investigation, DUB3 cannot conclusively be excluded as being linked to KWE until a 
comprehensive analysis of the expression pattern of the gene is conducted. The remaining 
conserved regions identified showed some evidence for the presence of regulatory elements 
in the form of TFBS, albeit solely based on computational predictions. These regions do 
however appear to be under some level of constraint to remain conserved across 
evolutionarily diverse organisms and therefore warrant some further experimental 
investigation to determine if they have potential functional roles. As further studies aimed at 
the genome wide identification of regulatory elements such as the ENCODE project and 1000 
Genomes project are completed further insight will be gained into the correlation between 
computationally predicted TFBS and experimentally validated sites.  
The copy number variation results suggest that the molecular cause of KWE is unlikely to be 
due to a variation in copy number of segments within the KWE critical region. It was 
expected that if this was the case the copy number variation would encompass a functional 
gene and this would be clearly observed in all of the affected individuals since KWE has a 
strong autosomal dominant inheritance pattern and is highly penetrant. However, as 
previously noted, the variation observed within the beta-defensin cluster did present as a 
possible avenue for further investigation since it has been previously implicated in skin 
disorders such as psoriasis. The determination of the exact copy number of these regions, 
which could not be determined in the present study, would be of interest. Although it may 
not be the sole molecular cause of KWE the copy number of the beta-defensin gene cluster 
may be involved in the interesting cyclic modulation of symptoms observed in KWE. The 
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absence of any consistent large copy number variants within all 5 of the affected individuals 
suggests that KWE is unlikely to be caused by a copy number variant as most other 
documented disease-causing CNVs are significantly larger than the regions of interest 
identified in the present study. 
In conclusion, the comparative genomics approach employed in the present study proved 
successful in identifying a novel protein-coding gene DUB3 which lies within the KWE critical 
region.  DUB3 has been identified as an excellent functional candidate gene for KWE 
although initial analysis of the gene in affected individuals revealed no possible pathogenic 
mutations. DUB3 still however presents as an interesting candidate gene for further 
exploration.  Additional putative functionally relevant highly conserved regions were 
identified within the critical region which was computationally predicted to harbour 
regulatory TFBS. The positioning of these regions within close to proximity to candidate 
genes necessitates the need for further experimental validation. The molecular cause of KWE 
is unlikely to be due to copy number variation within the KWE critical region, although 
further investigation of the beta-defensin cluster might yield some interesting results with 
regard to symptom modulation. The present study has provided valuable insight into the 
KWE critical region and revealed a number of potential regions of interests to be examined in 
further studies as the search for the elusive causative KWE gene continues. 
- References - 
118 
 
References 
Abbasi AA, Paparidis Z, Malik S, Goode DK, Callaway H, Elgar G, Grzeschik KH (2007) Human GLI3 
intragenic conserved non-coding sequences are tissue-specific enhancers. PLoS ONE 2:e366 
Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, 
Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LSt, Kurlan R, 
Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW (2005) Sequence 
variants in SLITRK1 are associated with Tourette's syndrome. Science 310:317-320 
Almeida AM, Murakami Y, Layton DM, Hillmen P, Sellick GS, Maeda Y, Richards S, Patterson S, 
Kotsianidis I, Mollica L, Crawford DH, Baker A, Ferguson M, Roberts I, Houlston R, Kinoshita T, 
Karadimitris A (2006) Hypomorphic promoter mutation in PIGM causes inherited 
glycosylphosphatidylinositol deficiency. Nat Med 12:846-851 
Ambros V (2004) The functions of animal microRNAs. Nature 431:350-355 
An P, Martin MP, Nelson GW, Carrington M, Smith MW, Gong K, Vlahov D, O'Brien SJ, Winkler CA 
(2000) Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. 
Aids 14:2117-2122 
Antequera F, Bird A (1993) Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci 
U S A 90:11995-11999 
Antonarakis SE, Beckmann JS (2006) Mendelian disorders deserve more attention. Nat Rev Genet 
7:277-282 
Appel S, Filter M, Reis A, Hennies HC, Bergheim A, Ogilvie E, Arndt S, Simmons A, Lovett M, Hide W, 
Ramsay M, Reichwald K, Zimmermann W, Rosenthal A (2002) Physical and transcriptional 
map of the critical region for keratolytic winter erythema (KWE) on chromosome 8p22-p23 
between D8S550 and D8S1759. Eur J Hum Genet 10:17-25 
Badano JL, Katsanis N (2002) Beyond Mendel: an evolving view of human genetic disease 
transmission. Nat Rev Genet 3:779-789 
Baek KH, Kim MS, Kim YS, Shin JM, Choi HK (2004) DUB-1A, a novel deubiquitinating enzyme 
subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes. J Biol Chem 
279:2368-2376 
Balikova I, Martens K, Melotte C, Amyere M, Van Vooren S, Moreau Y, Vetrie D, Fiegler H, Carter NP, 
Liehr T, Vikkula M, Matthijs G, Fryns JP, Casteels I, Devriendt K, Vermeesch JR (2008) 
Autosomal-dominant microtia linked to five tandem copies of a copy-number-variable region 
at chromosome 4p16. Am J Hum Genet 82:181-187 
Barber JC, Maloney V, Hollox EJ, Stuke-Sontheimer A, du Bois G, Daumiller E, Klein-Vogler U, Dufke A, 
Armour JA, Liehr T (2005) Duplications and copy number variants of 8p23.1 are 
cytogenetically indistinguishable but distinct at the molecular level. Eur J Hum Genet 
13:1131-1136 
Barber JC, Maloney VK, Huang S, Bunyan DJ, Cresswell L, Kinning E, Benson A, Cheetham T, Wyllie J, 
Lynch SA, Zwolinski S, Prescott L, Crow Y, Morgan R, Hobson E (2008) 8p23.1 duplication 
syndrome; a novel genomic condition with unexpected complexity revealed by array CGH. 
Eur J Hum Genet 16:18-27 
Barrandon Y, Green H (1987) Cell migration is essential for sustained growth of keratinocyte colonies: 
the roles of transforming growth factor-alpha and epidermal growth factor. Cell 50:1131-
1137 
Beetz C, Schule R, Deconinck T, Tran-Viet KN, Zhu H, Kremer BP, Frints SG, et al. (2008) REEP1 
mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia 
type 31. Brain 131:1078-1086 
- References - 
119 
 
Bejerano G, Lowe CB, Ahituv N, King B, Siepel A, Salama SR, Rubin EM, Kent WJ, Haussler D (2006) A 
distal enhancer and an ultraconserved exon are derived from a novel retroposon. Nature 
441:87-90 
Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321:209-213 
Boffelli D, McAuliffe J, Ovcharenko D, Lewis KD, Ovcharenko I, Pachter L, Rubin EM (2003) 
Phylogenetic shadowing of primate sequences to find functional regions of the human 
genome. Science 299:1391-1394 
Bonifas JM, Rothman AL, Epstein EH, Jr. (1991) Epidermolysis bullosa simplex: evidence in two 
families for keratin gene abnormalities. Science 254:1202-1205 
Brosius J (1999) Genomes were forged by massive bombardments with retroelements and 
retrosequences. Genetica 107:209-238 
Burrows JF, Kelvin AA, McFarlane C, Burden RE, McGrattan MJ, De la Vega M, Govender U, Quinn DJ, 
Dib K, Gadina M, Scott CJ, Johnston JA (2009) USP17 regulates Ras activation and cell 
proliferation by blocking RCE1 activity. J Biol Chem 284:9587-9595 
Burrows JF, McGrattan MJ, Rascle A, Humbert M, Baek KH, Johnston JA (2004) DUB-3, a cytokine-
inducible deubiquitinating enzyme that blocks proliferation. J Biol Chem 279:13993-14000 
Burrows JF, Scott CJ, Johnston JA (2010) The DUB/USP17 deubiquitinating enzymes: a gene family 
within a tandemly repeated sequence, is also embedded within the copy number variable 
beta-defensin cluster. BMC Genomics 11:250 
Buth H, Wolters B, Hartwig B, Meier-Bornheim R, Veith H, Hansen M, Sommerhoff CP, Schaschke N, 
Machleidt W, Fusenig NE, Boukamp P, Brix K (2004) HaCaT keratinocytes secrete lysosomal 
cysteine proteinases during migration. Eur J Cell Biol 83:781-795 
Calin GA, Croce CM (2007) Investigation of microRNA alterations in leukemias and lymphomas. 
Methods Enzymol 427:193-213 
Chance PF, Fischbeck KH (1994) Molecular genetics of Charcot-Marie-Tooth disease and related 
neuropathies. Hum Mol Genet 3 Spec No:1503-1507 
Chen X, Tan Z, Yue Q, Liu H, Liu Z, Li J (2006) The expression of interleukin-23 (p19/p40) and 
inteleukin-12 (p35/p40) in psoriasis skin. J Huazhong Univ Sci Technolog Med Sci 26:750-752 
Collin C, Moll R, Kubicka S, Ouhayoun JP, Franke WW (1992) Characterization of human cytokeratin 2, 
an epidermal cytoskeletal protein synthesized late during differentiation. Exp Cell Res 
202:132-141 
Cooper GM, Brown CD (2008) Qualifying the relationship between sequence conservation and 
molecular function. Genome Res 18:201-205 
Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S, Sidow A (2005) Distribution and intensity 
of constraint in mammalian genomic sequence. Genome Res 15:901-913 
Costa JL, Meijer G, Ylstra B, Caldas C (2008) Array comparative genomic hybridization copy number 
profiling: a new tool for translational research in solid malignancies. Semin Radiat Oncol 
18:98-104 
Coulombe PA, Hutton ME, Vassar R, Fuchs E (1991) A function for keratins and a common thread 
among different types of epidermolysis bullosa simplex diseases. J Cell Biol 115:1661-1674 
Dathe K, Kjaer KW, Brehm A, Meinecke P, Nurnberg P, Neto JC, Brunoni D, Tommerup N, Ott CE, 
Klopocki E, Seemann P, Mundlos S (2009) Duplications involving a conserved regulatory 
element downstream of BMP2 are associated with brachydactyly type A2. Am J Hum Genet 
84:483-492 
Davis E, Caiment F, Tordoir X, Cavaille J, Ferguson-Smith A, Cockett N, Georges M, Charlier C (2005) 
RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus. Curr Biol 15:743-
749 
- References - 
120 
 
de Wilde J, Wilting SM, Meijer CJ, van de Wiel MA, Ylstra B, Snijders PJ, Steenbergen RD (2008) Gene 
expression profiling to identify markers associated with deregulated hTERT in HPV-
transformed keratinocytes and cervical cancer. Int J Cancer 122:877-888 
Denda M, Sato J, Tsuchiya T, Elias PM, Feingold KR (1998) Low humidity stimulates epidermal DNA 
synthesis and amplifies the hyperproliferative response to barrier disruption: implication for 
seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol 111:873-878 
Dermitzakis ET, Reymond A, Antonarakis SE (2005) Conserved non-genic sequences - an unexpected 
feature of mammalian genomes. Nat Rev Genet 6:151-157 
Dermitzakis ET, Reymond A, Lyle R, Scamuffa N, Ucla C, Deutsch S, Stevenson BJ, Flegel V, Bucher P, 
Jongeneel CV, Antonarakis SE (2002) Numerous potentially functional but non-genic 
conserved sequences on human chromosome 21. Nature 420:578-582 
Dermitzakis ET, Reymond A, Scamuffa N, Ucla C, Kirkness E, Rossier C, Antonarakis SE (2003) 
Evolutionary discrimination of mammalian conserved non-genic sequences (CNGs). Science 
302:1033-1035 
DeSilva U, Elnitski L, Idol JR, Doyle JL, Gan W, Thomas JW, Schwartz S, Dietrich NL, Beckstrom-
Sternberg SM, McDowell JC, Blakesley RW, Bouffard GG, Thomas PJ, Touchman JW, Miller W, 
Green ED (2002) Generation and comparative analysis of approximately 3.3 Mb of mouse 
genomic sequence orthologous to the region of human chromosome 7q11.23 implicated in 
Williams syndrome. Genome Res 12:3-15 
Desnick RJ, Glass IA, Xu W, Solis C, Astrin KH (1998) Molecular genetics of congenital erythropoietic 
porphyria. Semin Liver Dis 18:77-84 
Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, 
Barnstable C, Pang CP, Hoh J (2006) HTRA1 promoter polymorphism in wet age-related 
macular degeneration. Science 314:989-992 
Di Nardo A, Wertz P, Giannetti A, Seidenari S (1998) Ceramide and cholesterol composition of the skin 
of patients with atopic dermatitis. Acta Derm Venereol 78:27-30 
Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, Puffenberger EG, Hamosh A, 
Nanthakumar EJ, Curristin SM, et al. (1991) Marfan syndrome caused by a recurrent de novo 
missense mutation in the fibrillin gene. Nature 352:337-339 
Donfack J, Schneider DH, Tan Z, Kurz T, Dubchak I, Frazer KA, Ober C (2005) Variation in conserved 
non-coding sequences on chromosome 5q and susceptibility to asthma and atopy. Respir Res 
6:145 
Drake JA, Bird C, Nemesh J, Thomas DJ, Newton-Cheh C, Reymond A, Excoffier L, Attar H, Antonarakis 
SE, Dermitzakis ET, Hirschhorn JN (2006) Conserved noncoding sequences are selectively 
constrained and not mutation cold spots. Nat Genet 38:223-227 
Dubchak I, Brudno M, Loots GG, Pachter L, Mayor C, Rubin EM, Frazer KA (2000) Active conservation 
of noncoding sequences revealed by three-way species comparisons. Genome Res 10:1304-
1306 
Eddy SR (2001) Non-coding RNA genes and the modern RNA world. Nat Rev Genet 2:919-929 
Elias PM (1983) Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 80 Suppl:44s-
49s 
Elias PM (2005) Stratum corneum defensive functions: an integrated view. J Invest Dermatol 125:183-
200 
Elias PM, Feingold KR (2001) Coordinate regulation of epidermal differentiation and barrier 
homeostasis. Skin Pharmacol Appl Skin Physiol 14 Suppl 1:28-34 
Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, Lin S, Portnoy ME, Cutler DJ, Green ED, 
Chakravarti A (2005) A common sex-dependent mutation in a RET enhancer underlies 
Hirschsprung disease risk. Nature 434:857-863 
- References - 
121 
 
Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, et al. (1996) A novel 
MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 
13:399-408 
Feliciani C, Gupta AK, Sauder DN (1996) Keratinocytes and cytokine/growth factors. Crit Rev Oral Biol 
Med 7:300-318 
Feuk L, Marshall CR, Wintle RF, Scherer SW (2006) Structural variants: changing the landscape of 
chromosomes and design of disease studies. Hum Mol Genet 15 Spec No 1:R57-66 
Findlay GH, Nurse GT, Heyl T, Hull PR, Jenkins T, Klevansky H, Morrison JG, Sher J, Schulz EJ, Swart E, 
Venter IJ, Whiting DA (1977) Keratolytic winter erythema or 'oudtshoorn skin': a newly 
recognized inherited dermatosis prevalent in South Africa. S Afr Med J 52:871-874 
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic 
interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811 
Flicek P, Keibler E, Hu P, Korf I, Brent MR (2003) Leveraging the mouse genome for gene prediction in 
human: from whole-genome shotgun reads to a global synteny map. Genome Res 13:46-54 
Fluckiger R, Itin PH (1993) Keratosis extremitatum (Greither's disease): clinical features, histology, 
ultrastructure. Dermatology 187:309-311 
Francova H, Trbusek M, Zapletalova P, Kuhrova V (2004) New promoter mutations in the low-density 
lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: molecular 
and functional analysis. J Inherit Metab Dis 27:523-528 
Frazer KA, Elnitski L, Church DM, Dubchak I, Hardison RC (2003) Cross-species sequence comparisons: 
a review of methods and available resources. Genome Res 13:1-12 
Freeman JL, Perry GH, Feuk L, Redon R, McCarroll SA, Altshuler DM, Aburatani H, Jones KW, Tyler-
Smith C, Hurles ME, Carter NP, Scherer SW, Lee C (2006) Copy number variation: new insights 
in genome diversity. Genome Res 16:949-961 
Fuchs E (2007) Scratching the surface of skin development. Nature 445:834-842 
Fuchs E, Raghavan S (2002) Getting under the skin of epidermal morphogenesis. Nat Rev Genet 
3:199-209 
Gallegos Ruiz MI, Floor K, Roepman P, Rodriguez JA, Meijer GA, Mooi WJ, Jassem E, Niklinski J, Muley 
T, van Zandwijk N, Smit EF, Beebe K, Neckers L, Ylstra B, Giaccone G (2008) Integration of 
gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as 
potential target. PLoS ONE 3:e0001722 
Gallo RL, Nizet V (2003) Endogenous production of antimicrobial peptides in innate immunity and 
human disease. Curr Allergy Asthma Rep 3:402-409 
Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710-720 
Gentles AJ, Karlin S (1999) Why are human G-protein-coupled receptors predominantly intronless? 
Trends Genet 15:47-49 
Gerstein MB, Bruce C, Rozowsky JS, Zheng D, Du J, Korbel JO, Emanuelsson O, Zhang ZD, Weissman S, 
Snyder M (2007) What is a gene, post-ENCODE? History and updated definition. Genome Res 
17:669-681 
Ghanem N, Jarinova O, Amores A, Long Q, Hatch G, Park BK, Rubenstein JL, Ekker M (2003) 
Regulatory roles of conserved intergenic domains in vertebrate Dlx bigene clusters. Genome 
Res 13:533-543 
Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, et al. (2004) 
Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 
428:493-521 
Giglio S, Broman KW, Matsumoto N, Calvari V, Gimelli G, Neumann T, Ohashi H, Voullaire L, Larizza D, 
Giorda R, Weber JL, Ledbetter DH, Zuffardi O (2001) Olfactory receptor-gene clusters, 
- References - 
122 
 
genomic-inversion polymorphisms, and common chromosome rearrangements. Am J Hum 
Genet 68:874-883 
Giglio S, Calvari V, Gregato G, Gimelli G, Camanini S, Giorda R, Ragusa A, Guerneri S, Selicorni A, 
Stumm M, Tonnies H, Ventura M, Zollino M, Neri G, Barber J, Wieczorek D, Rocchi M, Zuffardi 
O (2002) Heterozygous submicroscopic inversions involving olfactory receptor-gene clusters 
mediate the recurrent t(4;8)(p16;p23) translocation. Am J Hum Genet 71:276-285 
Giorda R, Ciccone R, Gimelli G, Pramparo T, Beri S, Bonaglia MC, Giglio S, Genuardi M, Argente J, 
Rocchi M, Zuffardi O (2007) Two classes of low-copy repeats comediate a new recurrent 
rearrangement consisting of duplication at 8p23.1 and triplication at 8p23.2. Hum Mutat 
28:459-468 
Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425-430 
Gondo Y, Okada T, Matsuyama N, Saitoh Y, Yanagisawa Y, Ikeda JE (1998) Human megasatellite DNA 
RS447: copy-number polymorphisms and interspecies conservation. Genomics 54:39-49 
Goto M, Katsumata N (2009) X-linked adrenal hypoplasia congenita caused by a novel intronic 
mutation of the DAX-1 gene. Horm Res 71:120-124 
Gottgens B, Barton LM, Chapman MA, Sinclair AM, Knudsen B, Grafham D, Gilbert JG, Rogers J, 
Bentley DR, Green AR (2002) Transcriptional regulation of the stem cell leukemia gene (SCL)--
comparative analysis of five vertebrate SCL loci. Genome Res 12:749-759 
Gottschaldt KM, Vahle-Hinz C (1981) Merkel cell receptors: structure and transducer function. 
Science 214:183-186 
Groth M, Szafranski K, Taudien S, Huse K, Mueller O, Rosenstiel P, Nygren AO, Schreiber S, 
Birkenmeier G, Platzer M (2008) High-resolution mapping of the 8p23.1 beta-defensin cluster 
reveals strictly concordant copy number variation of all genes. Hum Mutat 29:1247-1254 
Gurnett CA, Bowcock AM, Dietz FR, Morcuende JA, Murray JC, Dobbs MB (2007) Two novel point 
mutations in the long-range SHH enhancer in three families with triphalangeal thumb and 
preaxial polydactyly. Am J Med Genet A 143:27-32 
Harder J, Siebert R, Zhang Y, Matthiesen P, Christophers E, Schlegelberger B, Schroder JM (1997) 
Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-
p23.1. Genomics 46:472-475 
Hardison RC (2000) Conserved noncoding sequences are reliable guides to regulatory elements. 
Trends Genet 16:369-372 
Hardison RC (2003) Comparative genomics. PLoS Biol 1:E58 
Hollox EJ (2008) Copy number variation of beta-defensins and relevance to disease. Cytogenet 
Genome Res 123:148-155 
Hollox EJ, Armour JA, Barber JC (2003) Extensive normal copy number variation of a beta-defensin 
antimicrobial-gene cluster. Am J Hum Genet 73:591-600 
Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D, van de Kerkhof PC, Traupe H, 
de Jongh G, den Heijer M, Reis A, Armour JA, Schalkwijk J (2008) Psoriasis is associated with 
increased beta-defensin genomic copy number. Nat Genet 40:23-25 
Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asahina A, Granstein RD (1993) Regulation of 
Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 
363:159-163 
Hughes JR, Cheng JF, Ventress N, Prabhakar S, Clark K, Anguita E, De Gobbi M, de Jong P, Rubin E, 
Higgs DR (2005) Annotation of cis-regulatory elements by identification, subclassification, and 
functional assessment of multispecies conserved sequences. Proc Natl Acad Sci U S A 
102:9830-9835 
Hull P (1986) Keratolytic winter erythema (Oudtshoorn disease): clinical, genetic and ultrastructural 
aspects., University of the Witwatersrand, Johannesburg 
- References - 
123 
 
Itin PH, Fistarol SK (2005) Palmoplantar keratodermas. Clin Dermatol 23:15-22 
Iwai N, Naraba H (2005) Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 
331:1439-1444 
Jacob F, Monod J (1961) Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol 3:318-
356 
Kalff-Suske M, Wild A, Topp J, Wessling M, Jacobsen EM, Bornholdt D, Engel H, Heuer H, Aalfs CM, 
Ausems MG, Barone R, Herzog A, Heutink P, Homfray T, Gillessen-Kaesbach G, Konig R, Kunze 
J, Meinecke P, Muller D, Rizzo R, Strenge S, Superti-Furga A, Grzeschik KH (1999) Point 
mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome. Hum Mol 
Genet 8:1769-1777 
Kalinin AE, Kajava AV, Steinert PM (2002) Epithelial barrier function: assembly and structural features 
of the cornified cell envelope. Bioessays 24:789-800 
Kallioniemi A, Visakorpi T, Karhu R, Pinkel D, Kallioniemi OP (1996) Gene Copy Number Analysis by 
Fluorescence in Situ Hybridization and Comparative Genomic Hybridization. Methods 9:113-
121 
Kang S, Rosenberg M, Ko VD, Biesecker LG (1997) Gene structure and allelic expression assay of the 
human GLI3 gene. Hum Genet 101:154-157 
Kellis M, Patterson N, Endrizzi M, Birren B, Lander ES (2003) Sequencing and comparison of yeast 
species to identify genes and regulatory elements. Nature 423:241-254 
Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC 
(1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080 
Kim S, Kim Y, Lee Y, Cho KH, Kim KH, Chung JH (2007) Cholesterol inhibits MMP-9 expression in 
human epidermal keratinocytes and HaCaT cells. FEBS Lett 581:3869-3874 
Kim YK, Kim VN (2007) Processing of intronic microRNAs. Embo J 26:775-783 
Kimyai-Asadi A, Kotcher LB, Jih MH (2002) The molecular basis of hereditary palmoplantar 
keratodermas. J Am Acad Dermatol 47:327-343; quiz 344-326 
King DC, Taylor J, Elnitski L, Chiaromonte F, Miller W, Hardison RC (2005) Evaluation of regulatory 
potential and conservation scores for detecting cis-regulatory modules in aligned mammalian 
genome sequences. Genome Res 15:1051-1060 
King DC, Taylor J, Zhang Y, Cheng Y, Lawson HA, Martin J, Chiaromonte F, Miller W, Hardison RC 
(2007) Finding cis-regulatory elements using comparative genomics: some lessons from 
ENCODE data. Genome Res 17:775-786 
Kleinjan DA, van Heyningen V (2005) Long-range control of gene expression: emerging mechanisms 
and disruption in disease. Am J Hum Genet 76:8-32 
Klopocki E, Ott CE, Benatar N, Ullmann R, Mundlos S, Lehmann K (2008) A microduplication of the 
long range SHH limb regulator (ZRS) is associated with triphalangeal thumb-polysyndactyly 
syndrome. J Med Genet 45:370-375 
Knapp AC, Franke WW, Heid H, Hatzfeld M, Jorcano JL, Moll R (1986) Cytokeratin No. 9, an epidermal 
type I keratin characteristic of a special program of keratinocyte differentiation displaying 
body site specificity. J Cell Biol 103:657-667 
Knudsen TB, Kristiansen TB, Katzenstein TL, Eugen-Olsen J (2001) Adverse effect of the CCR5 
promoter -2459A allele on HIV-1 disease progression. J Med Virol 65:441-444 
Koenig M, Monaco AP, Kunkel LM (1988) The complete sequence of dystrophin predicts a rod-shaped 
cytoskeletal protein. Cell 53:219-228 
Kogi M, Fukushige S, Lefevre C, Hadano S, Ikeda JE (1997) A novel tandem repeat sequence located 
on human chromosome 4p: isolation and characterization. Genomics 42:278-283 
Komander D, Clague MJ, Urbe S (2009) Breaking the chains: structure and function of the 
deubiquitinases. Nat Rev Mol Cell Biol 10:550-563 
- References - 
124 
 
Krahl D, Sigwart A, Hartschuh W, Anton-Lamprecht I, Petzoldt D (1994) [Erythrokeratolysis hiemalis. 
Erythematosquamous genetic dermatosis with seasonal manifestation]. Hautarzt 45:776-779 
Kubo M, Hanada T, Yoshimura A (2003) Suppressors of cytokine signaling and immunity. Nat Immunol 
4:1169-1176 
Kunze J (1980) Neurological disorders in patients with chromosomal anomalies. Neuropediatrics 
11:203-249 
Langbein L, Heid HW, Moll I, Franke WW (1994) Molecular characterization of the body site-specific 
human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of 
gene expression. Differentiation 55:164 
Lanza G, Ferracin M, Gafa R, Veronese A, Spizzo R, Pichiorri F, Liu CG, Calin GA, Croce CM, Negrini M 
(2007) mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. 
Mol Cancer 6:54 
Larsen F, Gundersen G, Lopez R, Prydz H (1992) CpG islands as gene markers in the human genome. 
Genomics 13:1095-1107 
Lee JA, Madrid RE, Sperle K, Ritterson CM, Hobson GM, Garbern J, Lupski JR, Inoue K (2006) Spastic 
paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann 
Neurol 59:398-403 
Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs 
with antisense complementarity to lin-14. Cell 75:843-854 
Lettice LA, Heaney SJ, Purdie LA, Li L, de Beer P, Oostra BA, Goode D, Elgar G, Hill RE, de Graaff E 
(2003) A long-range Shh enhancer regulates expression in the developing limb and fin and is 
associated with preaxial polydactyly. Hum Mol Genet 12:1725-1735 
Lettice LA, Horikoshi T, Heaney SJ, van Baren MJ, van der Linde HC, Breedveld GJ, Joosse M, Akarsu N, 
Oostra BA, Endo N, Shibata M, Suzuki M, Takahashi E, Shinka T, Nakahori Y, Ayusawa D, 
Nakabayashi K, Scherer SW, Heutink P, Hill RE, Noji S (2002) Disruption of a long-range cis-
acting regulator for Shh causes preaxial polydactyly. Proc Natl Acad Sci U S A 99:7548-7553 
Linzmeier RM, Ganz T (2005) Human defensin gene copy number polymorphisms: comprehensive 
analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics 
86:423-430 
Loots GG, Locksley RM, Blankespoor CM, Wang ZE, Miller W, Rubin EM, Frazer KA (2000) 
Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence 
comparisons. Science 288:136-140 
Lucito R, Suresh S, Walter K, Pandey A, Lakshmi B, Krasnitz A, Sebat J, Wigler M, Klein AP, Brune K, 
Palmisano E, Maitra A, Goggins M, Hruban RH (2007) Copy-number variants in patients with a 
strong family history of pancreatic cancer. Cancer Biol Ther 6:1592-1599 
Lupski JR (1992) An inherited DNA rearrangement and gene dosage effect are responsible for the 
most common autosomal dominant peripheral neuropathy: Charcot-Marie-Tooth disease 
type 1A. Clin Res 40:645-652 
Lupski JR (2007) Genomic rearrangements and sporadic disease. Nat Genet 39:S43-47 
Lupski JR (2009) Genomic disorders ten years on. Genome Med 1:42 
Manco L, Ribeiro ML, Maximo V, Almeida H, Costa A, Freitas O, Barbot J, Abade A, Tamagnini G (2000) 
A new PKLR gene mutation in the R-type promoter region affects the gene transcription 
causing pyruvate kinase deficiency. Br J Haematol 110:993-997 
Margulies EH, Blanchette M, Haussler D, Green ED (2003) Identification and characterization of multi-
species conserved sequences. Genome Res 13:2507-2518 
Margulies EH, Chen CW, Green ED (2006) Differences between pair-wise and multi-sequence 
alignment methods affect vertebrate genome comparisons. Trends Genet 22:187-193 
- References - 
125 
 
Margulies EH, Cooper GM, Asimenos G, Thomas DJ, Dewey CN, Siepel A, Birney E, et al. (2007) 
Analyses of deep mammalian sequence alignments and constraint predictions for 1% of the 
human genome. Genome Res 17:760-774 
Margulies EH, Green ED (2003) Detecting highly conserved regions of the human genome by 
multispecies sequence comparisons. Cold Spring Harb Symp Quant Biol 68:255-263 
Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, 
Buchbinder S, Goedert JJ, O'Brien TR, Hilgartner MW, Vlahov D, O'Brien SJ, Carrington M 
(1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 
282:1907-1911 
Maston GA, Evans SK, Green MR (2006) Transcriptional regulatory elements in the human genome. 
Annu Rev Genomics Hum Genet 7:29-59 
Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi H, Yamada H, Suzuki M, Nagino 
M, Nimura Y, Osada H, Takahashi T (2007) Apoptosis induction by antisense oligonucleotides 
against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 
26:6099-6105 
Mattick JS, Makunin IV (2006) Non-coding RNA. Hum Mol Genet 15 Spec No 1:R17-29 
Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-
Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, Munch R, Reuter I, Rotert S, 
Saxel H, Scheer M, Thiele S, Wingender E (2003) TRANSFAC: transcriptional regulation, from 
patterns to profiles. Nucleic Acids Res 31:374-378 
McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM (1998) CCR5 
promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study 
(MACS). Lancet 352:866-870 
McLean WH, Irvine AD (2007) Disorders of keratinisation: from rare to common genetic diseases of 
skin and other epithelial tissues. Ulster Med J 76:72-82 
Meister G, Landthaler M, Dorsett Y, Tuschl T (2004) Sequence-specific inhibition of microRNA- and 
siRNA-induced RNA silencing. Rna 10:544-550 
Michael MZ, SM OC, van Holst Pellekaan NG, Young GP, James RJ (2003) Reduced accumulation of 
specific microRNAs in colorectal neoplasia. Mol Cancer Res 1:882-891 
Migone TS, Humbert M, Rascle A, Sanden D, D'Andrea A, Johnston JA (2001) The deubiquitinating 
enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription 
activation and suppresses apoptosis following cytokine withdrawal. Blood 98:1935-1941 
Moll I, Heid H, Franke WW, Moll R (1987) Distribution of a special subset of keratinocytes 
characterized by the expression of cytokeratin 9 in adult and fetal human epidermis of 
various body sites. Differentiation 33:254-265 
Niemann C, Watt FM (2002) Designer skin: lineage commitment in postnatal epidermis. Trends Cell 
Biol 12:185-192 
Nobrega MA, Ovcharenko I, Afzal V, Rubin EM (2003) Scanning human gene deserts for long-range 
enhancers. Science 302:413 
Nobrega MA, Pennacchio LA (2004) Comparative genomic analysis as a tool for biological discovery. J 
Physiol 554:31-39 
Okada T, Gondo Y, Goto J, Kanazawa I, Hadano S, Ikeda JE (2002) Unstable transmission of the RS447 
human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating 
enzyme gene. Hum Genet 110:302-313 
Pandit J, Danley DE, Schulte GK, Mazzalupo S, Pauly TA, Hayward CM, Hamanaka ES, Thompson JF, 
Harwood HJ, Jr. (2000) Crystal structure of human squalene synthase. A key enzyme in 
cholesterol biosynthesis. J Biol Chem 275:30610-30617 
- References - 
126 
 
Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M, Minovitsky S, Dubchak I, 
Holt A, Lewis KD, Plajzer-Frick I, Akiyama J, De Val S, Afzal V, Black BL, Couronne O, Eisen MB, 
Visel A, Rubin EM (2006) In vivo enhancer analysis of human conserved non-coding 
sequences. Nature 444:499-502 
Pennacchio LA, Rubin EM (2001) Genomic strategies to identify mammalian regulatory sequences. 
Nat Rev Genet 2:100-109 
Perier RC, Praz V, Junier T, Bonnard C, Bucher P (2000) The eukaryotic promoter database (EPD). 
Nucleic Acids Res 28:302-303 
Pinkel D, Albertson DG (2005) Comparative genomic hybridization. Annu Rev Genomics Hum Genet 
6:331-354 
Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale 
AL, Brown PO (2002) Microarray analysis reveals a major direct role of DNA copy number 
alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 
99:12963-12968 
Proksch E, Holleran WM, Menon GK, Elias PM, Feingold KR (1993) Barrier function regulates 
epidermal lipid and DNA synthesis. Br J Dermatol 128:473-482 
Radhakrishna U, Wild A, Grzeschik KH, Antonarakis SE (1997) Mutation in GLI3 in postaxial 
polydactyly type A. Nat Genet 17:269-271 
Rahimov F, Marazita ML, Visel A, Cooper ME, Hitchler MJ, Rubini M, Domann FE, Govil M, Christensen 
K, Bille C, Melbye M, Jugessur A, Lie RT, Wilcox AJ, Fitzpatrick DR, Green ED, Mossey PA, Little 
J, Steegers-Theunissen RP, Pennacchio LA, Schutte BC, Murray JC (2008) Disruption of an AP-
2alpha binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet 40:1341-1347 
Rana TM (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat 
Rev Mol Cell Biol 8:23-36 
Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, et al. (2006) Global variation 
in copy number in the human genome. Nature 444:444-454 
Reefman E, Limburg PC, Kallenberg CG, Bijl M (2005) Apoptosis in human skin: role in pathogenesis of 
various diseases and relevance for therapy. Ann N Y Acad Sci 1051:52-63 
Reich DE, Schaffner SF, Daly MJ, McVean G, Mullikin JC, Higgins JM, Richter DJ, Lander ES, Altshuler D 
(2002) Human genome sequence variation and the influence of gene history, mutation and 
recombination. Nat Genet 32:135-142 
Reis A, Hennies HC, Langbein L, Digweed M, Mischke D, Drechsler M, Schrock E, Royer-Pokora B, 
Franke WW, Sperling K, et al. (1994) Keratin 9 gene mutations in epidermolytic palmoplantar 
keratoderma (EPPK). Nat Genet 6:174-179 
Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA, Lupski JR (1996) A recombination 
hotspot responsible for two inherited peripheral neuropathies is located near a mariner 
transposon-like element. Nat Genet 12:288-297 
Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, 
Chou JL, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of 
complementary DNA. Science 245:1066-1073 
Rivas E, Eddy SR (2001) Noncoding RNA gene detection using comparative sequence analysis. BMC 
Bioinformatics 2:8 
Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A (2004) Identification of mammalian microRNA 
host genes and transcription units. Genome Res 14:1902-1910 
Ruiz M, Salvador J, Bayo J, Lomas M, Moreno A, Valero M, Bernabe R, Vicente D, Jimenez J, Lopez-
Ladron A (2008) Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin 
followed by a week off every 28 days for HER2+ metastatic breast cancer. Cancer Chemother 
Pharmacol 62:1085-1090 
- References - 
127 
 
Ruth K. Freinkel DW (2001) The Biology of the Skin. Parthenon Publishing Group, New York 
Sakharkar MK, Chow VT, Chaturvedi I, Mathura VS, Shapshak P, Kangueane P (2004) A report on 
single exon genes (SEG) in eukaryotes. Front Biosci 9:3262-3267 
Schwartz LM, Nambu JR, Wang Z (2002) Parkinsonism proteolysis and proteasomes. Cell Death Differ 
9:479-482 
Schwartz S, Kent WJ, Smit A, Zhang Z, Baertsch R, Hardison RC, Haussler D, Miller W (2003) Human-
mouse alignments with BLASTZ. Genome Res 13:103-107 
Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Maner S, Massa H, Walker M, Chi M, Navin 
N, Lucito R, Healy J, Hicks J, Ye K, Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, 
Wigler M (2004) Large-scale copy number polymorphism in the human genome. Science 
305:525-528 
Segre JA (2006) Epidermal barrier formation and recovery in skin disorders. J Clin Invest 116:1150-
1158 
Sharp AJ, Cheng Z, Eichler EE (2006) Structural variation of the human genome. Annu Rev Genomics 
Hum Genet 7:407-442 
Shimokawa O, Kurosawa K, Ida T, Harada N, Kondoh T, Miyake N, Yoshiura K, Kishino T, Ohta T, 
Niikawa N, Matsumoto N (2004) Molecular characterization of inv dup del(8p): analysis of five 
cases. Am J Med Genet A 128A:133-137 
Soifer HS, Rossi JJ, Saetrom P (2007) MicroRNAs in disease and potential therapeutic applications. 
Mol Ther 15:2070-2079 
Solis C, Aizencang GI, Astrin KH, Bishop DF, Desnick RJ (2001) Uroporphyrinogen III synthase erythroid 
promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic 
porphyria. J Clin Invest 107:753-762 
Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, Tengvall-Linder M, Norstedt G, Alenius H, Homey B, 
Scheynius A, Stahle M, Pivarcsi A (2007) MicroRNAs: novel regulators involved in the 
pathogenesis of Psoriasis? PLoS ONE 2:e610 
Stankiewicz P, Lupski JR Structural variation in the human genome and its role in disease. Annu Rev 
Med 61:437-455 
Starfield M, Hennies HC, Jung M, Jenkins T, Wienker T, Hull P, Spurdle A, Kuster W, Ramsay M, Reis A 
(1997) Localization of the gene causing keratolytic winter erythema to chromosome 8p22-
p23, and evidence for a founder effect in South African Afrikaans-speakers. Am J Hum Genet 
61:370-378 
Strahle U, Rastegar S (2008) Conserved non-coding sequences and transcriptional regulation. Brain 
Res Bull 75:225-230 
Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, Ingle CE, Dunning M, Flicek P, Koller D, 
Montgomery S, Tavare S, Deloukas P, Dermitzakis ET (2007) Population genomics of human 
gene expression. Nat Genet 39:1217-1224 
Strathdee CA, Gavish H, Shannon WR, Buchwald M (1992) Cloning of cDNAs for Fanconi's anaemia by 
functional complementation. Nature 356:763-767 
Sutrala SR, Goossens D, Williams NM, Heyrman L, Adolfsson R, Norton N, Buckland PR, Del-Favero J 
(2007) Gene copy number variation in schizophrenia. Schizophr Res 96:93-99 
Swensson O, Langbein L, McMillan JR, Stevens HP, Leigh IM, McLean WH, Lane EB, Eady RA (1998) 
Specialized keratin expression pattern in human ridged skin as an adaptation to high physical 
stress. Br J Dermatol 139:767-775 
Takahashi K, Paladini RD, Coulombe PA (1995) Cloning and characterization of multiple human genes 
and cDNAs encoding highly related type II keratin 6 isoforms. J Biol Chem 270:18581-18592 
Tautz D (2000) Evolution of transcriptional regulation. Curr Opin Genet Dev 10:575-579 
- References - 
128 
 
Thienpont B, de Ravel T, Van Esch H, Van Schoubroeck D, Moerman P, Vermeesch JR, Fryns JP, Froyen 
G, Lacoste C, Badens C, Devriendt K (2007) Partial duplications of the ATRX gene cause the 
ATR-X syndrome. Eur J Hum Genet 15:1094-1097 
Thomas JW, Touchman JW, Blakesley RW, Bouffard GG, Beckstrom-Sternberg SM, Margulies EH, 
Blanchette M, et al. (2003) Comparative analyses of multi-species sequences from targeted 
genomic regions. Nature 424:788-793 
Tierling S, Dalbert S, Schoppenhorst S, Tsai CE, Oliger S, Ferguson-Smith AC, Paulsen M, Walter J 
(2006) High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse 
chromosome 12. Genomics 87:225-235 
Tompa M, Li N, Bailey TL, Church GM, De Moor B, Eskin E, Favorov AV, Frith MC, Fu Y, Kent WJ, 
Makeev VJ, Mironov AA, Noble WS, Pavesi G, Pesole G, Regnier M, Simonis N, Sinha S, Thijs G, 
van Helden J, Vandenbogaert M, Weng Z, Workman C, Ye C, Zhu Z (2005) Assessing 
computational tools for the discovery of transcription factor binding sites. Nat Biotechnol 
23:137-144 
van Deursen D, Botma GJ, Jansen H, Verhoeven AJ (2007) Comparative genomics and experimental 
promoter analysis reveal functional liver-specific elements in mammalian hepatic lipase 
genes. BMC Genomics 8:99 
Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-
regulate translation. Science 318:1931-1934 
Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, et al. (2001) The sequence 
of the human genome. Science 291:1304-1351 
Villard J (2004) Transcription regulation and human diseases. Swiss Med Wkly 134:571-579 
Ward RD, Davis SW, Cho M, Esposito C, Lyons RH, Cheng JF, Rubin EM, Rhodes SJ, Raetzman LT, Smith 
TP, Camper SA (2007) Comparative genomics reveals functional transcriptional control 
sequences in the Prop1 gene. Mamm Genome 18:521-537 
Washietl S, Hofacker IL, Stadler PF (2005) Fast and reliable prediction of noncoding RNAs. Proc Natl 
Acad Sci U S A 102:2454-2459 
Wasserman WW, Palumbo M, Thompson W, Fickett JW, Lawrence CE (2000) Human-mouse genome 
comparisons to locate regulatory sites. Nat Genet 26:225-228 
Wasserman WW, Sandelin A (2004) Applied bioinformatics for the identification of regulatory 
elements. Nat Rev Genet 5:276-287 
Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, et al. (2002) Initial 
sequencing and comparative analysis of the mouse genome. Nature 420:520-562 
Wilkinson KD (1997) Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. 
Faseb J 11:1245-1256 
Woolfe A, Goodson M, Goode DK, Snell P, McEwen GK, Vavouri T, Smith SF, North P, Callaway H, Kelly 
K, Walter K, Abnizova I, Gilks W, Edwards YJ, Cooke JE, Elgar G (2005) Highly conserved non-
coding sequences are associated with vertebrate development. PLoS Biol 3:e7 
Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielsen H B, Saxild H, Nielsen C, Brunak S, 
Knudsen S (2002) A new non-linear normalization method for reducing variability in DNA 
microarray experiments. Genome Biology  3:research0048.1-0048.16 
Yamaguchi Y, Itami S, Tarutani M, Hosokawa K, Miura H, Yoshikawa K (1999) Regulation of keratin 9 in 
nonpalmoplantar keratinocytes by palmoplantar fibroblasts through epithelial-mesenchymal 
interactions. J Invest Dermatol 112:483-488 
Zhu Y, Carroll M, Papa FR, Hochstrasser M, D'Andrea AD (1996a) DUB-1, a deubiquitinating enzyme 
with growth-suppressing activity. Proc Natl Acad Sci U S A 93:3275-3279 
- References - 
129 
 
Zhu Y, Lambert K, Corless C, Copeland NG, Gilbert DJ, Jenkins NA, D'Andrea AD (1997) DUB-2 is a 
member of a novel family of cytokine-inducible deubiquitinating enzymes. J Biol Chem 
272:51-57 
Zhu Y, Pless M, Inhorn R, Mathey-Prevot B, D'Andrea AD (1996b) The murine DUB-1 gene is 
specifically induced by the betac subunit of interleukin-3 receptor. Mol Cell Biol 16:4808-
4817 
 
 
  
- References - 
130 
 
Online references 
 
Online Mendelian Inheritance in Man <http://www.ncbi.nlm.nih.gov/Omim> (Accessed 
January 2009) 
 
RefSeq <http://www.ncbi.nlm.nih.gov/RefSeq/> (Accessed June 2010) 
 
European Bioinformatics Institute <http://www.ebi.ac.uk/embl/> (Accessed May 2009) 
 
Swiss-Prot protein knowledge database <http://www.expasy.org/sprot> (Accessed April 
2009)  
 
Protein Information Resource <http://pir.georgetown.edu> (Accessed June 2008) 
 
Ensembl Genome Browser <http://www.ensembl.org/index.html> (Accessed August 2010) 
 
UCSC Genome Browser <http://genome.ucsc.edu/> (Accessed August 2010) 
 
The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff 
<http://www.hgmd.cf.ac.uk/ac/> (Accessed December 2010) 
 
The Human microRNA Disease Database <http://cmbi.bjmu.edu.cn/hmdd> (Accessed 
December 2010) 
 
Basic Local Alignment Search Tool (BLAST) <http://blast.ncbi.nlm.nih.gov/Blast.cgi> 
(Accessed April 2010) 
 
GeneID <http://genome.imim.es/geneid> (Accessed May 2009) 
 
GeneScan <http://genes.mit.edu/GENSCAN> (Accessed May 2009) 
 
Vienna RNAfold webserver <http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi> (Accessed June 2010) 
 
MultiExperiment Viewer (MeV) <http://www.tm4.org/> 
 
Galaxy  <http://main.g2.bx.psu.edu/> (Accessed November 2009) 
- Appendices - 
131 
 
Appendices 
 
Appendix A: Ethics Approval 
 
 
- Appendices - 
132 
 
Appendix B: GenomeVISTA Plots of KWE critical region 
 
 
 
 
 
- Appendices - 
133 
 
 
 
 
 
 
 
- Appendices - 
134 
 
 
 
 
 
 
 
- Appendices - 
135 
 
 
 
 
 
 
 
- Appendices - 
136 
 
 
 
 
 
 
 
- Appendices - 
137 
 
 
 
 
 
- Appendices - 
138 
 
Organism 
Human 
Chromosomal 
Coordinates   
Ortholgous 
Coordinates   
Sequence 
Length (Bp) 
% 
Conservation Type 
  Start End Start                                          End       
C8orf13 - Region 1               
Chimp Chr8: 11 319 292 Chr8: 11 319 555 
Contig 
187.40:886 
Contig 
187.40:1149 264 98.50% Exon 
Dog Chr8: 11 319 292 Chr8: 11 319 553 
Chr25:29 467 
282 
Chr25:29 467 
021 262 88.20% Exon 
Mouse Chr8: 11 319 292 Chr8: 11 319 552  
Chr14: 62 416 
750 
Chr14: 62 416 
490 261 88.50% Exon 
Chicken Chr8: 11 319 292 Chr8: 11 319 552  
Chr3: 110 013 
246 
Chr:3 110 013 
506 261 84.70% Exon 
Fugu Chr8: 11 319 242 Chr8: 11 319 552  
Scaffold_72 : 
128 526 
Scaffold_72:  
128 812 259 74.50% Exon 
Zebrafish Chr8: 11 319 292 Chr8: 11 319 552  
Zv6_Scaffold3
733: 552 
Zv6_Scaffold37
33: 295 262 71.00% Exon 
  Chr8: 11 319 294 Chr8: 11 319 552  
Chr20 : 20 052 
962 
Chr20: 20 052 
703 260 70.00% Exon 
Frog Chr8: 11 319 302 Chr8: 11 319 555 
Scaffold_63: 2 
788 622 
Scaffold_63: 2 
788 369 254 84.30% Exon 
                
                
C8orf13 - Region 2               
Chimp Chr8: 11 338 950 Chr8: 11 339 330 
Contig 187.36: 
13 100 
Contig 
187.36:13 480 381 99.50% Exon 
Rhesus Chr8: 11 338 950 Chr8: 11 339 330 
Chr8: 9 306 
543 
Chr8: 9 306 
163 381 96.90% Exon 
Dog Chr8: 11 338 950 Cgr8: 11 339 330 
Chr25: 29 445 
407 
Chr25: 29 445 
039 387 78.30% Exon 
Mouse Chr8: 11 338 950 Chr8: 11 339 330 
Chr14: 62 
406749 
Chr14: 62 406 
6366 384 79.90% Exon 
Chicken Chr8: 11 339 134 Chr8: 11 339 291 
Chr3: 110 023 
050 
Chr3: 110 023 
207 158 70.30% Exon 
Fugu Chr8: 11 339 184 Chr8: 11 339 261 
Scaffold_72: 
127 884 
Scaffold_72: 
127 155 272 82.10% Exon
Frog Chr8: 11 339 138 Chr8: 11 339 221 
Scaffold_63: 2 
782 865 
Scaffold_63: 2 
782 712 154 66.90% Exon 
Appendix C: Coordinates of orthologous regions for each of the 
highly conserved sequences 
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Region 3               
Chimp Chr8: 11 512 454  Chr8: 11 512 859 
Contig 187.22: 
3998 
Contig 187.22: 
4403 406 98.30% 
Inter
genic 
Rhesus Chr8: 11 512 454  Chr8: 11 512 859 
Chr8: 9 126 
851 
Chr8: 9 126 
438 414 93.20% 
Inter
genic 
Dog Chr8: 11 512 465 Chr8: 11 512 576 
Chr25: 29 271 
104 
Chr25: 29 270 
993 112 82.10% 
Inter
genic 
Mouse Chr8: 11 512 468 Chr8: 11 512 814 
Chr14: 62 293 
119 
Chr14: 62 292 
779 350 84.90% 
Inter
genic 
Chicken Chr8: 11 512 555 Chr8: 11 512 835 
Chr3: 110 100 
878  
Chr3: 110 101 
160  287 76.00% 
Inter
genic 
Frog Chr8: 11 512 646 Chr8: 11 512 773 
Scaffold_63: 2 
659 858 
Scaffold_63: 2 
659 727 132 82.60% 
Inter
genic 
                
                
Region 4                
Chimp Chr8: 12 023 858 Chr8: 12 024 011 
Chr12: 8 524 
857 
Chr12: 8 525 
010 154 90.30% 
Inter
genic 
Rhesus Chr8: 12 023 858 Chr8: 12 024 011 
Chr8: 8 342 
521 
Chr8: 8 342 
368 154 90.90% 
Inter
genic 
Dog Chr8: 12 023 886 Chr8: 12 024 011 
ChrUn: 70 218 
979 
ChrUn: 70 219 
104 126 75.40% 
Inter
genic 
  Chr8: 12 023 886 Chr8: 12 024 033 
Chr16: 57 021 
906 
Chr16: 57 022 
050 148 75.00% 
Inter
genic 
Mouse Chr8: 12 023 824 Chr8: 12 023 369 
Chr7: 103 125 
240 
Chr7: 103 125 
385 146 71.90% 
Inter
genic 
  Chr8: 12 023 824 Chr8: 12 023 969 
Chr7: 103 291 
625 
Chr7: 103 291 
480 146 71.90% 
Inter
genic 
Fugu Chr8: 12 023 887 Chr8: 12 023 985 
Scaffold_115: 
724 663 
Scaffold_115:7
24 565 99 71.70% 
Inter
genic 
Zebrafish Chr8: 12 023 859  Chr8: 12 023 981 
Chr12: 15 213 
452 
Chr12: 15 213 
574 123 74.80% 
Inter
genic 
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Region 5 
       
Chimp Chr8: 12 028 566 Chr8: 12 028 689 
Chr12: 8 520 
137 
Chr12: 8 520 
260 124 91.90% 
Inter
genic 
Rhesus Chr8: 12 028 566 Chr8: 12 028 689 
Chr8: 8 342 
525 
Chr8: 8 342 
402 124 85.50% 
Inter
genic 
Dog  Chr8: 12 028 577 Chr8: 12 028 687 
Chr16: 57 066 
600 
Chr16: 57 066 
710 111 72.10% 
Inter
genic 
Mouse Chr8: 12 028 574 Chr8: 12 028 687 
Chr7: 103 125 
278 
Chr7: 103 125 
391 114 74.60% 
Inter
genic 
Zebrafish Chr8: 12 028 577 Chr8: 12 028 690 
Chr12: 15 213 
458 
Chr12: 15 213 
571 114 71.10% 
Inter
genic 
                
                
Region 6                
Chimp Chr8: 12 032 672 Chr8: 12 032 771  
Contig82435.1: 
170 
Contig82435.1: 
71 100 98.00% 
Inter
genic 
  Chr8: 12 032 672 Chr8: 12 032 771  
Chr12: 8 524 
209 
Chr12: 8 524 
308 100 98.00% 
Inter
genic 
Rhesus Chr8: 12 032 674 Chr8: 12 032 771  
Chr8: 8 343 
168 
Chr8: 8 343 
070 98 98.00% 
Inter
genic 
Dog  Chr8: 12 032 672 Chr8: 12 032 771  
Chr16: 57 065 
941 
Chr16: 57 066 
040 100 81.00% 
Inter
genic 
  Chr8: 12 032 672 Chr8: 12 032 771  
ChrUn: 70 228 
241 
ChrUn: 70 228 
247 100 77.00% 
Inter
genic 
Mouse  Chr8: 12 032 672 Chr8: 12 032 771 
Chr:7 103 292 
246 
Chr7: 103 292 
147 100 74.00% 
Inter
genic 
Fugu Chr8: 12 032 670 Chr8; 12 032 766 
Scaffold_115: 
727 739 
Scaffold_115: 
727 643 100 70.00% 
Inter
genic 
                
                
Region 7                
Chimp Chr8: 12 033 308 Chr8: 12 033 490 
Chr12: 8 524 
844 
Chr12: 8 525 
026 183 94.50% 
Inter
genic 
Rhesus Chr8: 12 033 308 Chr8: 12 033 489 
Chr8: 8 342 
534  
Chr8: 8 342 
353 182 91.20% 
Inter
genic 
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Dog  Chr8: 12 033 308 Chr8: 12 033 490 
Chr16: 57 021 
865 
Chr16: 57 022 
044 183 72.10% 
Inter
genic 
Mouse  Chr8: 12 033 311 Chr8: 12 033 438 
Chr7: 103 291 
601 
Chr7: 103 291 
474 128 73.40% 
Inter
genic 
Fugu Chr8: 12 033 340  Chr8: 12 033 448 
Scaffold_115: 
724 673 
Scaffold_115: 
724 565 109 71.60% 
Inter
genic 
                
                
Region 8                
Chimp Chr8: 12 412 983 Chr8: 12 413 244 
Chr8: 7 739 
492 
Chr8: 7 739 
231 262 94.30% 
Inter
genic 
Dog  Chr8: 12 412 939 Chr8: 12 413 209 
Chr6: 39 360 
063 
Chr6: 39 359 
796 274 74.80% 
Inter
genic 
Fugu Chr8:12 412 997 Chr8: 12 413 163 
Scaffold_450: 
91 639 
Scaffold_450:9
1474 167 73.70% 
Inter
genic 
Zebrafish Chr8: 12412 996 Chr8: 12 413 187 
Chr20: 27 726 
082 
Chr20: 27 726 
275 194 69.60% 
Inter
genic 
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Appendix D: Probe coverage of the custom Nimblegen-Roche CGH tiling array 
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Appendix E: Summary of the pairwise copy number variation analysis 
 
CNV regions present only in affected samples in 100bp averaged dataset based on pairwise comparisons 
Duplicated Regions                     
  Start Stop   Start Stop   Start Stop   Start Stop     
  8975064 8975085   7133722 7133867   7419057 7419144   7660772 7661468     
  9054010 9054036   7142566 7142601   7419444 7419476   7661468 7661612     
  9359360 9359388   7145064 7145085   7419476 7419826   7662093 7662116     
  11773425 11773452   7145793 7145816   7419826 7420056   7662116 7662167     
  12657336 12657360   7217733 7217760   7420079 7420556   7662753 7662801     
        7288762 7288787   7421576 7421807   7665852 7665876     
Deleted Regions 7373939 7373960   7425444 7425476   7666352 7666376     
  Start Stop   7394553 7394592   7425476 7425824   7668360 7668407     
  6575099 6575196   7394708 7394733   7426173 7426197   7792520 7792548     
  6826232 6826260   7395228 7395252   7426511 7426583   7813392 7813415     
  6844378 6844401   7395417 7395453   7426703 7426796   7816127 7816151     
  6845016 6845052   7395896 7396040   7429212 7429620   7904372 7904397     
  6863480 6863508   7396532 7396620   7607879 7607964   7907601 7907662     
  6864178 6864203   7398708 7398824   7610148 7610364   7908514 7908692     
  7101356 7101622   7398849 7398956   7610372 7610783   7909065 7909164     
  7102906 7103000   7399368 7399389   7611441 7611728   7909788 7909812     
  7103204 7103232   7399389 7399496   7611742 7611766   7910072 7910244     
  7103544 7103904   7402294 7402316   7611766 7611909   7910457 7910674     
  7110610 7110803   7403568 7403700   7619412 7619543   7912713 7912762     
  7110812 7110992   7406360 7406591   7620320 7620416   7915188 7915488     
  7111161 7111548   7407036 7407191   7623540 7623864   7915497 7915595     
  7116850 7117068   7407200 7407240   7627964 7628062   7915604 7915668     
  7118252 7118424   7409891 7409951   7634385 7634663   7915668 7915689     
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  7118444 7118614   7414724 7414784   7638524 7638670   7915689 7915820     
  7124460 7124480   7417220 7417426   7639164 7639416   7916517 7916552     
  7125777 7125861   7417511 7417572   7648235 7648416   7916552 7916649     
  7126066 7126222   7417655 7417676   7650908 7651005   7917560 7917887     
  7132092 7132316   7417784 7418171   7653119 7653718   7918103 7918160     
  7133337 7133374   7418340 7418361   7654464 7654714   7919900 7919952     
  7133674 7133709   7418640 7418818   7658554 7658660   7920368 7920432     
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  Start Stop   Start Stop   Start Stop       
  7923227 7923252   10078016 10078044   11857856 11857881       
  7923297 7923321   10318776 10318857   11972073 11972098       
  7923704 7923804   10345210 10345234   12069203 12069249       
  7924283 7924304   10368492 10368516   12070416 12070439       
  7925088 7925111   10413189 10413215   12318620 12318644       
  7927968 7928312   10433289 10433312   12844882 12844904       
  8239772 8239800   10562516 10562580   12969776 12969801       
  8358600 8358624   10571493 10571517   
  
      
  8426300 8426326   10618880 10618905   
  
      
  8442332 8442360   10740597 10740621   
  
      
  8599223 8599248   10849700 10849724   
  
      
  8652120 8652141   10854693 10854716   
  
      
  8871656 8871683   10899000 10899020   
  
      
  8891746 8891769   10917560 10917620   
  
      
  8945528 8945556   11002668 11002690   
  
      
  9014180 9014204   11096624 11096648   
  
      
  9022822 9022844   11200244 11200272   
  
      
  9050015 9050036   11207492 11207553   
  
      
  9089927 9089952   11242308 11242332   
  
      
  9135093 9135116   11243484 11243505   
  
      
  9373560 9373584   11251845 11251870   
  
      
  9466892 9466919   11355104 11355128   
  
      
  9655821 9655848   11359604 11359631   
  
      
  9692277 9692303   11426088 11426112   
  
      
  9815460 9815483   11519844 11519865   
  
      
  9883124 9883152   11655492 11655512   
  
      
  9903668 9903696   11731317 11731342   
  
      
  10013637 10013662   11841560 11841585   
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Appendix F: CNV Pairwise Comparison Results 
 
Red blocks indicate CNV regions identified in more than one of the affected\unaffected pairs  
100bp Averaged Pairwise Comparisons Duplicated Regions 
9302_9102 9402_8902 8002_7902 5202_7602 2502_2402       
Start Stop Start Stop Start Stop Start Stop Start Stop       
6585300 6585400 6579300 6579400 8294900 8295300 7988100 7988300 6579300 6579400       
6936500 6936600 6922900 6923200 9372000 9372100 8615400 8615500 6976600 6976700       
7003700 7003800 6958900 6959000 9550700 9553200 11188500 11188600 6978500 6978600       
7067300 7067400 7020450 7019400 11435900 11436200 11770400 11770700 7022800 7022900       
7067600 7067700 7026400 7026500 11949800 11949900     7045300 7045400       
7112200 7112500 7045400 7045500 11952200 11952300     7179200 7179300       
7177800 7178000 7204900 7205000 12228300 12228700     7204800 7205100       
7179900 7180000 7441000 7441100 12228800 12229000     7381600 7381700       
7182500 7182700 7984200 7984300         7845200 7845300       
7582000 7582100 7992500 7992600         7981900 7982000       
7611300 7611400 8170800 8170900         7997900 7998600       
7628400 7628800 8975000 8975100         7999600 7999700       
7633800 7634100 9080000 9080300         8170800 8170900       
7643700 7644100 9450200 9450300         8975000 8975100       
7656800 7657000 9703700 9703800         9550700 9553200       
7862400 7862500 9769400 9769700         10045400 10045500       
7863300 7863400 10232900 10233000         11082700 11082800       
7867400 7867500 10429500 10429600         11283200 11283300       
7867600 7867700 10478900 10479100         11773200 11773500       
7872300 7872400 10719100 10719200         11824800 11824900       
7922900 7923200 11034700 11034900         11965000 11965200       
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8133800 8134100 11059500 11059600         12005900 12006000       
8615400 8615500 11082700 11082800         12249800 12250200       
11268900 11269200 11253900 11254000         12259100 12259200       
11338300 11338400 11269900 11270200         12278300 12278400       
11344900 11345000 11770700 11771700         12475600 12475900       
12024000 12024100 11824800 11824900         12514300 12514400       
12027200 12027300 11929700 11930100         12540000 12540100       
12027900 12028000 12208100 12208200         12602200 12602300       
12031000 12031100 12218500 12218700         12775700 12775800       
12032800 12032900 12460100 12460200                   
12033100 12033200 12481900 12482000                   
12033400 12033500 12514200 12514300                   
12276500 12276600 12540000 12540100                   
12277000 12277200 12582900 12583000                   
12281500 12281600 12587300 12587400                   
12283800 12283900 12775700 12775800                   
12819700 12820000                       
12866500 12866700                       
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100bp Averaged Pairwise Comparisons Deleted Regions 
9302_9102 9402_8902 8002_7902 5202_7602 2502_2402       
Start Stop Start Stop Start Stop Start Stop Start Stop       
6551700 6551800 6700000 6700200 7068200 7068300 7794100 7794200 6575100 6575200       
6697300 6697400 6855500 6855500 7072600 7072700 9184400 9185200 6845200 6845300       
6700000 6700100 6915000 6915000 7103300 7103900 9403500 9403600 6846900 6847000       
6820400 6820600 6932900 6932900 7106300 7106600 10728500 10728600 7099100 7099400       
6839500 6839700 7019300 7019300 7116000 7116100 11506200 11506400 7100700 7100800       
6858600 6858700 7077300 7077500 7129500 7129700 11640200 11640500 7101400 7102200       
6863400 6863500 7099700 7100000 7131200 7131300 11722800 11723200 7102600 7102800       
6864100 6864200 7100100 7100600 7134100 7134500     7102900 7103500       
7238700 7238900 7100900 7101000 7141800 7141900     7103600 7104000       
7756000 7756100 7101200 7101800 7144700 7144800     7104100 7104500       
7756200 7756300 7101900 7102600 7145100 7145200     7104900 7105200       
7816100 7816200 7102700 7102900 7262000 7262100     7109300 7109800       
8543100 8543200 7104000 7104100 7262300 7262400     7110000 7110500       
9403500 9403600 7104300 7105400 7286700 7286900     7110600 7110700       
9686500 9686800 7106300 7106600 7287100 7287200     7110800 7111700       
10561400 10561600 7107200 7107600 7289600 7289900     7111900 7112500       
12396100 12396300 7107800 7108200 7290000 7290100     7115000 7115500       
12712900 12713200 7108300 7108400 7307200 7307300     7116600 7117500       
    7108500 7108900 7307600 7307700     7117600 7118000       
    7109900 7110200 7307800 7307900     7118200 7118600       
    7110500 7110600 7313500 7313600     7118900 7119800       
    7111200 7111700 7330500 7330600     7124300 7125100       
    7111800 7112900 7331100 7331200     7125200 7126400       
    7113700 7114100 7354200 7354300     7126500 7127300       
    7114900 7115300 7371100 7371150     7127500 7127900       
    7115400 7115800 7371300 7371400     7130600 7130800       
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    7116000 7116100 7371500 7371700     7131200 7131300       
    7116200 7116300 7371900 7372300     7131900 7132100       
    7116400 7117000 7372500 7372600     7132200 7132700       
    7117100 7117900 7373000 7373100     7132800 7133300       
    7118000 7118200 7385800 7385900     7133400 7133700       
    7118700 7118800 7386200 7386300     7133800 7134000       
    7118900 7119300 7386500 7386900     7134100 7134500       
    7119500 7120600 7388500 7388600     7134600 7135000       
    7121200 7121900 7395800 7395900     7137500 7137600       
    7122500 7122900 7398900 7399000     7139500 7140300       
    7123000 7123200 7403600 7403700     7140700 7140900       
    7123300 7123500 7405600 7405700     7141100 7141200       
    7123800 7123900 7410200 7410300     7141300 7141400       
    7124000 7124600 7410400 7410500     7142300 7143000       
    7124800 7125500 7413700 7414000     7144800 7144900       
    7125600 7125800 7417500 7417600     7391700 7391800       
    7126800 7126900 7421600 7421800     7394200 7394900       
    7127400 7128300 7429300 7429600     7395000 7395100       
    7128400 7128500 7455100 7455200     7395600 7395700       
    7128900 7129500 7576800 7576900     7395900 7396100       
    7130100 7130200 7582700 7582800     7396700 7397400       
    7130700 7131100 7582900 7583100     7398600 7398900       
    7131200 7131300 7608100 7608200     7399400 7399500       
    7131400 7131500 7611300 7611400     7401800 7402600       
    7131700 7132000 7616900 7617000     7402800 7402900       
    7132800 7133100 7620500 7620600     7403100 7403200       
    7133200 7133400 7626100 7626300     7403300 7403700       
    7133800 7134500 7635800 7636000     7404300 7405100       
    7134800 7135300 7639200 7639400     7405600 7405700       
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    7135400 7135900 7640600 7641300     7406400 7406500       
    7136600 7136700 7643100 7643200     7407100 7407200       
    7136800 7137100 7655800 7656000     7409500 7410000       
    7137600 7138100 7656700 7656900     7410900 7411100       
    7138300 7138500 7658000 7658400     7411200 7411400       
    7138600 7138900 7665000 7665200     7412000 7412100       
    7139000 7139100 7671000 7671100     7414000 7414300       
    7139200 7139900 7672300 7672400     7416700 7417200       
    7140400 7140600 7673200 7673300     7417500 7417700       
    7140700 7140900 7674000 7674100     7417800 7418100       
    7141000 7141100 7674200 7674300     7418300 7418800       
    7141500 7141600 7674400 7674600     7418900 7419100       
    7141700 7141800 7687600 7687700     7419500 7420300       
    7142000 7142500 7688500 7688800     7421600 7421800       
    7142600 7143000 7688900 7689000     7424400 7424700       
    7199650 7143400 7689100 7689300     7424800 7425800       
    7144700 7144800 7689400 7689500     7426000 7426200       
    7145000 7145100 7720200 7720300     7426300 7426800       
    7145300 7145600 7736700 7736800     7427200 7428200       
    7145800 7145900 7743000 7743100     7429200 7429300       
    7238100 7238200 7743500 7743600     7607600 7608000       
    7246000 7246100 7743700 7743800     7608300 7608600       
    7261700 7261800 7744000 7744200     7609900 7610700       
    7261900 7262000 7746500 7746600     7611200 7611400       
    7269200 7269300 7759200 7759300     7611500 7612000       
    7272400 7272500 7760800 7760900     7612200 7613400       
    7287000 7287100 7761300 7761400     7617700 7618400       
    7288700 7288900 7761700 7762000     7618500 7618800       
    7290700 7291000 7764600 7764700     7618900 7619000       
- Appendices - 
151 
 
    7304600 7304700 7789400 7789500     7619300 7619700       
    7371200 7371200 7804900 7805000     7619800 7620200       
    7373400 7373500 7805200 7805300     7620300 7620700       
    7374100 7374200 7810100 7810200     7623600 7624100       
    7385800 7385900 7812500 7812600     7625300 7626000       
    7387600 7387800 7816600 7816700     7626200 7626600       
    7391300 7391700 7905000 7905200     7626900 7627200       
    7392000 7392300 7925200 7926000     7627400 7627800       
    7392500 7392600 7952900 7953000     7627900 7628300       
    7392800 7392900 8110100 8110600     7630800 7630900       
    7393300 7393500 8942400 8942600     7633000 7634100       
    7393600 7394100 9709400 9709900     7634200 7634300       
    7394200 7394500 10654400 10654500     7634400 7634800       
    7394700 7394800 12064900 12065000     7634900 7636000       
    7395100 7395200 12065500 12065600     7640600 7641300       
    7395300 7395600 12068000 12068100     7641500 7641700       
    7395800 7396000 12069700 12069800     7641800 7641900       
    7396300 7396600 12072300 12072400     7642000 7642100       
    7396900 7397900 12314100 12314300     7642300 7642600       
    7398000 7398300 12314800 12314900     7642700 7643300       
    7398400 7398600 12317900 12318000     7645500 7646100       
    7399100 7399300 12504600 12504700     7646800 7647000       
    7399800 7400500 12510700 12510800     7648200 7649000       
    7400800 7400900         7649500 7649600       
    7401100 7401700         7649900 7650000       
    7401800 7401900         7650400 7650700       
    7402000 7402200         7650800 7651300       
    7402300 7402400         7654500 7654700       
    7402900 7403200         7655800 7656600       
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    7403400 7403700         7657100 7657300       
    7403900 7404200         7657500 7657700       
    7404600 7405500         7658400 7659200       
    7405600 7406000         7660800 7661400       
    7406100 7406300         7662100 7662200       
    7406700 7406800         7664400 7664600       
    7406900 7407000         7664800 7664900       
    7407900 7408200         7665200 7665400       
    7408500 7408600         7665900 7666000       
    7408700 7409400         7666100 7666200       
    7409500 7409600         7666300 7666500       
    7410000 7410300         7666700 7667100       
    7410400 7410500         7669000 7669200       
    7410600 7410900         7686700 7686800       
    7411100 7411200         7904400 7904500       
    7411300 7411400         7907200 7907800       
    7411600 7411900         7907900 7908500       
    7412200 7413200         7908600 7909200       
    7413300 7413600         7909300 7909500       
    7414200 7414600         7909900 7910600       
    7414800 7415300         7912700 7913200       
    7415400 7415800         7915100 7915800       
    7415900 7416100         7916400 7917100       
    7416500 7417200         7917500 7918200       
    7417300 7417500         7919700 7919800       
    7417600 7417800         7920300 7920400       
    7418400 7418500         7922400 7923700       
    7418700 7419100         7924000 7924600       
    7419200 7419800         7924700 7925000       
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    7420100 7420700         7925200 7926000       
    7420900 7421500         7928000 7928300       
    7422000 7422100         8884700 8885000       
    7422200 7422300         9342200 9342300       
    7422500 7423400         9372000 9372100       
    7423500 7423600         9719800 9719900       
    7423800 7424000         10851400 10851500       
    7424100 7425200         11045500 11045700       
    7425400 7425800         11352100 11352200       
    7425900 7426000         11446800 11446900       
    7426100 7426200         12067600 12067700       
    7426400 7426800         12067900 12068000       
    7426900 7427200         12068100 12068200       
    7427500 7428700         12068300 12068500       
    7428800 7429100         12069300 12069400       
    7429700 7429900         12069800 12070000       
    7442600 7442600         12070400 12070900       
    7607300 7607500         12316800 12317000       
    7608000 7608100         12317100 12317800       
    7608200 7608500         12317900 12318000       
    7608700 7609200         12318600 12318700       
    7609300 7609600         12318900 12319200       
    7609700 7610300         12319700 12320000       
    7610400 7611100         12320100 12320200       
    7611200 7611300         12353300 12353500       
    7611800 7612100         12742100 12742400       
    7612500 7612600                   
    7612800 7614000                   
    7614500 7615100                   
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    7615800 7616200                   
    7616300 7616800                   
    7616900 7617000                   
    7617100 7617500                   
    7618500 7618800                   
    7618900 7619300                   
    7619500 7619700                   
    7620700 7621800                   
    7622100 7622200                   
    7623300 7623800                   
    7623900 7624500                   
    7624700 7625200                   
    7626200 7626400                   
    7626500 7626800                   
    7627100 7627300                   
    7628100 7629600                   
    7629800 7630100                   
    7630900 7631000                   
    7631100 7631500                   
    7631600 7632300                   
    7632400 7632900                   
    7633800 7634100                   
    7634200 7634600                   
    7634800 7635000                   
    7635100 7635500                   
    7636000 7637100                   
    7637400 7637500                   
    7637700 7637800                   
    7638700 7639100                   
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    7639300 7639800                   
    7640000 7640700                   
    7641500 7641700                   
    7641800 7642200                   
    7642400 7642600                   
    7643400 7644400                   
    7644500 7644800                   
    7645100 7645200                   
    7645300 7646000                   
    7646200 7646300                   
    7646400 7646700                   
    7646900 7647600                   
    7647700 7648200                   
    7649100 7649400                   
    7649500 7649700                   
    7651000 7651200                   
    7651300 7652400                   
    7652700 7652800                   
    7653000 7653100                   
    7654100 7654400                   
    7654600 7655100                   
    7655300 7655700                   
    7656800 7657000                   
    7657100 7657400                   
    7657700 7657900                   
    7658400 7658500                   
    7658700 7659200                   
    7659300 7660000                   
    7660400 7660600                   
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    7661700 7662000                   
    7662300 7662900                   
    7663000 7664000                   
    7664400 7664700                   
    7664800 7665100                   
    7665400 7665500                   
    7665600 7665700                   
    7666100 7666200                   
    7666300 7666500                   
    7666600 7666700                   
    7666800 7667600                   
    7668000 7668200                   
    7668400 7668500                   
    7668600 7668800                   
    7669300 7669500                   
    7686350 7674900                   
    7715100 7715200                   
    7762600 7762700                   
    7763600 7763700                   
    7789000 7789100                   
    7810100 7810200                   
    7904600 7904800                   
    7904900 7905200                   
    7905400 7905500                   
    7907200 7907600                   
    7907700 7907900                   
    7908600 7908700                   
    7909100 7909300                   
    7909400 7909500                   
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    7909600 7910000                   
    7911100 7911200                   
    7911300 7911500                   
    7911600 7912000                   
    7912100 7912600                   
    7912800 7913900                   
    7914100 7914300                   
    7914400 7915400                   
    7915700 7915800                   
    7916700 7917500                   
    7917900 7918200                   
    7918300 7918800                   
    7918900 7919500                   
    7920200 7920300                   
    7920500 7920900                   
    7921100 7921200                   
    7921400 7921500                   
    7921900 7923100                   
    7923900 7924100                   
    7924500 7924700                   
    7924800 7926300                   
    7926500 7927100                   
    7927300 7927900                   
    8573200 8573500                   
    8583900 8584100                   
    9372000 9372100                   
    9690400 9690500                   
    9765900 9766000                   
    11212400 11212500                   
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    12064900 12065000                   
    12065100 12065200                   
    12065300 12065400                   
    12067200 12067700                   
    12067900 12068000                   
    12068100 12068300                   
    12068400 12068500                   
    12068600 12068700                   
    12068800 12069300                   
    12069500 12069600                   
    12069800 12070000                   
    12070300 12070400                   
    12070700 12070900                   
    12071000 12071100                   
    12071500 12071600                   
    12072000 12072100                   
    12072200 12072400                   
    12267800 12267900                   
    12314000 12314100                   
    12314400 12314700                   
    12314800 12315000                   
    12315100 12315200                   
    12315800 12315900                   
    12316500 12316900                   
    12317200 12317300                   
    12317400 12317800                   
    12318200 12318600                   
    12318800 12318900                   
    12319000 12319100                   
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    12319200 12319300                   
    12319600 12319700                   
    12320000 12320200                   
    12320300 12320400                   
    12320800 12320900                   
    12321100 12321200                   
    12321500 12321600                   
 
